
<html lang="en"     class="pb-page"  data-request-id="214fd558-d7eb-42dd-91ed-4909989a0143"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm400221d;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors" /></meta><meta name="dc.Creator" content="Sevil  Ozcan" /></meta><meta name="dc.Creator" content="Aslamuzzaman  Kazi" /></meta><meta name="dc.Creator" content="Frank  Marsilio" /></meta><meta name="dc.Creator" content="Bin  Fang" /></meta><meta name="dc.Creator" content="Wayne C.  Guida" /></meta><meta name="dc.Creator" content="John  Koomen" /></meta><meta name="dc.Creator" content="Harshani R.  Lawrence" /></meta><meta name="dc.Creator" content="Saïd M.  Sebti" /></meta><meta name="dc.Description" content="Screening of the 50 000 ChemBridge compound library led to the identification of the oxadiazole-isopropylamide 1 (PI-1833) which inhibited chymotrypsin-like (CT-L) activity (IC50 = 0.60 μM) with li..." /></meta><meta name="Description" content="Screening of the 50 000 ChemBridge compound library led to the identification of the oxadiazole-isopropylamide 1 (PI-1833) which inhibited chymotrypsin-like (CT-L) activity (IC50 = 0.60 μM) with li..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 13, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400221d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400221d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400221d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400221d" /></link>
        
    
    

<title>Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400221d" /></meta><meta property="og:title" content="Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0017.jpeg" /></meta><meta property="og:description" content="Screening of the 50 000 ChemBridge compound library led to the identification of the oxadiazole-isopropylamide 1 (PI-1833) which inhibited chymotrypsin-like (CT-L) activity (IC50 = 0.60 μM) with little effects on the other two major proteasome proteolytic activities, trypsin-like (T-L) and postglutamyl-peptide-hydrolysis-like (PGPH-L). LC–MS/MS and dialysis show that 1 is a noncovalent and rapidly reversible CT-L inhibitor. Focused library synthesis provided 11ad (PI-1840) with CT-L activity (IC50 = 27 nM). Detailed SAR studies indicate that the amide moiety and the two phenyl rings are sensitive toward modifications. Hydrophobic residues, such as propyl or butyl in the para position (not ortho or meta) of the A-ring and a m-pyridyl group as B-ring, significantly improve activity. Compound 11ad (IC50 = 0.37 μM) is more potent than 1 (IC50 = 3.5 μM) at inhibiting CT-L activity in intact MDA-MB-468 human breast cancer cells and inhibiting their survival. The activity of 11ad warrants further preclinical investigation of this class as noncovalent proteasome inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400221d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400221d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400221d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400221d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400221d&amp;href=/doi/10.1021/jm400221d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 3783-3805</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301234k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301689x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sevil++Ozcan">Sevil Ozcan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aslamuzzaman++Kazi">Aslamuzzaman Kazi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Marsilio">Frank Marsilio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bin++Fang">Bin Fang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wayne+C.++Guida">Wayne C. Guida</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Koomen">John Koomen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harshani+R.++Lawrence">Harshani R. Lawrence</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sa%C3%AFd+M.++Sebti">Saïd M. Sebti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Drug Discovery Department, <sup>‡</sup>Molecular Oncology Department, <sup>§</sup>Chemical Biology Core, and <sup>∥</sup>Proteomics Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>⊥</sup>Department of Oncologic Sciences and <sup>¶</sup>Department of Chemistry, University of South Florida, Tampa, Florida 33620, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (813)-745-6076. Fax: (813)-745-6748. E-mail: <a href="/cdn-cgi/l/email-protection#521a3320213a333c3b7c1e332520373c3137123f3d34343b26267c3d2035"><span class="__cf_email__" data-cfemail="1c547d6e6f747d727532507d6b6e79727f795c71737a7a75686832736e7b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400221d&amp;href=/doi/10.1021%2Fjm400221d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 3783–3805</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 2, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 October 2012</li><li><span class="item_label"><b>Published</b> online</span>13 May 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400221d" title="DOI URL">https://doi.org/10.1021/jm400221d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3783%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSevil%2BOzcan%252C%2BAslamuzzaman%2BKazi%252C%2BFrank%2BMarsilio%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D10%26contentID%3Djm400221d%26title%3DOxadiazole-isopropylamides%2Bas%2BPotent%2Band%2BNoncovalent%2BProteasome%2BInhibitors%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3805%26publicationDate%3DMay%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400221d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3266</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400221d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sevil&quot;,&quot;last_name&quot;:&quot;Ozcan&quot;},{&quot;first_name&quot;:&quot;Aslamuzzaman&quot;,&quot;last_name&quot;:&quot;Kazi&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Marsilio&quot;},{&quot;first_name&quot;:&quot;Bin&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Wayne&quot;,&quot;last_name&quot;:&quot;C. Guida&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Koomen&quot;},{&quot;first_name&quot;:&quot;Harshani&quot;,&quot;last_name&quot;:&quot;R. Lawrence&quot;},{&quot;first_name&quot;:&quot;Saïd&quot;,&quot;last_name&quot;:&quot;M. Sebti&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;3783-3805&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400221d&quot;},&quot;abstract&quot;:&quot;Screening of the 50 000 ChemBridge compound library led to the identification of the oxadiazole-isopropylamide 1 (PI-1833) which inhibited chymotrypsin-like (CT-L) activity (IC50 = 0.60 μM) with little effects on the other two major proteasome proteolytic activities, trypsin-like (T-L) and postglutamyl-peptide-hydrolysis-like (PGPH-L). LC–MS/MS and dialysis show that 1 is a noncovalent and rapidly reversible CT-L inhibitor. Focused library synthesis provided 11ad (PI-1840) with CT-L activity (IC50 = 27 nM). Detailed SAR studies indicate that the amide moiety and the two phenyl rings are sensitive toward modifications. Hydrophobic residues, such as propyl or butyl in the para position (not ortho or meta) of the A-ring and a m-pyridyl group as B-ring, significantly improve activity. Compound 11ad (IC50 = 0.37 μM) is more potent than 1 (IC50 = 3.5 μM) at inhibiting CT-L activity in intact MDA-MB-468 human breast cancer cells and inhibiting their survival. The activity of 11ad warrants further preclinical investi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400221d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400221d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400221d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400221d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400221d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400221d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400221d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400221d&amp;href=/doi/10.1021/jm400221d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400221d" /></input><a href="/doi/pdf/10.1021/jm400221d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400221d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400221d%26sid%3Dliteratum%253Aachs%26pmid%3D23547706%26genre%3Darticle%26aulast%3DOzcan%26date%3D2013%26atitle%3DOxadiazole-isopropylamides%2Bas%2BPotent%2Band%2BNoncovalent%2BProteasome%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D10%26spage%3D3783%26epage%3D3805%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jmcmar.2013.56.issue-10/production/jmcmar.2013.56.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Screening of the 50 000 ChemBridge compound library led to the identification of the oxadiazole-isopropylamide <b>1</b> (PI-1833) which inhibited chymotrypsin-like (CT-L) activity (IC<sub>50</sub> = 0.60 μM) with little effects on the other two major proteasome proteolytic activities, trypsin-like (T-L) and postglutamyl-peptide-hydrolysis-like (PGPH-L). LC–MS/MS and dialysis show that <b>1</b> is a noncovalent and rapidly reversible CT-L inhibitor. Focused library synthesis provided <b>11ad</b> (PI-1840) with CT-L activity (IC<sub>50</sub> = 27 nM). Detailed SAR studies indicate that the amide moiety and the two phenyl rings are sensitive toward modifications. Hydrophobic residues, such as propyl or butyl in the para position (not ortho or meta) of the A-ring and a <i>m</i>-pyridyl group as B-ring, significantly improve activity. Compound <b>11ad</b> (IC<sub>50</sub> = 0.37 μM) is more potent than <b>1</b> (IC<sub>50</sub> = 3.5 μM) at inhibiting CT-L activity in intact MDA-MB-468 human breast cancer cells and inhibiting their survival. The activity of <b>11ad</b> warrants further preclinical investigation of this class as noncovalent proteasome inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The ATP-dependent ubiquitin–proteasome pathway is responsible for the controlled degradation of proteins in eukaryotic cells.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1-6)</a> The 26S proteasome is a multifunctional complex consisting of a 19S regulatory particle (RP) and a 20S core particle (CP).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The three main catalytic activities of the proteasome, peptidylglutamyl-peptide-hydrolyzing-like (PGPH-L), trypsin-like (T-L), and chymotrypsin-like (CT-L), are mediated by three distinct catalytic β-1, β-2, and β-5 subunits, respectively.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> For each of the catalytic β-subunits, the <i>N</i>-terminal Thr-1 serves as the nucleophile that initiates cleavage of the peptide bond.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Development of inhibitors of CT-L activity has been the subject of considerable interest in the treatment of cancer because of its critical role in the degradation of apoptotic and tumor suppressor proteins.<a onclick="showRef(event, 'ref8 ref10 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref10 ref12">(8, 10, 12)</a> The proteasome inhibitors advanced to clinic or clinical trials are derived from three structural classes (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A): (1) boronic acid containing compounds such as bortezomib, a dipeptide boronic acid (clinically approved by FDA),<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> MLN9708,<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> and CEP-18770<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18-21)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A); (2) β-lactones such as salinosporamide A (NPI-0052)<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> which is a marine microbial natural product (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A); (3) epoxy ketone containing tetrapeptide carfilzomib<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A), clinically approved by FDA which is related to the natural product epoxomicin. Each inhibitor class reacts with the proteasome <i>N</i>-terminal threonine (Thr-1 at the active site) by a distinct mechanism. Peptide boronic acids form covalent and slowly reversible tetrahedral adducts with the OH group of the catalytic Thr-1.<a onclick="showRef(event, 'ref11 ref25'); return false;" href="javascript:void(0);" class="ref ref11 ref25">(11, 25)</a> For the β-lactone salinosporamide A, attack of the lactone ring by catalytic Thr-1<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> forms an ester bond (that undergoes intramolecular rearrangement) which makes this compound an irreversible inhibitor. The epoxy ketone<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> moiety of carfilzomib reacts with the OH and the α-amino group of Thr-1 to form two covalent bonds, also making the inhibition irreversible.</div><div class="NLM_p">Covalent proteasome inhibitors are classified as slow reversible or irreversible inhibitors according to their chemical structures and mechanisms of inhibition. Covalent irreversible or covalent slow reversible inhibitors as described above possess a chemically reactive group that bind to the proteasome covalently. In contrast, noncovalent inhibitors inhibit the proteasome through a network of interactions (hydrophobic, hydrogen bonds, electrostatic, and/or van der Waals). Although some proteasome inhibitors have been suggested to bind noncovalently,<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34">(27-34)</a> structural evidence to support this was provided for only three of these. The X-ray structures of TMC-95A,<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> hydroxylurea<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B), and the peptide<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> from Millenium (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) bound to proteasome demonstrate that the binding modes of these compounds are noncovalent.</div><div class="NLM_p">Since noncovalent inhibitors do not have a reactive electrophilic moiety or “warhead”, which is often associated with metabolic instability, poor specificity, and excessive reactivity, they have the advantage of exerting fewer side effects over the covalent ones. It has been shown that the proteasome activity recovers at the same rate with covalent irreversible inhibitors as with covalent slow reversible inhibitors, presumably via de novo proteasome synthesis.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The clinical advantages/benefits of noncovalent proteasome inhibitors in cancer treatment are not well understood. Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B shows the structures of small molecules that have been identified as noncovalent proteasome inhibitors.<a onclick="showRef(event, 'ref11 ref38'); return false;" href="javascript:void(0);" class="ref ref11 ref38">(11, 38)</a> We have been actively engaged in the discovery of novel proteasome inhibitors.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> We reported the discovery of compound <b>1</b> as a proteasome inhibitor in a poster at the 2011 American Association for Cancer Research (AACR) meeting.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Villoutreix et al. also have reported oxadiazole-isopropylamide containing compounds as proteasome modulators.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Although Villoutreix et al. and our group have independently identified similar scaffolds, each group focused on different modifications of the hits that led to important findings that are complementary but not overlapping. In our study, we have extensively explored SAR (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) on the oxadiazole-isopropylamide containing compounds as proteasome inhibitors by systematically synthesizing focused libraries around key features of the pharmacophore. We present compound <b>1</b> and its most potent analogues as nonpeptidic, noncovalent, and reversible proteasome inhibitors that have the potential to become clinical candidates.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structures of clinically advanced covalent proteasome inhibitors. (B) Structures of noncovalent small molecule proteasome inhibitors: hydroxyurea pharmacophore<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and peptidic pharmacophore from Millennium.<a onclick="showRef(event, 'ref11 ref45'); return false;" href="javascript:void(0);" class="ref ref11 ref45">(11, 45)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The screening hit <b>1</b> was identified as a CT-L proteasome inhibitor with an IC<sub>50</sub> value of 0.60 ± 0.18 μM (in vitro). Validation of the synthetic route to <b>1</b> was undertaken to confirm both the structure and the in vitro CT-L inhibitory activity. Synthesis of <b>1</b> was achieved using the route shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The substituted acetyl chloride building block library <b>5</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was synthesized from readily available phenol derivatives via the ester <b>3</b> and acid <b>4</b> using reported protocols.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49 ref50">(46-50)</a> The oxadiazole portion of compound <b>1</b> was synthesized from readily available nitrile building blocks <b>6</b>. The nitrile building blocks were reacted with hydroxylamine hydrochloride and sodium carbonate at 70 °C in water to yield the hydroxyamidines<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a><b>7</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, condition g). The 5-substituted pyrimidinehydroxyamidine <b>7h</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) was synthesized starting from the commercially available methyl pyrimidine-5-carboxylate via amide <b>24</b> and nitrile <b>25</b>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The intermediate hydroxyamidine library <b>7</b> was reacted with chloroacetyl chloride (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, condition h) to provide the library <b>8</b>,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> which was cyclized in refluxing toluene to provide the oxadiazole portion of the pharmacophore <b>9</b>. The library <b>9</b> was subsequently reacted with appropriate alkylamines (isopropyl-, isobutyl-, methyl-. ethyl-, cyclopropyl-, and <i>tert</i>-butylamines) to obtain the amine building block library <b>10</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, condition j). For the synthesis of <b>10n</b> (R<sup>3</sup> = H), compound <b>9a</b> (R<sup>2</sup> = <i>p</i>-tolyl, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> compound <b>26</b>) was first reacted with phthalimide in the presence of potassium carbonate in refluxing acetonitrile, followed by reaction with hydrazine to obtain compound <b>10n</b> in high yield.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> We were able to generate library <b>10</b> with a variety of substituted aryl and heteroaryl R<sup>2</sup> moieties and library <b>5</b> with substituted/unsubstituted aromatic R<sup>1</sup> moieties (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Modifications around <b>1</b> for library synthesis are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, and initially we focused our synthetic efforts to modify R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> moieties. The two key building block libraries <b>10</b> and <b>5</b> were then reacted in the presence of triethylamine to provide compound <b>1</b> and libraries <b>11</b> and <b>12</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) in good yields. The route described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was efficient and convenient for rapid synthesis and optimization of the substituted phenyl and amide moieties. The final libraries <b>11</b> and <b>12</b> and compound <b>1</b> were characterized using NMR, LC–MS, and HRMS, and the purity was >95% as determined by HPLC. The final compound libraries <b>11</b> and <b>12</b> (including compound <b>1</b>) showed formation of approximately 3:1 atropisomers (hindered rotation about the C–N amide bond) by <sup>1</sup>H NMR and <sup>13</sup>C NMR spectroscopy (see the section <a class="ref internalNav" href="#sec6" aria-label="Syntheses">Syntheses</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Analysis of <sup>1</sup>H NMR spectra of compound <b>1</b> at variable temperatures (20–50 °C) showed that the peaks from the minor rotamer coalesced with the major rotamer as the temperature increased.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modifications and library synthesis around <b>1</b> for design of new proteasome inhibitors and SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Compound <b>1</b> and Libraries <b>11</b> and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl bromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 14 h; (b) <i>tert</i>-butyl bromoacetate, DMF, 80 °C, 14 h; (c) ethyl bromoacetate, K<sub>2</sub>CO<sub>3,</sub> DMF, rt, 14 h; (d) NaOH, THF, reflux, 2 h (R = ethyl); (e) CF<sub>3</sub>COOH, DCM, rt, 2 h (R = <sup><i>t</i></sup>Bu); (f) SOCl<sub>2</sub>, benzene, reflux, 3 h; (g) NH<sub>2</sub>OH.HCl, Na<sub>2</sub>CO<sub>3,</sub> water, 70 °C, 14 h; (h) chloroacetyl chloride, acetone, rt, 30 min; (i) toluene, reflux, 2 h; (j) alkylamine, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 30 min; (k) Et<sub>3</sub>N, THF, rt, 15 min.</p></p></figure><div class="NLM_p">Next, we focused our efforts to modify the chemical space between the amide moiety, A and B rings (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) in compound <b>1</b>. First, we introduced a urea moiety to assess the SAR. To install the urea moiety, the intermediate <b>10d</b> was reacted with commercially available isocyanate <b>13</b> in the presence of triethylamine in refluxing benzene, and under these conditions urea <b>14</b> was obtained in good yield (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, condition l). Further modifications included replacement of the ether moiety (H-bond acceptor) in <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) with an NH (H-bond acceptor/donor) group. The amine <b>10d</b> was first reacted with chloroacetyl chloride in the presence of triethylamine in THF at room temperature to obtain intermediate <b>15</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) followed by coupling <b>15</b> with <i>p</i>-methylaniline using sodium acetate in refluxing ethanol to obtain the final compound <b>16</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, conditions m and n, respectively) also in good yield. The ether moiety in <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) was also replaced by a methylene unit using 3-(4-(trifluoromethyl)phenyl)propanoic acid building block (<b>17a</b>). The acid starting material <b>17a</b> was converted to the corresponding acid chloride <b>18a</b> and coupled with <b>10d</b> to provide the oxadiazole <b>19a</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The final compound <b>19b</b> with bulky R groups was synthesized following the route in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> starting from benzofuran-2-carboxylic acid (<b>17b</b>) via the formation of acid chloride <b>18b</b> and subsequent coupling with <b>10f</b>. The intermediate <b>10d</b> was chosen for synthesis of compounds <b>14</b>, <b>16</b>, and <b>19a</b>, since our early SAR indicated unsubstituted B ring is desirable to retain in vitro CT-L potency together with <i>p</i>-CH<sub>3</sub> group on the A ring and the isopropyl moiety in the amide group. Extension of the linker between the oxadiazole moiety and amide group in <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) by one carbon atom was achieved by first reacting the intermediate <b>7d</b> with 3-chloropropanoyl chloride to generate intermediate <b>20</b> which provided <b>21</b> upon refluxing in toluene. The intermediate <b>21</b> was next reacted with isopropylamine to obtain <b>22</b>, which was further reacted with intermediate <b>5a</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) to obtain the final compound <b>23</b> in good yield. The intermediates and final compounds were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, LC–MS; the purity of final compounds was determined using HPLC.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (l) Et<sub>3</sub>N, benzene, reflux, 14 h, 78%; (m) chloroacetyl chloride, Et<sub>3</sub>N, THF, rt, 15 min, 80%; (n) <i>p</i>-methylaniline, NaOAc, ethanol, reflux, 15 h, 78%; (f) SOCl<sub>2</sub>, benzene, reflux, 3 h, 94%; (k) Et<sub>3</sub>N, THF, rt, 15 min, 88% (<b>19a</b>), 82% (<b>19b</b>), 87%, (<b>23</b>); (o) DCM, rt, 14 h, 76%; (i) toluene, reflux, 2 h, 81%; (j) isopropylamine, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 30 min, 86%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Unlike Lactacystin, <b>1</b> is a Noncovalent and Reversible CT-L Inhibitor</h3><div class="NLM_p">To determine whether our hit compound <b>1</b> is a noncovalent CT-L inhibitor, we used two approaches, liquid chromatography–tandem mass spectrometry (LC–MS/MS) and dialysis. With both approaches we used lactacystin, a known covalent and irreversible CT-L inhibitor as a control.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> For LC–MS/MS, <b>1</b> or lactacystin was incubated with the 20S proteasome and digested with trypsin and the resulting peptides were purified by HPLC and analyzed by LC–MS/MS as described under <a class="ref internalNav" href="#sec5" aria-label="Materials and Methods">Materials and Methods</a>. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A shows that peptides purified from the vehicle-treated samples contained unmodified TTTLAFK peptide (observed as a protonated molecule at <i>m</i>/<i>z</i> 781.4401) corresponding to the <i>N</i>-terminal tryptic peptide of rabbit proteasome subunit β type-5. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B shows that peptides purified from compound <b>1</b> treated samples also contained the unmodified Thr-1 containing TTTLAFK peptide (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D). Both intact mass spectrum and tandem mass spectrum indicate unmodified Thr-1 containing peptide. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C shows that lactacystin-treated samples contained a lactacystin-modified threonine adduct corresponding to the doubly charged modified peptide at <i>m</i>/<i>z</i> 497.7795 (structure shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>E). The searches matching experimental data to peptides, from the database of rabbit proteasome subunits, produced only one modified peptide, which indicated that Thr-1 on β-5 was modified by lactacystin. No other modifications to β-5 subunit from samples treated with DMSO, compound <b>1</b>, or lactacystin were observed. In addition, no modifications were detected for other proteasome subunits, such as β-1 and β-2 subunits included in the database (<i>n</i> = 22). These results suggest that, unlike lactacystin, <b>1</b> does not bind covalently to the proteasome.</div><div class="NLM_p">To confirm these results, we incubated <b>1</b> and lactacystin with the 20S proteasome and determined the reversibility of binding by dialysis as described under <a class="ref internalNav" href="#sec5" aria-label="Materials and Methods">Materials and Methods</a>. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows that more than 70% of the CT-L activity in the dialysis compartment from the sample that was treated with <b>1</b> was recovered within the first 20 min and recovered fully by 2 h of dialysis. In contrast, very little CT-L activity was recovered from the sample that was treated with lactacystin even after 18 h of dialysis (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Taken together, these results confirm the well established fact that lactacystin is a covalent and irreversible CT-L inhibitor and indicate that <b>1</b> is a noncovalent and reversible CT-L inhibitor. This is consistent with the chemical structure of <b>1</b> that lacks any reactive groups, unlike <i>clasto</i>-lactacystin that contains the reactive β-lactone moiety. The β-lactone moiety of the <i>clasto</i>-lactacystin covalently modifies the β-subunits of the proteasome and is responsible for inhibiting 20S proteasome in an irreversible mode of action.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) LC–MS/MS analysis of tryptic digests from proteasome CT-L subunit after incubation with vehicle. LC–MS/MS analysis of Thr-1 containing peptide from the proteasome CT-L subunit β5 after tryptic digestion is shown. Singly charged unmodified peptide was observed at <i>m</i>/<i>z</i> 781.4401, which represents a mass error of 6.9 ppm. The tandem mass spectrum was matched to peptide TTTLAFK. The b ions (labeled in red) contain the N-terminus of the peptide, and y ions (labeled in blue) contain the C-terminus of the peptide. The number associated with each ion indicates the number of amino acids in that fragment (for example, y4 contains LAFK from C-terminus of the peptide). (B) LC–MS/MS analysis of tryptic digests from proteasome CT-L subunit after incubation with compound <b>1</b>. The Thr-1 containing peptide did not show any modification. Both intact mass spectrum and tandem mass spectrum indicate unmodified Thr-1 containing peptide. (C) LC–MS/MS analysis of tryptic digests from proteasome CT-L subunit after incubation with lactacystin shows <i>clasto</i>-lactacystin-modified Thr-1 containing peptide. Doubly charged lactacystin-Thr modified peptide was detected at <i>m</i>/<i>z</i> 497.7795, which represents a mass error 6.1 ppm. The tandem mass spectrum confirms the modification of the peptide by lactacystin. (D) Structure of the unmodified TTTLAFK tryptic peptide. (E) Structure of the <i>clasto</i>-lactacystin modified peptide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Recovery of CT-L activity upon dialysis of the 20S proteasome–compound complexes after preincubation with lead <b>1</b> and lactacystin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Structure–Activity Relationship Studies and Chemistry Leading to Compound <b>11ad</b></h3><div class="NLM_p">Our screening efforts of the 50 000 in-house ChemBridge compound library led to the discovery of the hit <b>1</b>, an inhibitor of the CT-L activity of the proteasome. After confirming the structure and in vitro CT-L activity of the in-house synthesized <b>1</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), we embarked on synthetic modifications to develop structure–activity relationship (SAR) data to identify novel, potent, and selective CT-L proteasome inhibitors that block the action of the proteasome in a noncovalent manner. Proteasome CT-L activity was measured using a fluorogenic assay as previously described.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Focused library synthesis was undertaken by independently varying the R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> groups in compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Initially, we replaced the isopropyl R<sup>3</sup> group in <b>1</b> with H, isobutyl, ethyl, methyl, <i>tert</i>-butyl, and cyclopropyl moieties (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The loss of CT-L activities of these analogues indicated that the isopropyl group is essential and optimal for proteasome inhibitory activity (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The isobutylamide <b>12a</b> and ethylamide <b>12b</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, entries 2 and 3) showed 4- to 10-fold loss of activity with IC<sub>50</sub> values of 2.37 and 6.02 μM, respectively, compared to <b>1</b>. Methyl, H, <i>tert</i>-butyl, and cyclopropyl as R<sup>3</sup> groups were detrimental for CT-L activity (<b>12c</b>, <b>12d</b>, <b>12e</b>, <b>12f</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> showed weak or no proteasome inhibition at 10 μM). The <sup>1</sup>H and <sup>13</sup>C NMR spectra of the compound <b>1</b> with the isopropylamide group indicated the presence of a mixture of 3:1 atropisomers (isomers that exist because of the hindered rotation about the carbon–nitrogen bond). We observed a similar ratio of atropisomers with <b>12b</b> (R<sup>3</sup> = ethyl) and <b>12c</b> (R<sup>3</sup> = methyl) by analysis of <sup>1</sup>H and <sup>13</sup>C NMR spectra. Compound <b>12d</b> with unsubstituted amide (entry 5, R<sup>3</sup> = H, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), compound <b>12e</b> with bulky <i>tert</i>-butyl group (entry 6, R<sup>3</sup> = <sup><i>t</i></sup>Bu, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and compound <b>12f</b> with cyclopropyl group (entry 7, R<sup>3</sup> = cyclopropyl) did not show any atropisomers by <sup>1</sup>H or <sup>13</sup>C NMR spectra.</div><div class="NLM_p">In the next generation of synthetic analogues, we retained the isopropyl R<sup>3</sup> group (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and modified the phenyl rings in <b>1</b> [i.e., library <b>11</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>)]. Initial SAR studies demonstrated that substitutions at the para position of the R<sup>1</sup> and R<sup>2</sup> with small hydrophobic groups are tolerable. For example, changing the <i>p</i>-methyl in R<sup>1</sup> and R<sup>2</sup> to trifluoromethyl or chlorine as in compounds <b>11a</b>, <b>11c</b>, <b>11d</b>, <b>11e</b>, <b>11f</b>, <b>11g</b>, <b>11i</b>, and <b>11n</b> retained the in vitro CT-L inhibitory activities (entries 14, 16–20, 22, 27, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Next we demonstrated that the R<sup>1</sup> methyl is required whereas the R<sup>2</sup> methyl is dispensable. Indeed, compounds <b>11b</b>, <b>11h</b>, and <b>11m</b> (entries 15, 21, and 26, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) with an unsubstituted phenyl ring as R<sup>2</sup> showed slightly improved IC<sub>50</sub> values around 0.3–0.5 μM, indicating that para substitution of R<sup>2</sup> phenyl in <b>1</b> is not required for inhibitory activity. However, compound <b>11j</b> with both unsustituted phenyl rings resulted in a 10-fold loss of CT-L activity (entry 23, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, IC<sub>50</sub> = 6.22 μM). Removal of the R<sup>1</sup><i>p</i>-methyl group as in compounds <b>11k</b> and <b>11l</b> (entries 24 and 25, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) also led to 14- and 18-fold loss of activity with IC<sub>50</sub> values of 8.5 and 11 μM, respectively. The loss of in vitro potency of compounds <b>11j</b>, <b>11k</b>, and <b>11l</b> suggest that para substitution in the R<sup>1</sup> phenyl ring is critical to maintain CT-L proteasome activity. Changing the R<sup>1</sup><i>p</i>-methyl to meta or ortho positions as in compounds <b>11o</b> and <b>11p</b> (entries 28 and 29, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) was detrimental for in vitro potency, further suggesting that R<sup>1</sup> para substitution is important for CT-L proteasome activity. Overall our SAR indicated that the <i>p</i>-methyl group in R<sup>1</sup> but not in R<sup>2</sup> and the R<sup>3</sup> isopropylamide are key features that are responsible for retaining the CT-L proteasome activity of compound <b>1</b> and loss of activity was consistent with unsubstituted R<sup>1</sup> aromatic rings in this class of compounds.</div><div class="NLM_p">We next modified the chemical space between the amide moiety and R<sup>1</sup>/R<sup>2</sup> in the parent compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) using the synthetic routes and protocols described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> (also see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). First, replacement of the ether oxygen by methylene showed significant loss of CT-L activity (<b>19a</b>, IC<sub>50</sub> = 53.48 μM, entry 8, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Furthermore, substituting the amide group by urea as in <b>14</b> (entry 9, IC<sub>50</sub> > 10 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) also led to loss of activity. Replacement of the ether (H-bond acceptor) with NH (H-bond donor/acceptor) also decreased the in vitro CT-L activity (<b>16</b>, IC<sub>50</sub> = 5.67 μM, entry 10, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These modifications confirmed that the ether moiety, most likely as H-bond acceptor, is critical for focused library synthesis and improving the CT-L inhibitory activity. Extending the spacer between the amide and the oxadiazole by one carbon as shown in <b>23</b> (entry 11, IC<sub>50</sub> > 10 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) was detrimental for CT-L inhibitory activity, probably because of the increased flexibility of the molecule. Compound <b>19b</b> (IC<sub>50</sub> = 0.37 μM, entry 12, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), a bulky R<sup>1</sup> substituent with a rigid ether moiety and <i>m</i>-pyridyl as R<sup>2</sup>, showed improved inhibitory activity compared to <b>1</b> (pyridyl moiety was chosen for the synthesis of <b>19b</b>, based on the most potent analogues described in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Overall, synthetic modifications of the linkers between R<sup>1</sup>, R<sup>2</sup> and the amide moiety in <b>1</b> were not tolerated.</div><div class="NLM_p">To gain more insight in the interactions between R<sup>1</sup> and the binding region, we modified the R<sup>1</sup> via several synthetic modifications. For example, synthesis of <b>11q</b> and <b>11r</b> that possessed large hydrophobic groups such as phenyl and Br-naphthyl as para-R<sup>1</sup> groups, respectively, further revealed that large hydrophobic groups are not tolerated in the binding region (entries 30, 31, IC<sub>50</sub> > 10 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Replacement of the R<sup>1</sup> methyl group in compound <b>1</b> by small hydrophobic fluorine as in <b>11s</b> (entry 32, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) also displayed poor CT-L inhibitory activity. The 16-fold loss of CT-L inhibitory activity in compound <b>11s</b> with <i>p</i>-fluorine compared to <b>11b</b> with <i>p</i>-CF<sub>3</sub> (entry 15, IC<sub>50</sub> = 0.43 μM) was not unexpected, since fluorine is isosteric to hydrogen<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and as described above, we have already observed the detrimental effects of unsubstituted R<sup>1</sup> rings in compounds <b>11k</b>, <b>11l</b>, and <b>11ac</b> (entries 24, 25, and 42, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) toward the CT-L inhibitory activity. The hydrophilic COOH, COO<sup><i>t</i></sup>Bu, and OH groups at the para position of the R<sup>1</sup> as in compounds <b>11t</b>, <b>11aq</b>, and <b>11v</b>, respectively, also failed to maintain the CT-L inhibitory activity (entries 33, 56, and 35, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), indicating that H-bond acceptor/donor moieties are not desirable. In contrast, compound <b>11u</b> (entry 34, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) with <i>p</i>-hydroxyphenyl as R<sup>1</sup> and <i>m</i>-pyridyl as R<sup>2</sup> showed an IC<sub>50</sub> of 1 μM, and comparison of in vitro CT-L activities of <b>11u</b> and <b>11v</b> (entries 34 and 35, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) with <i>p</i>-hydoxyphenyl as R<sup>1</sup> highlights the significance of the R<sup>2</sup><i>m</i>-pyridyl group toward CT-L activity in this class of compounds.</div><div class="NLM_p">We next made two major observations that led us to our most potent compounds. First, we demonstrated that increasing the alkyl length from methyl in <b>1</b> to a propyl as in <b>11ap</b> (IC<sub>50</sub> = 0.27 μM) increased potency (entry 55, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Second, replacing the tolyl R<sup>2</sup> in <b>1</b> by a <i>m</i>-pyridyl (as in <b>11x</b>, entry 37, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) or <i>p</i>-pyridyl (as in <b>11y</b>, entry 38, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) but not <i>o</i>-pyridyl (as in <b>11w</b>, entry 36, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) improved potency with the <i>m</i>-pyridyl (IC<sub>50</sub> = 0.22 μM, entry 37, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) being slightly better than the <i>p</i>-pyridyl (IC<sub>50</sub> = 0.37 μM, entry 38, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Substituting both the R<sup>1</sup> methyl with a propyl and the R<sup>2</sup> tolyl with a <i>m</i>-pyridyl as in <b>11ad</b> (combined features of compounds <b>11ap</b> and <b>11x</b>) resulted in our most potent compound with an IC<sub>50</sub> of 27 nM. Furthermore, the length of the alkyl group at the para position of the R<sup>1</sup>-ring is critical with the propyl or butyl groups being the optimal size. Indeed, decreasing the size from propyl (or butyl) to ethyl, methyl, and hydrogen as in <b>11ab</b>, <b>11x</b>, and <b>11ac</b> resulted in progressive loss of inhibitory activity from 27 to 99, 220, and 2710 nM, respectively. Increasing the size of the R<sup>1</sup> para hydrophobic moiety also resulted in progressive loss of potency from propyl or butyl to pentyl, hexyl, isobutyl, isopropyl, cyclohexyl, and <i>tert</i>-butyl as in <b>11af</b> (IC<sub>50</sub> = 120 nM, entry 45, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), <b>11ag</b> (IC<sub>50</sub> = 430 nM, entry 46, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), <b>11ak</b> (IC<sub>50</sub> = 140 nM, entry 50, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), <b>11ai</b> (IC<sub>50</sub> = 440 nM, entry 48, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), <b>11ah</b> (IC<sub>50</sub> = 1356 nM, entry 47, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), and <b>11aj</b> (IC<sub>50</sub> = 46.49 μM, entry 49, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), respectively. Furthermore, substituting the pyridyl in <b>11ad</b> with 5-substituted pyrimidine as in <b>11al</b> did not alter the potency (IC<sub>50</sub> = 32 nM), which further supports the importance of a meta-positioned nitrogen atom in the ring. In contrast, substituting the pyridyl in <b>11ad</b> by 2-substituted pyrazine as in <b>11am</b> (entry 52, IC<sub>50</sub> = 105 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) with one meta-positioned nitrogen or 2-substituted pyrazine as in <b>11ao</b> (entry 54, IC<sub>50</sub> = 1269 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), which possesses two ortho-positioned nitrogen atoms, led to 3-fold and 40-fold loss of CT-L activity, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), further highlighting the importance of the nitrogen in the meta-position of the ring. Compounds <b>11am</b> and <b>11an</b> that show CT-L inhibitory activities with IC<sub>50</sub> values of about 100 nM also demonstrate that propyl or butyl at the para position of the R<sup>1</sup> is equally tolerated in the binding region. Interestingly, compounds <b>11ar</b> and <b>11as</b> with hydrophobic, electron withdrawing fluorine and chlorine at the para position of the R<sup>1</sup> and <i>m</i>-pyridyl as R<sup>2</sup> (entries 57 and 58, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) showed 3- and 5-fold improvement in inhibitory activities, respectively, compared to its related analogues <b>11s</b> (entry 32, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) and <b>11h</b> (entry 21, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Overall, our detailed SAR studies signify the importance of <i>m</i>-pyridyl, isopropylamide, and <i>p</i>-propyl/<i>p</i>-butylphenyl groups in the oxadiazole pharmacophore shown in <b>1</b> for inhibition of CT-L activity of the proteasome.</div><div class="NLM_p">The parent compounds <b>1</b> and <b>11ad</b> were further evaluated for T-L and PGPH-L activities of the proteasome as shown in the Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The in vitro data (IC<sub>50</sub>) indicated that this class of compounds shows excellent selectivity for CT-L inhibitory activity over both T-L and PGPH-L activities. This level of CT-L selectivity is impressive for a nonpeptidic, small molecule compared to the covalent proteasome inhibitors reported to date. Only a small number of compound classes have been reported with this level of activity.<a onclick="showRef(event, 'ref11 ref38'); return false;" href="javascript:void(0);" class="ref ref11 ref38">(11, 38)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Synthetic analogues of Library <b>12</b> and SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM) CT-L<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.18(<i>n</i> = 27)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">2.37 ± 0.40(<i>n</i> = 2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">6.04 ± 1.34(<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">29.90 ± 3.9(<i>n</i> = 2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">no inhibition at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left"><i>tert</i>-butyl</td><td class="colsep0 rowsep0" align="left">no inhibition at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">no inhibition at 10 μM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are given as the average of two or more determinations. <i>n</i> = number of determinations.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Modifications of the Spacer between the Amide, R<sup>1</sup> and R<sup>2</sup> Groups, and SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0009.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0010.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values are given as the average of two or more determinations. <i>n</i> = number of determinations.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Compound <b>1</b> and Synthetic Analogues of Library <b>11</b> and SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0011.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0012.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0013.gif" alt="" id="GRAPHIC-d7e1997-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0014.gif" alt="" id="GRAPHIC-d7e1998-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values are given as the average of two or more determinations. <i>n</i> = number of determinations.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. IC<sub>50</sub> Values of <b>1</b> and <b>11ad</b> for CT-L, T-L, and PGPH-L Activities of the Proteasome</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">CT-L</th><th class="colsep0 rowsep0" align="center">T-L</th><th class="colsep0 rowsep0" align="center">PGPH-L</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.60 ± 0.18(<i>n</i> = 27)</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11ad</b></td><td class="colsep0 rowsep0" align="left">0.027 ± 0.014(<i>n</i> = 20)</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The values given are the mean of three experiments. <i>n</i> = number of determinations.</p></div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Lead Compound <b>11ad</b> Is More Potent than the Parent Compound <b>1</b> at Inhibiting CT-L Activity and Survival/Proliferation of Intact Human Breast Cancer Cells</h3><div class="NLM_p">Our in vitro SAR studies demonstrated that substituting the methyl of ring A with a propyl and replacing ring B tolyl with <i>m</i>-pyridine in <b>1</b> (IC<sub>50</sub> = 600 nM) led to 22 fold more potent <b>11ad</b> (IC<sub>50</sub> = 27 nM). To determine whether these CT-L proteasome inhibitors are cell permeable and inhibit CT-L activity in intact cells, human breast cancer MDA-MB-468 cells were treated with increasing concentrations of <b>1</b> or <b>11ad</b> for 2 h and the cells were processed for CT-L activity,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> determined as described under <a class="ref internalNav" href="#sec5" aria-label="Materials and Methods">Materials and Methods</a>. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A shows that <b>1</b> inhibited CT-L activity in a dose dependent manner with an IC<sub>50</sub> of 3.5 μM. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A also shows that consistent with the in vitro results, <b>11ad</b> was more potent than the parent compound <b>1</b> and inhibited the CT-L activity with an IC<sub>50</sub> of 0.37 μM. We next determined whether compounds <b>1</b> and <b>11ad</b> are capable of inhibiting tumor cell survival/proliferation. To this end, MDA-MB-468 cells were treated with parent compounds <b>1</b> and <b>11ad</b> and processed for MTT assay as described under <a class="ref internalNav" href="#sec5" aria-label="Materials and Methods">Materials and Methods</a>. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B shows that treatment with both compounds inhibited survival/proliferation but that <b>11ad</b> was more potent than the parent compound <b>1</b>.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Lead <b>11ad</b> is more potent at inhibiting proteasomal CT-L activity in intact human MDA-MB-468 cancer cells compared to the parent compound <b>1</b>. (B) Lead <b>11ad</b> is more potent at inhibiting proliferation/survival of human MDA-MB-468 cells compared to the parent hit <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study we have extensively explored the SAR of oxadiazole-isopropylamide containing analogues as noncovalent CT-L proteasome inhibitors. The structure of the hit <b>1</b> (IC<sub>50</sub> = 0.60 ± 0.18 μM) served as a starting point for synthetic modifications and design and synthesis of novel, highly potent, and noncovalent proteasome inhibitors. The LC–MS/MS and dialysis experiments confirmed that <b>1</b> binds to CT-L β-5 subunit of the proteasome in a noncovalent and rapidly reversible binding mode. Compound <b>11ad</b> with an IC<sub>50</sub> of 27 nM was identified as one of the most potent and cell permeable proteasome inhibitors. Our detailed SAR analysis indicated that extending the R<sup>1</sup> methyl in <b>1</b> to an optimal size with propyl or butyl in combination with <i>m</i>-pyridyl as R<sup>2</sup> significantly improves the CT-L proteasome inhibitory activity (<b>11ad</b> and <b>11ae</b>, IC<sub>50</sub> of 27 and 39 nM, respectively). The isopropylamide and the ether moieties in <b>1</b> are critical for inhibitory activity, and modification of these moieties substantially reduced the CT-L inhibitory activity. The SAR demonstrated the importance of the length and composition of the linking chain between the amide moiety, R<sup>1</sup> and R<sup>2</sup> groups. The potent lead <b>11ad</b> demonstrated efficacy in cellular assays and showed antiproliferative activity at low micromolar concentrations. Our in vitro data also highlighted that this class of compounds shows high level of selectivity for CT-L proteasome inhibition over T-L and PGPH-L activities. Moreover, activities observed for some of the other analogues presented herein (such as <b>11al</b> [IC<sub>50</sub> = 32 nM], <b>11am</b> [IC<sub>50</sub> = 105 nM], and <b>11an</b> [IC<sub>50</sub> = 107 nM]) could also be optimized in the development of novel noncovalent CT-L proteasome inhibitors.</div></div><div id="secz" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Materials and Methods</h3><div id="secy" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> CT-L, T-L, and PGPH-L Proteolytic Activity Assays</h4><div class="NLM_p last">In the high-throughput screen, we used fluorogenic peptides as substrates to assay (at 10 μM) the 50 000 compounds library from ChemBridge for inhibitory activity against the CT-L proteolytic activity of the purified rabbit 20S proteasome, resulting in the identification of hit <b>1</b>. To test for selectivity for CT-L over T-L and PGPH-L, we used the corresponding fluorogenic peptides. Briefly, 1 nM purified 20S rabbit proteasome was incubated with 20 μM Suc-Leu-Leu-Val-Tyr-AMC for the CT-L activity, Bz-Val-Gly-Arg-AMC for the T-L activity, and benzyloxycarbonyl Z-Leu-Leu-Glu-AMC for the PGPH-L activity for 1 h at 37 °C in 100 μL of assay buffer (50 mM Tris-HCl, pH 7.6) with or without compound. After incubation, production of hydrolyzed 7-amido-4-methylcoumarin (AMC) groups was measured using a WALLAC Victor<sup>2</sup> 1420 multilabel counter with an excitation filter of 355 nm and an emission filter of 460 nm (Perkin-Elmer Life Sciences, Turku, Finland). The amount of AMC released is within the linear range. Bortezomib was used as a positive control for IC<sub>50</sub> determinations (IC<sub>50</sub> of bortezomib was typically around 10–30 nM). We used the following equation to calculate the in vitro IC<sub>50</sub> values,<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/jm-2013-00221d_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>A</i> is the fraction of activity remaining, [I] is the concentration of inhibitor, and <i>n</i> is the Hill coefficient. To determine proteasome activity in whole cell, extracts (5 μg) from cultured cell lysate were used instead of 20S rabbit proteasome and followed the same assay mentioned above except using the following equation from GraphPad software,<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/jm-2013-00221d_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span>where <i>Y</i> is the percent inhibition, <i>X</i> is the inhibitor concentration, <i>M</i> is the maximum percent inhibition, and <i>L</i> is the lowest percent inhibition.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Cell Culture and Cell Lysate Preparation</h4><div class="NLM_p last">Human MDA-MB-468 breast cancer cells were cultured in DMEM medium containing 10% fetal bovine serum (FBS) supplemented with 100 units/mL penicillin and 100 μg/mL streptomycin. Cells were maintained at 37 °C in a humidified incubator in an atmosphere of 5% CO<sub>2</sub>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Preparation of Whole Cell Lysates</h4><div class="NLM_p last">Cells were harvested, washed with PBS twice, and homogenized in a lysis buffer (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl, 0.5% NP-40) for 30 min at 4 °C. Cell lysates were centrifuged at 12000<i>g</i> for 15 min, and the supernatants were collected as whole cell lysates.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Dialysis Using Purified Rabbit 20S Proteasome</h4><div class="NLM_p last">To measure the effect of dialysis on CT-L activity, <b>1</b> (10 μM), lactacystin (2.5 μM), or vehicle (DMSO) were added to rabbit 20S proteasome at a final concentration of 1 nM in proteasome assay buffer (50 mM Tris-HCl, pH 7.6) and incubated at room temperature for 30 min. After 30 min of incubation, proteasome–compound mixtures were added to 3500 MWCO Thermo Scientific Slide-A-Lyzer minidialysis units (Rockford, IL) and dialyzed against proteasome assay buffer. Immediately (<i>t</i> = 0) and at 0.25, 1, 2, 4, and 18 h of dialysis at 4 °C, samples were removed from the dialysis cassette and the CT-L activity of 20S proteasome was determined as described above under the section “<a class="ref internalNav" href="#secy" aria-label="CT-L, T-L, and PGPH-L Proteolytic Activity Assays">CT-L, T-L, and PGPH-L Proteolytic Activity Assays</a>”. Proteasome activity was normalized against proteasome activity of DMSO control.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> MTT (3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium Bromide) Proliferation/Survival Assay</h4><div class="NLM_p last">Cells were plated in 96-well plates in 100 μL of medium and allowed to attach overnight. Cells were then incubated for 120 h with varying concentrations of inhibitors. Medium was aspirated and replaced with 100 μL of complete medium containing 1 mg/mL MTT and incubated for 3 h at 37 °C in 5% CO<sub>2</sub> humidified incubator. Medium was then aspirated, and DMSO was added. Cells were incubated for 10 min at room temperature while shaking, and the absorbance was determined at 540 nm using a μQuant spectrophotometric plate reader (Bio-TEK, Winooski, VT). The IC<sub>50</sub> values were determined using eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> in <a class="ref internalNav" href="#secy" aria-label="CT-L, T-L, and PGPH-L Proteolytic Activity Assays">CT-L, T-L, and PGPH-L Proteolytic Activity Assays</a>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Protein Digestion and Peptide Purification</h4><div class="NLM_p last">Rabbit 20S proteasome (1 nM), inhibitors, and buffer (50 mM Tris-HCl, pH 7.6) were incubated (450 μL total reaction volume) for 30 min at room temperature. After incubation, 112.5 μL of acetonitrile was added to quench the reaction and denature the protein. Trypsin was added with an enzyme-to-substrate ratio of 1:50. The digestion was carried out for 4 h at 37 °C. The digest was concentrated by vacuum centrifugation (ISS110, Speedvac, Thermo), and the peptides were extracted with C18 reversed phase pipet tip columns (Ziptip, Millipore). An aliquot (25%) of the total digest was injected into the mass spectrometer. To assess LC–MS/MS performance, tryptic peptides from horse myoglobin (25 fmol) were spiked in each LC–MS/MS analysis.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> LC–MS/MS Analysis</h4><div class="NLM_p last">Liquid chromatography–tandem mass spectrometry (LC–MS/MS) peptide sequencing experiments were performed using a nanoflow liquid chromatograph (U3000, Dionex, Sunnyvale, CA) interfaced with an electrospray ion trap mass spectrometer (LTQ-Orbitrap, Thermo, San Jose, CA) in order to detect and localize modified peptides from the proteasome. The sample was first loaded onto a trap column (5 mm × 300 μm i.d. packed with C18 reversed-phase resin, 5 μm particle size, 100 Å pore size) and washed for 8 min with aqueous 2% acetonitrile and 0.04% trifluoroacetic acid. The trapped peptides were eluted onto the analytical column (C18 Pepmap 100, 75 μm i.d. × 15 cm, Dionex, Sunnyvale, CA). The 120 min gradient was programmed as follows: 95% solvent A (2% acetonitrile + 0.1% formic acid) for 8 min, solvent B (90% acetonitrile + 0.1% formic acid) from 5% to 50% in 90 min, then solvent B from 50% to 90% B in 7 min and held at 90% for 5 min, followed by solvent B from 90% to 5% in 1 min and re-equilibration for 10 min. The flow rate on the analytical column was 300 nL/min. Five tandem mass spectra were collected in a data-dependent manner following each survey scan. The MS survey scans were performed in an Orbitrap to obtain accurate peptide mass measurements, and the MS/MS scans were performed in linear ion trap using a 60 s exclusion for previously sampled peptide peaks.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Database Searching and Data Analysis</h4><div class="NLM_p last">Sequest<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> searches were performed against a database containing all rabbit proteasome protein sequences (<i>n</i> = 22) extracted from the UniProt (<a href="http://www.uniprot.org" class="extLink">http://www.uniprot.org</a>). Cleavage was set to partially tryptic, allowing up to two missed cleavages; the precursor mass tolerance was 1.08 Da, and MS/MS mass tolerance was 0.8 Da. Dynamic modifications included oxidation (Met + 15.994 92) and potential modifications on threonine (Thr + 379.189 57 for compound <b>1</b>, Thr + 394.200 47 for compound <b>11ad</b>, and +213.100 09 for β-lactone modification by lactacystin<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a>). The search results were summarized in Scaffold 3.0. (<a href="http://www.proteomesoftware.com" class="extLink">www.proteomesoftware.com</a>). The integrated peak areas for peptide quantification were calculated from extracted ion chromatograms (EIC) using QuanBrowser from Xcalibur 2.0. These values were restricted by <i>m</i>/<i>z</i> (±0.02) and retention time (120 s). The accuracy of the <i>m</i>/<i>z</i> values and the fragmentation patterns of the target peptides were manually inspected to ensure proper sequence assignment.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Syntheses</h3><div id="secs" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General</h4><div class="NLM_p last">All reagents were purchased from commercial suppliers and used without further purification. Melting points were determined using a Barnstead International melting point apparatus or Optimelt automated melting point system (Stanford Research Systems) and remain uncorrected. Proton NMR spectra were recorded on an Agilent-Varian Mercury 400 MHz spectrometer with CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as the solvent. Carbon (<sup>13</sup>C) NMR spectra are recorded at 100 MHz. All coupling constants are measured in hertz (Hz), and the chemical shifts (δ<sub>H</sub> and δ<sub>C</sub>) are quoted in parts per million (ppm) relative to TMS (δ 0), which was used as the internal standard. Formula guided high resolution mass spectrometry (HRMS) was carried out on an Agilent 6210 LC–MS (ESI-TOF) instrument. HPLC analysis was performed using a JASCO HPLC system equipped with a PU-2089 Plus quaternary gradient pump and a UV-2075 Plus UV–vis detector, using an Alltech Kromasil C-18 column (150 mm × 4.6 mm, 5 μm) and Agilent Eclipse XDB-C18 (150 mm × 4.6 mm, 5 μm). Thin layer chromatography was performed using silica gel 60 F254 plates (Fisher), with observation under UV when necessary. Anhydrous solvents (acetonitrile, dimethylformamide, ethanol, isopropanol, methanol, and tetrahydrofuran) were used as purchased from Aldrich. Burdick and Jackson HPLC grade solvents (methanol, acetonitrile, and water) were purchased from VWR for HPLC and high resolution mass analysis. HPLC grade TFA was purchased from Fisher.</div></div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-Isopropyl-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>1</b>)</h4><div class="NLM_p last">To a solution of <b>10a</b> (187 mg, 0.81 mmol) and triethylamine (164 mg, 1.62 mmol) in THF (15 mL) at room temperature was added <b>5a</b> (179 mg, 0.97 mmol) in THF (3 mL) dropwise (1–2 min). Upon addition of the acetyl chloride <b>5a</b>, a precipitate was formed, and the reaction was completed in 15 min (monitored by TLC, <i>R</i><sub><i>f</i></sub> = 0.75, TLC, EtOAc/hexane [1:1]). The THF was evaporated, and the residue was dissolved in EtOAc (20 mL), washed with HCl (4 M, 2 × 15 mL) and water (15 mL). The organic phase was dried (MgSO<sub>4</sub>), evaporated and the crude product obtained was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to obtain <b>1</b> (270 mg, 88%) as a white solid. Mp 142.1–143.4 °C. HPLC 100% (<i>t</i><sub>R</sub> = 11.8 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91 (d, <i>J</i> = 8.0 Hz, 2H, [7.93 minor isomer]), 7.30–7.25 (m, 2H), 7.10 (d, <i>J</i> = 8.3 Hz, 2H, [7.05 minor isomer]), 6.87 (d, <i>J</i> = 8.5 Hz, 2H, [6.82 minor isomer]), 4.78 (s, 2H, [4.84 minor isomer]), 4.70 (s, 2H, [4.83 minor isomer]), 4.45–4.39 (m, 1H), 2.40 (s, 3H, [2.42 minor isomer]), 2.28 (s, 3H, [2.25 minor isomer]), 1.29 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.84 (d, <i>J</i> = 8.2 Hz, 2H, [7.87 minor isomer]), 7.36 (d, <i>J</i> = 7.9 Hz, 2H, [7.37 minor]), 7.01 (d, <i>J</i> = 8.6 Hz, 2H), 6.78 (d, <i>J</i> = 8.6 Hz, 2H, [6.75 minor isomer]), 4.88 (s, 2H, [4.98 minor isomer]), 4.71 (s, 2H, [4.82 minor isomer]), 4.31–4.21 (m, 1H, [4.62–4.52 minor isomer]), 2.37 (s, 3H), 2.18 (s, 3H), 1.26 (d, <i>J</i> = 6.6 Hz, 6H, [1.06 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.40 [176.54 minor isomer], 168.51, 168.56, 156.01 [155.81 minor isomer], 141.68, 131.23 [131.25 minor isomer shown], 130.29 [130.24 minor isomer], 129.68 [129.84 minor isomer shown], 127.65, 124.08, 114.68 [114.64 minor isomer], 67.99 [68.74 minor isomer], 48.96 [46.96 minor isomer], 37.20 [38.40 minor isomer], 21.49 [19.97 minor isomer], 20.81, 20.73. Anal. Calcd for C<sub>22</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>: C, 69.64; H, 6.64; N, 11.07. Found: C, 69.51; H, 6.74; N, 11.13. LC–MS (ESI+) <i>m</i>/<i>z</i> 380.20 (M+H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 380.1969, found 380.1975.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-Isopropyl-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)-2-(4-(trifluoromethyl)phenoxy)acetamide (<b>11a</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5b</b> (149 mg, 0.62 mmol) and <b>10a</b> (120 mg, 0.52 mmol) using triethylamine (105 mg, 1.04 mmol) in a similar manner as described for compound <b>1</b>. The crude product was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11a</b> (196 mg, 87%) as a white solid. Mp 76.6–78.5 °C. HPLC 99.5% (<i>t</i><sub>R</sub> = 14.8 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 8.1 Hz, 2H), 7.57–7.49 (m, 2H), 7.25 (d, <i>J</i> = 7.9 Hz, 2H, [7.29 minor isomer]), 7.04 (d, <i>J</i> = 8.5 Hz, 2H, [6.99 minor isomer]), 4.88 (s, 2H, [4.94 minor isomer]), 4.71 (s, 2H, [4.76 minor isomer]), 4.38–4.32 (m, 1H), 2.41 (s, 3H, [2.43 minor isomer]), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.16 [176.23 minor isomer], 168.57 [167.84 minor isomer], 167.80 [167.87 minor isomer], 160.48, 141.86 [142.43 minor isomer], 129.73, 127.58, 127.29 (q, <i>J</i> = 3.67 Hz), 124.47 (q, <i>J</i> = 270 Hz), 124.11 (q, <i>J</i> = 32.5 Hz), 123.88 [123.86 minor isomer], 114.96 [114.82 minor isomer], 67.48 [67.90 minor isomer], 49.00 [47.05 minor isomer], 37.23 [38.35 minor isomer], 21.81, 21.45 [19.96 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.02 [−62.06 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 434.18 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 434.1686, found 434.1711.</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-Isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-2-(4-(trifluoromethyl)phenoxy)acetamide (<b>11b</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5b</b> (131 mg, 0.55 mmol) and <b>10d</b> (100 mg, 0.46 mmol) using triethylamine (93 mg, 0.92 mmol) in a similar manner as described for compound <b>1</b>. The crude product was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11b</b> (172 mg, 89%) as a white solid. Mp 97.9–99.3 °C. HPLC 100% (<i>t</i><sub>R</sub> = 10.4 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02–7.98 (m, 2H), 7.55–7.43 (m, 5H), 7.04 (d, <i>J</i> = 8.8 Hz, 2H, [7.01 minor isomer]), 4.88 (s, 2H, [4.94 minor isomer]), 4.72 (s, 2H, [4.79 minor isomer]), 4.39–4.35 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.36 [176.47 minor isomer], 168.58 [168.54 minor isomer shown], 167.66 [166.71 minor isomer], 160.50 [160.47 minor isomer], 131.47 [131.92 minor isomer], 129.00 [129.20 minor isomer], 127.65, 127.29 (q, <i>J</i> = 3.74 Hz), 126.78 [126.17 minor isomer], 124.46 (q, <i>J</i> = 270 Hz), 124.14 (q, <i>J</i> = 32.7 Hz), 114.97 [114.90 minor isomer], 67.56 [68.07 minor isomer], 48.96 [47.07 minor isomer], 37.21 [38.41 minor isomer], 21.48 [19.98 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.03 [−62.07 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 420.16 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 420.1530, found 420.1547.</div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-Isopropyl-2-(4-(trifluoromethyl)phenoxy)-<i>N</i>-((3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11c</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5b</b> (100 mg, 0.42 mmol) and <b>10b</b> (100 mg, 0.35 mmol) using triethylamine (71 mg, 0.70 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11c</b> (157 mg, 92%) as a white solid. Mp 96.8–98.9 °C. HPLC 95% (<i>t</i><sub>R</sub> = 19.0 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (d, <i>J</i> = 8.3 Hz, 2H), 7.72 (d, <i>J</i> = 8.3 Hz, 2H), 7.54 (d, <i>J</i> = 8.8 Hz, 2H, [7.49 minor isomer]), 7.04 (d, <i>J</i> = 8.7 Hz, 2H, [6.97 minor isomer]), 4.88 (s, 2H, [4.91 minor isomer]), 4.72 (s, 2H, [4.84 minor isomer]), 4.42–4.38 (m, 1H), 1.34 (d, <i>J</i> = 6.6 Hz, 6H, [1.17 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.91, 167.87 [167.90 minor isomer], 167.60, 160.42 [160.02 minor isomer], 133.18 (q, <i>J</i> = 33 Hz), 130.16, 128.01 [128.12 minor isomer], 127.32 (q, <i>J</i> = 3.59 Hz), 126.03 (q, <i>J</i> = 3.81 Hz), 124.41 (q, <i>J</i> = 270 Hz), 124.23 (q, <i>J</i> = 32.59 Hz), 123.94 (q, <i>J</i> = 270 Hz), 114.94 [114.83 minor isomer], 67.51 [64.80 minor isomer], 49.08, 37.30, 29.94, 21.50 [19.97 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.07 [−62.02 minor isomer], −62.13 [−62.14 minor isomer], −62.45 [−62.52 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 488.14 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>20</sub>F<sub>6</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 488.1403, found 488.1419.</div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-((3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl)methyl)-<i>N</i>-isopropyl-2-(4-(trifluoromethyl)phenoxy)acetamide (<b>11d</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5b</b> (115 mg, 0.48 mmol) and <b>10c</b> (101 mg, 0.40 mmol) using triethylamine (81 mg, 0.80 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11d</b> (154 mg, 85%) as a white solid. Mp 79.0–80.5 °C. HPLC 100% (<i>t</i><sub>R</sub> = 16.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.93 (d, <i>J</i> = 8.6 Hz, 2H), 7.54 (d, <i>J</i> = 8.7 Hz, 2H, [7.50 minor isomer]), 7.43 (d, <i>J</i> = 8.6 Hz, 2H, [7.46 minor isomer]), 7.04 (d, <i>J</i> = 8.6 Hz, 2H, [6.99 minor isomer]), 4.88 (s, 2H, [4.92 minor isomer]), 4.70 (s, 2H, [4.80 minor isomer]), 4.41–4.35 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.60 [176.74 minor isomer], 167.81, 167.70, 160.46 [160.40 minor isomer], 137.61, 129.35 [129.54 minor isomer], 128.96, 127.31 (q, <i>J</i> = 3.7 Hz), 125.28, 124.45 (q, <i>J</i> = 270 Hz), 124.17(q, <i>J</i> = 32 Hz), 114.95 [114.87 minor isomer], 67.54 [68.25 minor isomer], 49.00 [ 47.16 minor isomer], 37.25 [38.50 minor isomer], 21.50 [19.98 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.03 [−62.08 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 454.12 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>20</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 454.1140, found 454.1149.</div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(4-Chlorophenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11e</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5d</b> (106 mg, 0.52 mmol) and <b>10a</b> (100 mg, 0.43 mmol) using triethylamine (87 mg, 0.86 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11e</b> (151 mg, 88%) as a white solid. Mp 133.1–136.5 °C. HPLC 99.6% (<i>t</i><sub>R</sub> = 12.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 8.3 Hz, 2H, [7.91 minor isomer]), 7.30–7.26 (m, 2H), 7.23 (d, <i>J</i> = 9.0 Hz, 2H, [7.20 minor isomer]), 6.86 (d, <i>J</i> = 9.0 Hz, 2H, [6.87 minor isomer]), 4.81 (s, 2H, [4.86 minor isomer]), 4.70 (s, 2H, [4.79 minor isomer]), 4.42–4.35 (m, 1H), 2.41 (s, 3H, [2.41 minor isomer]), 1.30 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.22 [176.34 minor isomer], 168.57, 168.01, 156.75, 141.75 [142.36 minor isomer], 129.90, 129.74 [129.72 minor isomer], 129.67, 127.61 [126.90 minor isomer], 123.98 [123.42 minor isomer], 116.24 [116.17 minor isomer], 67.95 [68.47 minor isomer], 48.93 [46.97 minor isomer], 37.17 [38.37 minor isomer], 21.82, 21.47 [19.98 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 400.15 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 400.1423, found 400.1448.</div></div><div id="sec6_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(4-Chlorophenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11f</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5d</b> (86 mg, 0.42 mmol) and <b>10b</b> (100 mg, 0.35 mmol) using triethylamine (71 mg, 0.70 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11f</b> (129 mg, 81%) as a white solid. Mp 106.4–108.9 °C. HPLC 99.8% (<i>t</i><sub>R</sub> = 17.1 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (d, <i>J</i> = 8.1 Hz, 2H, [8.13 minor isomer]), 7.73 (d, <i>J</i> = 8.2 Hz, 2H, [7.76 minor isomer]), 7.23 (d, <i>J</i> = 9.0 Hz, 2H, [7.18 minor isomer]), 6.91 (d, <i>J</i> = 9.0 Hz, 2H, [6.83 minor isomer]), 4.81 (s, 2H, [4.85 minor isomer]), 4.70 (s, 2H, [4.83 minor isomer]), 4.45–4.39 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.00 [177.20 minor isomer], 168.16, 167.64, 156.68, 133.11 (q, <i>J</i> = 32.6 Hz), 130.18, 129.76, 128.04, 126.96, 126.08 (q, <i>J</i> = 3.8 Hz), 123.96 (q, <i>J</i> = 270 Hz), 116.20 [116.08 minor isomer], 67.91 [68.88 minor isomer], 49.01 [47.09 minor isomer], 37.24 [38.52 minor isomer], 21.50 [19.88 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −63.40 [−63.46 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 454.11 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>20</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 454.1140, found 454.1142.</div></div><div id="sec6_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(4-Chlorophenoxy)-<i>N</i>-((3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)methyl)-<i>N</i>-isopropylacetamide (<b>11g</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5d</b> (98 mg, 0.48 mmol) and <b>10c</b> (101 mg, 0.40 mmol) using triethylamine (81 mg, 0.80 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11g</b> (133 mg, 79%) as a white solid. Mp 133.4–135.8 °C. HPLC 99.9% (<i>t</i><sub>R</sub> = 15.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (d, <i>J</i> = 8.7 Hz, 2H, [7.96 minor isomer]), 7.44 (d, <i>J</i> = 8.6 Hz, 2H, [7.48 minor isomer]), 7.23 (d, <i>J</i> = 9.0 Hz, 2H, [7.19 minor isomer]), 6.91 (d, <i>J</i> = 9.1 Hz, 2H, [6.84 minor isomer]), 4.80 (s, 2H, [4.83 minor isomer]), 4.69 (s, 2H, [4.81 minor isomer]), 4.40–4.37 (m, 1H), 1.30 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.66 [176.83 minor isomer], 168.10, 167.78, 156.69, 137.56, 129.75, 129.36 [129.54 minor isomer], 128.99, 126.93, 125.29, 116.20 [116.11 minor isomer], 67.90 [68.68 minor isomer], 48.96, 37.20, 21.49 [19.98 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 420.08 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 420.0876, found 420.0891.</div></div><div id="sec6_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(4-Chlorophenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11h</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5d</b> (119 mg, 0.58 mmol) and <b>10d</b> (104 mg, 0.48 mmol) using triethylamine (97 mg, 0.96 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11h</b> (152 mg, 82%) as a white solid. Mp 108.3–109.5 °C. HPLC 99.8% (<i>t</i><sub>R</sub> = 9.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03–7.99 (m, 2H), 7.56–7.41 (m, 3H), 7.23 (d, <i>J</i> = 9.0 Hz, 2H, [7.19 minor isomer]), 6.91 (d, <i>J</i> = 9.0 Hz, 2H, [6.87 minor isomer]), 4.80 (s, 2H, [4.85 minor isomer]), 4.70 (s, 2H), 4.43–4.36 (m, 1H), 1.30 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.42, 168.56, 168.08, 156.73, 131.44 [131.87 minor isomer], 129.75 [129.68 minor isomer], 129.75 [129.02 minor isomer], 127.69, 126.91, 126.79, 116.23 [116.16 minor isomer], 67.92 [68.52 minor isomer], 48.97 [47.07 minor isomer], 37.19 [38.43 minor isomer], 21.47 [19.98 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 386.14 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>21</sub>ClN<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 386.1266, found 386.1269.</div></div><div id="sec6_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-((3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl)methyl)-<i>N</i>-isopropyl-2-(p-tolyloxy)acetamide (<b>11i</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (89 mg, 0.48 mmol) and <b>10c</b> (101 mg, 0.40 mmol) using triethylamine (81 mg, 0.80 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11i</b> (131 mg, 82%) as a white solid. Mp 133.5–134.3 °C. HPLC 99.7% (<i>t</i><sub>R</sub> = 21.0 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.95 (d, <i>J</i> = 8.6 Hz, 2H), 7.43 (d, <i>J</i> = 8.6 Hz, 2H, [7.45 minor isomer]), 7.08 (d, <i>J</i> = 8.3 Hz, 2H, [7.03 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.79 minor isomer]), 4.78 (s, 2H, [4.86 minor isomer]), 4.69 (s, 2H, [4.81 minor isomer]), 4.46–4.40 (m, 1H), 2.28 (s, 3H, [2.25 minor isomer]), 1.30 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 176.85, [176.00 minor isomer], 168.56, 167.78, 156.26, 137.34, 131.26, 130.28 [130.24 minor], 129.30 [129.45 minor isomer], 129.04, 125.42, 114.67 [114.59 minor isomer], 67.98 [68.95 minor isomer], 48.96 [47.05 minor isomer], 37.22 [38.48 minor isomer], 21.50 [19.99 minor isomer], 20.74; LC–MS (ESI+) <i>m</i>/<i>z</i> 400.14 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 400.1423, found 400.1423.</div></div><div id="sec6_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-Isopropyl-2-phenoxy-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11j</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5c</b> (47 mg, 0.28 mmol) and <b>10d</b> checked (50 mg, 0.23 mmol) using triethylamine (47 mg, 0.46 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11j</b> (61 mg, 76%) as a white solid. Mp 77.9–79.0 °C. HPLC 94.4% (<i>t</i><sub>R</sub> = 11.6 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02 (dd, <i>J</i> = 8.1, 1.6 Hz, 2H, partially overlapped, [8.05 minor isomer, overlapped]), 7.53–7.43 (m, 3H), 7.32–7.25 (m, 2H), 7.03–6.85 (m, 3H), 4.83 (s, 2H, [4.88 minor isomer]), 4.72 (s, 2H, [4.86 minor isomer]), 4.46–4.40 (m, 1H), 1.31 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.53 [176.65 minor isomer], 168.72 [168.80 minor isomer], 168.53, 158.01 [157.85 minor isomer], 156.40, 131.44 [131.81 minor isomer], 129.88 [129.82 minor isomer], 129.79, 129.00 [129.17 minor isomer], 127.73 [127.69 minor isomer], 127.04, 126.78, 122.00, 116.21, 114.86 [114.81 minor isomer shown], 67.66 [68.34 minor isomer shown], 49.09 [47.12 minor isomer], 37.28 [38.45 minor isomer], 21.43 [19.95 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 352.16 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 352.1656, found 352.1662.</div></div><div id="sec6_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-Isopropyl-2-phenoxy-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11k</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5c</b> (80 mg, 0.47 mmol) and <b>10a</b> (90 mg, 0.39 mmol) using triethylamine (78 mg, 0.77 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11k</b> (111 mg, 78%) as a white solid. Mp 97.8–99.5 °C. HPLC 99.8% (<i>t</i><sub>R</sub> = 8.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.90 (d, <i>J</i> = 8.2 Hz, 2H, [7.93 minor isomer shown]), 7.34–7.22 (m, 4H), 7.02–6.94 (m, 3H), 4.82 (s, 2H [4.87 minor isomer]), 4.71 (s, 2H, [4.83 minor isomer]), 4.45–4.39 (m, 1H), 2.41 (s, 3H [2.42 minor isomer]), 1.30 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.49 [176.50 minor isomer], 168.34, 168.55, 158.08, 141.68 [142.23 minor isomer],129.86 [129.81 minor isomer],129.68, 127.65, 124.01, 121.95, 114.86 [114.83 minor isomer], 67.81 [68.49 minor isomer], 48.96 [46.89 minor isomer], 37.21 [38.37 minor isomer], 21.82, 21.48 [19.98 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 366.19 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 366.1812, found 366.1816.</div></div><div id="sec6_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-Isopropyl-2-phenoxy-<i>N</i>-((3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11l</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5c</b> (57 mg, 0.34 mmol) and <b>10b</b> (80 mg, 0.28 mmol) using triethylamine (57 mg, 0.56 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11l</b> (95 mg, 81%) as a white solid. Mp 122.8–123.8 °C. HPLC 100% (<i>t</i><sub>R</sub> = 11.6 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 8.1 Hz, 2H, [8.15 minor isomer]), 7.72 (d, <i>J</i> = 8.2 Hz, 2H, [7.75 minor isomer]), 7.35–7.26 (m, 2H), 7.03–6.94 (m, 3H, [6.90 minor isomer]), 4.83 (s, 2H, [4.89 minor isomer]), 4.72 (s, 2H, [4.86 minor isomer]), 4.48–4.43 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.15 [177.39 minor isomer], 168.45, 167.58, 158.04, 133.07 (q, <i>J</i> = 32.6 Hz), 130.29 [130.27 minor isomer shown], 129.87 [129.83 minor isomer],128.09, 125.97 (q, <i>J</i> = 3.7 Hz), 123.99 (q, <i>J</i> = 271 Hz), 121.99 [122.07 minor isomer], 114.83 [114.75 minor isomer], 67.75 [68.75 minor isomer], 49.01 [47.05 minor isomer], 37.27 [38.58 minor isomer], 21.50 [19.98 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −63.37, [−63.43 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 420.15 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 420.1530, found 420.1530.</div></div><div id="sec6_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-Isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>11m</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (102 mg, 0.55 mmol) and <b>10d</b> (100 mg, 0.46 mmol) using triethylamine (93 mg, 0.92 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11m</b> (153 mg, 91%) as a white solid. Mp 134.7–136.5 °C. HPLC 96.3% (<i>t</i><sub>R</sub> = 8.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02 (dd, <i>J</i> = 8.0, 1.6 Hz, 2H overlapped, [8.04 minor isomer overlapped]), 7.55- 7.41 (m, 3H), 7.08 (d, <i>J</i> = 8.3 Hz, 2H, [7.04 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.81 minor isomer]), 4.78 (s, 2H, [4.85 minor isomer]), 4.71 (s, 2H, [4.83 minor isomer]), 4.45–4.40 (m, 1H), 2.28 (s, 3H, [2.25 minor isomer]), 1.30 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.62, 168.55, 168.53, 156.00 [155.80 minor isomer], 131.37 [131.74 minor isomer], 131.22 [131.25 minor isomer], 130.28 [130.24 minor isomer], 128.97 [129.13 minor isomer], 127.73, 126.89, 114.68 [114.62 minor isomer], 67.97 [68.75 minor isomer], 48.93 [46.94 minor isomer], 37.20 [38.44 minor isomer], 21.48, [19.98 minor isomer], 20.74; LC–MS (ESI+) <i>m</i>/<i>z</i> 366.18 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 366.1812, found 366.1828.</div></div><div id="sec6_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-Isopropyl-2-(<i>p</i>-tolyloxy)-<i>N</i>-((3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11n</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (78 mg, 0.42 mmol) and <b>10b</b> (100 mg, 0.35 mmol) using triethylamine (71 mg, 0.70 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11n</b> (127 mg, 84%) as a white solid. Mp 146.9–148.6 °C. HPLC 99% (<i>t</i><sub>R</sub> = 16.1 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 8.1 Hz, 2H), 7.72 (d, <i>J</i> = 8.2 Hz, 2H, overlapped, [7.75 minor isomer, overlapped]), 7.08 (d, <i>J</i> = 8.3 Hz, 2H, [7.02 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.77 minor isomer]), 4.79 (s, 2H, [4.89 minor isomer]), 4.70 (s, 2H, [4.81 minor isomer]), 4.48–4.42 (m, 1H), 2.28 (s, 3H, [2.23 minor isomer]), 1.31 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.20 [177.43 minor isomer], 168.63, 167.57, 155.98 [155.73 minor isomer], 133.05 (q, <i>J</i> = 32.5 Hz), 131.27 [131.37 minor isomer], 130.29 [130.24 minor isomer], 128.09, 125.97 (q, <i>J</i> = 3.8 Hz), 124.0 (q, <i>J</i> = 270.6 Hz), 114.65 [114.54 minor isomer], 67.94 [68.85 minor isomer], 48.97 [47.08 minor isomer], 37.26 [38.63 minor isomer], 21.50 [19.62 minor isomer], 20.74; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −63.39 [−63.45 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 434.18 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 434.1686, found 434.1693.</div></div><div id="sec6_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-Isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>m</i>-tolyloxy)acetamide (<b>11o</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5h</b> (66 mg, 0.36 mmol) and <b>10d</b> (65 mg, 0.30 mmol) using triethylamine (61 mg, 0.60 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11o</b> (83 mg, 76%) as a colorless viscous compound; HPLC 98.8% (<i>t</i><sub>R</sub> = 8.6 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (dd, <i>J</i> = 8.0, 1.5 Hz, 2H, [8.08 minor isomer]), 7.52–7.42 (m, 4H), 7.17 (t, <i>J</i> = 7.6 Hz, 1H, overlapped, [7.15, minor isomer]), 6.82–6.69 (m, 2H), 4.79 (s, 2H, [4.85 minor isomer]), 4.71 (s, 2H, [4.84 minor isomer]), 4.46–4.40 (m, 1H), 2.31 (s, 3H, [2.25 minor isomer]), 1.31 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer shown]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.58, 168.56, 168.43, 158.09, 139.99, 131.36 [131.74 minor isomer], 129.58 [129.53 minor isomer], 128.96 [129.13 minor isomer], 127.72, 126.90, 122.80 [122.84 minor isomer], 115.64 [115.74 minor isomer], 111.70 [111.46 minor isomer], 67.79 [68.59 minor isomer], 48.97 [46.97 minor isomer shown], 37.22 [38.52 minor isomer], 21.76, 21.49 [19.98 minor isomer shown]; LC–MS (ESI+) <i>m</i>/<i>z</i> 366.19 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 366.1812, found 366.1817.</div></div><div id="sec6_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-Isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>o</i>-tolyloxy)acetamide (<b>11p</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5i</b> (51 mg, 0.28 mmol) and <b>10d</b> (50 mg, 0.23 mmol) using triethylamine (57 mg, 0.56 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11p</b> (71 mg, 85%) as a white solid. Mp 97.3–98.0 °C. HPLC 98.0% (<i>t</i><sub>R</sub> = 9.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.95 (broad dd, <i>J</i> = 7.9, 1.6 Hz, 2H), 7.51–7.43 (m, 3H), 7.17–7.09 (m, 2H), 6.92–6.87 (m, 2H), 4.82 (s, 2H, [4.81 minor isomer]), 4.71 (s, 2H), 4.48–4.38 (m, 1H), 2.28 (s, 3H, [2.20 minor isomer]), 1.29 (d, <i>J</i> = 6.6 Hz, 6H, [1.14 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.57 [176.68 minor isomer], 168.57, 168.50, 156.23, 131.38 [131.77 minor isomer], 131.18, 128.98 [129.15 minor isomer], 127.73, 127.25, 126.87, 126.84, 121.61 [121.69 minor isomer], 111.28 [111.63 minor isomer], 68.01 [68.86 minor isomer], 48.94 [48.90 minor isomer], 37.22 [38.26 minor isomer], 21.51 [20.07 minor isomer], 16.62; LC–MS (ESI+) <i>m</i>/<i>z</i> 366.18 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 366.1812, found 366.1821.</div></div><div id="sec6_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(Biphenyl-4-yloxy)-<i>N</i>-isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11q</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5e</b> (116 mg, 0.47 mmol) and <b>10d</b> (85 mg, 0.39 mmol) using triethylamine (79 mg, 0.78 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11q</b> (145 mg, 87%) as a white solid. Mp 147.8–148.7 °C. HPLC 99.6% (<i>t</i><sub>R</sub> = 14.6 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02 (dd, <i>J</i> = 8.2, 1.4 Hz, 2H), 7.55–7.36 (m, 9H), 7.31 (t, <i>J</i> = 7.4 Hz, 1H), 7.05 (d, <i>J</i> = 8.8 Hz, 2H, [7.00 minor isomer]), 4.87 (s, 2H, [4.91 minor isomer]), 4.73 (s, 2H), 4.48–4.42 (m, 1H), 1.33 (d, <i>J</i> = 6.6 Hz, 6H, [1.17 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.55 [176.69 minor isomer], 168.58, 168.30 [168.38 minor isomer], 157.63 [157.49 minor isomer], 140.78, 135.04 [135.07 minor isomer], 131.36 [131.77 minor isomer], 128.98 [129.16 minor isomer], 128.94, 128.53, 127.71, 127.04, 127.01, 126.88, 115.17 [115.10 minor isomer], 67.86 [68.62 minor isomer], 48.98 [47.02 minor isomer], 37.22 [38.50 minor isomer], 21.51 [20.00 minor isomer shown]; LC–MS (ESI+) <i>m</i>/<i>z</i> 428.19 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 428.1969, found 428.1968.</div></div><div id="sec6_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(6-Bromonaphthalen-2-yloxy)-<i>N</i>-isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11r</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5g</b> (140 mg, 0.47 mmol) and <b>10d</b> (85 mg, 0.39 mmol) using triethylamine (79 mg, 0.78 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11r</b> (141 mg, 75%) as a white solid. Mp 97.7–98.4 °C. HPLC 98.1% (<i>t</i><sub>R</sub> = 19.6 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.99–7.86 (m, 3H), 7.67 (d, <i>J</i> = 9.0 Hz, 1H), 7.56 (d, <i>J</i> = 8.9 Hz, 1H), 7.53–7.36 (m, 4H), 7.24 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.19 (d, <i>J</i> = 2.3 Hz, 1H), 4.93 (s, 2H, [4.98 minor isomer]), 4.72 (s, 2H, [4.86 minor isomer]), 4.52–4.46 (m, 1H), 1.33 (d, <i>J</i> = 6.6 Hz, 6H, [1.18 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.47, 168.59, 168.14, 156.26, 133.02, 131.80, 131.36 [131.40 minor isomer], 130.63, 130.00 [129.94 minor isomer], 129.82, 129.03 [129.14 minor isomer], 128.94, 127.63 [127.68 minor isomer], 126.75, 119.65 [119.49 minor isomer], 117.90, 107.72, 67.89 [68.50 minor isomer], 49.03 [47.10 minor isomer], 37.23 [38.65 minor isomer], 21.53 [19.99 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 480.09 and 482.09 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>23</sub>BrN<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 480.0917, found 480.0914.</div></div><div id="sec6_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(4-Fluorophenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11s</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5f</b> (95 mg, 0.50 mmol) and <b>10d</b> (91 mg, 0.42 mmol) using triethylamine (85 mg, 0.84 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11s</b> (127 mg, 82%) as a white solid. Mp 87.9–89.9 °C. HPLC 99.5% (<i>t</i><sub>R</sub> = 16.00 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.00 (dd, <i>J</i> = 8.1, 1.6 Hz, 2H, [8.04 minor isomer]), 7.54–7.44 (m, 3H), 7.02–6.88 (m, 4H), 4.80 (s, 2H, [4.85 minor isomer]), 4.72 (s, 2H, [4.83 minor isomer]), 4.44–4.38 (m, 1H), 1.31 (d, <i>J</i> = 6.7 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.49 [177.63 minor isomer], 168.82 [168.56 minor isomer], 168.24, 157.98 (d, <i>J =</i> 238 Hz), 154.24 (d, <i>J =</i> 2.07 Hz), 131.44 [131.86 minor], 129.00 [129.19 minor isomer], 127.69, 126.82, 116.34 (d, <i>J =</i> 23 Hz), 116.03 (d, <i>J</i> = 8.11 Hz), 68.30 [68.92 minor isomer], 48.91 [46.94 minor isomer], 37.18 [38.39 minor isomer], 21.46 [19.97 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −123.13; LC–MS (ESI+) <i>m</i>/<i>z</i> 370.15 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 370.1562, found 370.1567.</div></div><div id="sec6_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-Isopropyl-(3-phenyl-1,2,4-oxadiazol-5-yl)methylamino-2-oxoethoxy)benzoic Acid (<b>11t</b>)</h4><div class="NLM_p last">A solution of <b>11aq</b> (50 mg, 0.11 mmol) in trifluoroacetic acid (3 mL) and dichloromethane (5 mL) was stirred at room temperature for 2 h. Acetone (5 mL) was added to the reaction mixture and the solvents were evaporated under vacuum to give the pure compound <b>11t</b> (41 mg, 95%) as a white compound. Mp 211.3-213.8 °C. HPLC 100% (<i>t</i><sub>R</sub> = 14.8 min, 40% MeOH in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.58 (brs, 1H), 7.97–7.90 (m, 2H, [8.03–7.98 minor isomer]), 7.82 (d, <i>J</i> = 8.8 Hz, 2H), 7.58–7.53 (m, 3H), 6.96 (d, <i>J</i> = 8.8 Hz, 2H, [6.99 minor isomer]), 5.09 (s, 2H, [5.02 minor isomer]), 4.75 (s, 2H, [5.00 minor isomer]), 4.32–4.20 (m, 1H, [4.66–4.60 minor isomer]), 1.28 (d, <i>J</i> = 6.5 Hz, 6H, [1.07 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.32, 171.41, 168.58, 167.80, 162.38, 132.70 [132.63 minor isomer], 131.48 [131.94 minor isomer], 129.22, 129.01 [129.22 minor isomer], 127.68 [126.71 minor isomer], 122.97 [122.90 minor isomer], 114.71 [114.68 minor isomer], 67.46 [67.96 minor isomer], 49.07 [47.24 minor isomer], 37.24 [38.43 minor isomer], 21.46 [19.96 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 396.15 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub> (M + H)<sup>+</sup> 396.1554, found 396.1566.</div></div><div id="sec6_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(4-Hydroxyphenoxy)-<i>N</i>-isopropyl-<i>N</i>-((pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11u</b>)</h4><div class="NLM_p last">To a solution of <b>10f</b> (59 mg, 0.27 mmol) and triethylamine (55 mg, 0.54 mmol) in THF (10 mL) at room temperature was added 2-(4-hydroxyphenoxy)acetyl chloride (<b>5s</b>) (60 mg, 0.32 mmol) in THF (1 mL, dropwise 3–4 min). Upon addition of acetyl chloride, a precipitate was formed and the reaction was completed in 15 min (monitored by TLC, <i>R</i><sub><i>f</i></sub> = 0.50, EtOAc/hexane [2:1]). The THF was evaporated and the crude product obtained was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to obtain pure <b>11u</b> (83 mg, 83%) as a white solid. Mp 140.0–142.4 °C. HPLC 95.5% (<i>t</i><sub>R</sub> = 5.47 min, 45% MeOH in 0.1% TFA water 20 min). The <sup>1</sup>H NMR showed 5:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.11 (s, 1H, [9.23 minor isomer]), 8.70 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H, [8.74 minor isomer]), 8.30 (dt, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.43 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 6.88 (d, <i>J</i> = 9.1 Hz, 2H), 6.80 (d, <i>J</i> = 9.1 Hz, 2H), 4.78 (s, 2H, [4.88 minor isomer]), 4.69 (s, 2H), 4.60–4.52 (m, 1H), 1.29 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.39, 169.00, 166.13, 152.05, 151.05, 148.10, 135.85, 124.36, 117.00 [116.45 minor isomer] 115.97, 68.37, 48.88, 37.08, 21.49 [19.99 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 369.15 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub> (M + H)<sup>+</sup> 369.1557, found 369.1571.</div></div><div id="sec6_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(4-Hydroxyphenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11v</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5s</b> (52 mg, 0.28 mmol) and <b>10d</b> (50 mg, 0.23 mmol) using triethylamine (47 mg, 0.46 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11v</b> (68 mg, 80%) as a white solid. Mp 155.5–158.5 °C. HPLC 100% (<i>t</i><sub>R</sub> = 13.1 min, 40% CH<sub>3</sub>CN in 0.1% TFA water 20 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (dd, <i>J</i> = 7.8, 1.7 Hz, 2H, [8.04 minor isomer]), 7.51–7.43 (m, 3H), 6.85 (d, <i>J</i> = 9.0 Hz, 2H, [6.80 minor isomer]), 6.73 (d, <i>J</i> = 9.0 Hz, 2H, [6.70 minor isomer]), 4.75 (s, 2H, [4.85 minor isomer]), 4.71 (s, 2H, [4.80 minor isomer]), 4.48–4.41 (m, 1H), 1.30 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]); <sup>13</sup>C NMR (100 MHz, DMSO) δ 178.76 [178.92 minor isomer], 168.57 [168.67 minor isomer], 168.12 [168.25 minor isomer], 152.16 [152.02 minor isomer], 151.45, 150.38, 132.27 [132.45 minor isomer], 129.97 [130.02 minor isomer], 127.61 [127.69 minor isomer], 126.78 [126.55 minor isomer], 116.21 [116.30 minor isomer], 116.16 [116.13 minor isomer], 67.33 [67.42 minor isomer], 48.31, 37.77, 21.34 [19.94 minor isomer]. LC–MS (ESI+) <i>m</i>/<i>z</i> 368.16 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub> (M + H)<sup>+</sup> 368.1605, found 368.1615.</div></div><div id="sec6_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-Isopropyl-<i>N</i>-((3-(pyridin-2-yl)-1,2,4-oxadizaol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>11w</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (43 mg, 0.23 mmol) and <b>10e</b> (42 mg, 0.19 mmol) using triethylamine (39 mg, 0.38 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11w</b> (52 mg, 75%) as a white solid. Mp 125.7–126.9 °C; HPLC 96.2% (<i>t</i><sub>R</sub> = 15.7 min, 40% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.79 (d, <i>J</i> = 4.7 Hz, 1H), 8.06 (d, <i>J</i> = 7.9 Hz, 1H), 7.82 (td, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.42 (appdd, <i>J</i> = 6.7, 4.9 Hz, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H, [7.03 minor isomer]), 6.87 (d, <i>J</i> = 8.5 Hz, 2H, [6.80 minor isomer]), 4.79 (s, 2H, [4.93 minor isomer]), 4.77 (s, 2H, [4.81 minor isomer]), 4.46–4.38 (m, 1H), 2.29 (s, 3H, [2.24 minor isomer]), 1.29 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.38, 168.57, 168.37, 155.96, 150.60 [150.73 minor isomer], 146.46, 137.19, 131.25, 130.30, 125.72, 123.51, 114.66, 67.98 [68.99 minor isomer], 49.01, 37.24, 21.44 [19.95 minor isomer], 20.72; LC–MS (ESI+) <i>m</i>/<i>z</i> 367.17 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> 367.1765, found 367.1774.</div></div><div id="sec6_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-Isopropyl-<i>N</i>-((3-(pyridin-3-yl)-1,2,4-oxadizaol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide <b>11x</b></h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (51 mg, 0.28 mmol) and <b>10f</b> (50 mg, 0.23 mmol) using triethylamine (47 mg, 0.46 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11x</b> (69 mg, 82%) as a white solid. Mp 126.5–128.3 °C. HPLC 98.3% (<i>t</i><sub>R</sub> = 10.6 min, 35% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.24 (s, 1H), 8.72 (appdd, <i>J</i> = 4.8, 1.2 Hz, 1H, [8.75 minor isomer]), 8.27 (dt, <i>J</i> = 7.9, 1.6 Hz, 1H), 7.39 (dd, <i>J</i> = 8.0, 4.9 Hz, 1H, [7.43 minor isomer]), 7.08 (d, <i>J</i> = 8.6 Hz, 2H, [7.02 minor isomer]), 6.86 (d, <i>J</i> = 8.5 Hz, 2H, [6.77 minor isomer]), 4.78 (s, 2H, [4.88 minor isomer]), 4.70 (s, 2H, [4.78 minor isomer]), 4.49–4.39 (m, 1H), 2.27 (s, 3H, [2.22 minor isomer]), 1.31 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.23, 168.60, 166.65, 155.94 [155.72 minor isomer], 152.24 [152.52 minor isomer], 148.92 [148.87 minor isomer], 134.97, 131.30, 130.28, 123.79 [123.86 minor isomer], 123.20, 114.64 [114.53 minor isomer], 67.91 [69.02 minor isomer], 48.99 [48.96 minor isomer], 37.27 [38.66 minor isomer], 21.52 [19.99 minor isomer], 20.72; LC–MS (ESI+) <i>m</i>/<i>z</i> 367.17 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> 367.1765, found 367.1774.</div></div><div id="sec6_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-Isopropyl-<i>N</i>-((3-(pyridin-4-yl)-1,2,4-oxadizaol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>11y</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (21 mg, 0.12 mmol) and <b>10g</b> (22 mg, 0.10 mmol) using triethylamine (19 mg, 0.19 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11y</b> (29 mg, 78%) as a white solid. Mp 150.6–151.7 °C. HPLC 96.6% (<i>t</i><sub>R</sub> = 14.7 min, 30% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.75 (d, <i>J</i> = 4.8 Hz, 2H), 7.87 (d, <i>J</i> = 4.6 Hz, 2H), 7.09 (d, <i>J</i> = 8.1 Hz, 2H, [7.02 minor isomer]), 6.87 (d, <i>J</i> = 8.5 Hz, 2H, [6.76 minor isomer]), 4.80 (s, 2H, [4.90 minor isomer]), 4.70 (s, 2H, [4.79 minor isomer]), 4.51–4.40 (m, 1H), 2.29 (s, 3H, [2.23 minor isomer]), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.57, 168.65, 167.05, 155.94, 150.79 [150.91 minor isomer], 134.35, 131.30, 130.29, 121.57, 114.64 [114.50 minor isomer], 67.91 [69.08 minor isomer], 49.01 [48.97 minor isomer], 37.27 [38.61 minor isomer], 21.52 [19.98 minor isomer], 20.72; LC–MS (ESI+) <i>m</i>/<i>z</i> 367.18 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> 367.1765, found 367.1780.</div></div><div id="sec6_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-Isopropyl-2-(6-methylpyridin-3-yloxy)-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11z</b>)</h4><div class="NLM_p last">A solution of 6-methyl-3-hydroxypyridin (80 mg, 0.73 mmol), <i>N</i>-isopropyl-2-chloro-<i>N</i>-((3-phenyl-1,2,4-oxodiazol-5-yl)methyl)acetamide (<b>15</b>) (214 mg, 0.73 mmol) and potassium carbonate (510 mg, 3.67 mmol) in acetonitrile (25 mL) was refluxed for 14 h. The solvent was evaporated, and the residue was dissolved in ethyl acetate (20 mL) and washed with water (2 × 20 mL). The organic phase was dried (MgSO<sub>4</sub>), evaporated and the crude compound obtained was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford <b>11z</b> as (193 mg, 72%) a white solid. Mp 130.3–132.2 °C. HPLC 97.26% (<i>t</i><sub>R</sub> = 8.3 min, 30% CH<sub>3</sub>CN in 0.1% TFA water 30 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (d, <i>J</i> = 2.9 Hz, 1H, [8.26 minor isomer]), 8.00 (dd, <i>J</i> = 7.9, 1.6 Hz, 1H, [8.04 minor isomer]), 7.52–7.44 (m, 4H), 7.20 (d, <i>J</i> = 8.5 Hz, 1H), 4.93 (s, 2H, [5.01 minor isomer]), 4.89–4.80 (m, 1H), 4.72 (s, 2H, [4.78 minor isomer]), 4.30–4.23 (m, 1H, [4.89–4.80 minor isomer]), 2.63 (s, 3H), 1.35 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.25, 168.58, 166.98, 153.61, 149.71, 131.50 [131.94 minor isomer], 129.26, 129.04, 127.69, 126.73, 125.54, 67.68, 48.90 [47.05 minor isomer], 37.21, 21.61, 21.51 [19.99 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 367.18 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 367.1765, found 367.1759.</div></div><div id="sec6_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(4-Ethylphenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11aa</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5j</b> (93 mg, 0.47 mmol) and <b>10d</b> (85 mg, 0.39 mmol) using triethylamine (79 mg, 0.78 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11aa</b> (123 mg, 83%) as a white solid. Mp 106.7–109.2 °C. HPLC 95.5% (<i>t</i><sub>R</sub> = 11.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 2:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (dd, <i>J</i> = 7.9, 1.4 Hz, 2H), 7.55–7.38 (m, 3H), 7.11 (d, <i>J</i> = 8.4 Hz, 2H, [7.07 minor isomer]), 6.90 (d, <i>J</i> = 8.5 Hz, 2H, [6.84 minor isomer]), 4.79 (s, 2H, [4.86 minor isomer]), 4.71 (s, 2H, [4.83 minor isomer]), 4.46–4.40 (m, 1H), 2.59 (q, <i>J</i> = 7.5 Hz, 2H, [2.55 minor isomer]), 1.31 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer partially overlapped]), 1.20 (t, <i>J</i> = 7.6 Hz, 3H, partially overlapped with the doublet at 1.16); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.62 [176.77 minor isomer], 168.56 [168.66 minor isomer], 168.55 [168.65 minor isomer], 156.14 [155.94 minor isomer], 137.73, 131.38 [δ 131.75 minor isomer], 129.11, 128.98, 127.73, 126.90, 114.72 [114.65 minor isomer], 67.97 [68.74 minor isomer], 48.98, 37.23 [38.44 minor isomer], 28.21, 21.48 [19.99 minor isomer], 16.01; LC–MS (ESI+) <i>m</i>/<i>z</i> 380.21 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 380.1969, found 380.1964.</div></div><div id="sec6_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(4-Ethylphenoxy)-<i>N-</i>isopropyl-<i>N</i>-((3-pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methylacetamide (<b>11ab</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5j</b> (50 mg, 0.25 mmol) and <b>10f</b> (46 mg, 0.21 mmol) using triethylamine (43 mg, 0.42 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ab</b> (65 mg, 81%) as a white solid. Mp 104.4–106.3 °C. HPLC 95.7% (<i>t</i><sub>R</sub> = 5.3 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.21 (s, 1H), 8.67 (brs, 1H), 8.23 (d, <i>J</i> = 7.7 Hz, 1H), 7.42–7.29 (broad m, 1H), 7.04 (d, <i>J</i> = 8.5 Hz, 2H, [6.98 minor isomer]), 6.82 (d, <i>J</i> = 8.5 Hz, 2H, [6.73 minor isomer]), 4.72 (s, 2H, [4.82 minor isomer]), 4.64 (s, 2H, [4.74 minor isomer]), 4.40–4.32 (m, 1H), 2.51 (q, <i>J</i> = 7.6 Hz, 2H partially overlapped, [2.47 minor isomer]), 1.25 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]), 1.11 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.26, [ 177.46 minor isomer], 168.59, [168.65 minor isomer], 166.65, [166.87 minor isomer], 156.09, 152.11, 148.82, 137.79, 135.02, 129.10, 114.68 [114.57 minor isomer], 67.97 [69.01 minor isomer], 49.00 [46.98 minor isomer], 37.29 [38.61 minor isomer], 28.19 [29.93 minor isomer], 21.49 [19.99 minor isomer], 16.00; LC–MS (ESI+) <i>m</i>/<i>z</i> 381.19 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 381.1921, found 381.1912.</div></div><div id="sec6_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-Isopropyl-2-phenoxy-<i>N</i>-((3-(pyridine-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ac</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5c</b> (55 mg, 0.32 mmol) and <b>10f</b> (59 mg, 0.27 mmol) using triethylamine (55 mg, 0.54 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ac</b> (81 mg, 85%) as a white solid. Mp 83.0–85.5 °C. HPLC 97.5% (<i>t</i><sub>R</sub> = 11.4 min, 30% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.29 (s, 1H), 8.79 (brs, 1H), 8.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (m, 1H), 7.33–7.22 (m, 2H), 7.02–6.87 (m, 3H), 4.82 (s, 2H, [4.89 minor isomer]), 4.71 (s, 2H, [4.84 minor isomer]), 4.51–4.37 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.21 [177.41 minor isomer]), 168.43, 166.62, [166.87 minor isomer], 158.01 [157.83 minor isomer], 152.20 [152.53 minor isomer], 148.85, 134.99, 129.85, 123.83, 123.19, 121.98, 114.81 [114.71 minor isomer], 67.65 [68.66 minor isomer], 48.97 [47.08 minor isomer], 37.28 [38.61 minor isomer], 21.49 [19.97 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 353.16 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 353.1608, found 353.1614.</div></div><div id="sec6_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-Isopropyl-2-(4-propylphenoxy)-<i>N</i>-((3-pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ad</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5k</b> (84 mg, 0.40 mmol) and <b>10f</b> (72 mg, 0.33 mmol) using triethylamine (67 mg, 0.66 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ad</b> (109 mg, 84%) as a white solid. Mp 103.2–105.5 °C. HPLC 100% (<i>t</i><sub>R</sub> = 7.58 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.26 (s, 1H), 8.78–8.70 (m, 1H), 8.29 (dt, <i>J</i> = 8.0 Hz, <i>J</i> = 2.0 Hz, 1H), 7.42 (appdd, <i>J</i> = 8.0, 4.9 Hz, 1H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H, [ 7.03 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.79 minor isomer]), 4.78 (s, 1H), 4.79 (s, 2H, [4.89 minor isomer]), 4.70 (s, 2H, [4.81 minor isomer shown]), 4.48–4.38 (m, 1H), 2.51 (t, <i>J</i> = 7.7 Hz, 2H, [2.47 minor isomer]), 1.63–1.52 (m, 2H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]), 0.91 (t, <i>J</i> = 7.3 Hz, 3H, [0.89 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.06 [177.24 minor isomer], 168.34 [168.40 minor isomer], 166.33 [166.57 minor isomer], 155.86 [155.62 minor isomer], 151.74 [152.16 minor isomer], 148.44 [148.50 minor isomer]), 135.98 [136.05 minor isomer], 134.93[134.83 minor isomer], 129.45 [129.41 minor isomer], 123.66 [123.09 minor isomer], 114.34 [114.24 minor isomer], 67.62 [68.73 minor isomer], 48.74 [46.81 minor isomer], 37.11 [38.41 minor isomer], 37.06, 24.69 [23.47 minor isomer], 21.26 [19.74 minor isomer], 13.78; LC–MS (ESI+) <i>m</i>/<i>z</i> 395.21 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> 395.2078, found 395.2080.</div></div><div id="sec6_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-(4-Butylphenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-(pyridine-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ae</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5l</b> (76 mg, 0.34 mmol) and <b>10f</b> (61 mg, 0.28 mmol) using triethylamine (57 mg, 0.56 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ae</b> (94 mg, 82%) as a white solid. Mp 94.5–95.2 °C. HPLC 98.13% (<i>t</i><sub>R</sub> = 10.2 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.29 (s, 1H, [9.26 minor isomer overlapped]), 8.80–8.73 (m, 1H), 8.46 (d, <i>J</i> = 7.7 Hz, 1H, [8.33 minor isomer]), 7.56–7.52 (m, 1H [7.50 minor isomer]), 7.09 (d, <i>J</i> = 8.6 Hz, 2H, [7.02 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.78 minor isomer]), 4.78 (s, 2H, [4.90 minor isomer]), 4.70 (s, 2H, [4.80 minor isomer]), 4.47–4.40 (m, 1H), 2.54 (t, <i>J</i> = 7.3 Hz, 2H, [2.48 minor isomer]), 1.59–1.46 (m, 2H), 1.36–1.29 [m, 8H and around 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]), 0.91 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.23, 168.58, 166.66, 156.07, 152.24 [152.54 minor isomer]), 148.93, 136.46, 134.97, 129.64, 123.80, 123.21, 114.59 [114.50 minor isomer]), 67.91, 48.97, 37.29, 34.95, 34.03, 22.53, 21.50 [19.99 minor isomer], 14.20; LC–MS (ESI+) <i>m</i>/<i>z</i> 409.23 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 409.2234, found 409.2238.</div></div><div id="sec6_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-Isopropyl-2-(4-pentylphenoxy)-<i>N</i>-((3-pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11af</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5m</b> (78 mg, 0.32 mmol) and <b>10f</b> (59 mg, 0.27 mmol) using triethylamine (55 mg, 0.54 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11af</b> (95 mg, 83%) as a white solid. Mp 93.0–95.9 °C. HPLC 96.5% (<i>t</i><sub>R</sub> = 17.1 min, 70% MeOH in 0.1% TFA water 20 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.19 (s, 1H, [9.24 minor isomer]), 8.67 (appdd, <i>J</i> = 4.9, 1.6 Hz, 1H), 8.24–8.22 (m, 1H, [8.30 minor isomer]), 7.37–7.28 32 (m, 1H), 7.02 (d, <i>J</i> = 8.4 Hz, 2H, [6.95 minor isomer]), 6.81 (d, <i>J</i> = 8.4 Hz, 2H, [6.72 minor isomer]), 4.72 (s, 2H, [4.83 minor isomer]), 4.64 (s, 2H, [4.74 minor isomer]), 4.40–4.33 (m, 1H), 2.46 (t, <i>J</i> = 7.8 Hz, 2H, partially overlapped [2.41 minor isomer partially overlapped]), 1.52–1.41 (m, 2H), 1.36–1.13 [broad m, 10H, and around 1.25 (d, <i>J</i> = 6.8 Hz, 6H)]), 0.81 (t, <i>J</i> = 6.6 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.29 [177.50 minor isomer], 168.62, [168.67 minor isomer], 166.56 [ 166.79 minor isomer], 156.07 [155.82 minor isomer], 152.19, 151.88 [152.19 minor isomer], 148.60, 136.51 [136.33 minor isomer], 135.25, 129.63 [129.59 minor isomer], 123.97, 114.60 [114.50 minor isomer], 67.90 [69.04 minor isomer], 49.00 [47.08 minor isomer], 37.30 [38.65 minor isomer], 35.24, 31.69, 31.57 [29.93 minor], 22.77, 21.51 [19.99 minor isomer], 14.29; LC–MS (ESI+) <i>m</i>/<i>z</i> 423.24 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 423.2391, found 423.2393.</div></div><div id="sec6_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(4-Hexylphenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ag</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5n</b> (98 mg, 0.38 mmol) and <b>10f</b> (70 mg, 0.32 mmol) using triethylamine (65 mg, 0.64 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ag</b> (122 mg, 87%) as a white solid. Mp 94.4–96.1 °C. HPLC 93.8% (<i>t</i><sub>R</sub> = 7.7 min, 80% MeOH in 0.1% TFA water 20 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.28 (s, 1H), 8.75 (brs, 1H), 8.33 (appd, <i>J</i> = 7.9 Hz, 1H, [8.29 minor isomer]), 7.50–7.43 (m, 1H), 7.09 (d, <i>J</i> = 8.6 Hz, 2H, [7.03 minor isomer]), 7.87 (d, <i>J</i> = 8.7 Hz, 2H, [6.79 minor isomer]), 4.79 (s, 2H, [4.90 minor isomer]), 4.71 (s, 2H, [4.81 minor isomer]), 4.49–4.36 (m, 1H), 2.53 (t, <i>J</i> = 7.8 Hz, 2H partially overlapped, [2.48 minor isomer partially overlapped]), 1.59–1.51 (m, 2H), 1.33–1.27 (m, 12H and around 1.32 [d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]), 0.91–0.83 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.32 [177.51 minor isomer], 168.58, [168.64 minor isomer], 166.54, 156.07 [155.82 minor isomer], 151.91 [152.38 minor isomer], 148.59 [148.68 minor isomer], 136.48 [136.54 minor isomer], 135.25 [135.13 minor isomer], 129.62 [129.58 minor isomer], 123.99 [123.40 minor isomer], 114.59 [114.50 minor isomer], 67.86 [68.96 minor isomer], 48.97 [47.05 minor isomer], 37.30 [38.64 minor isomer], 35.27 [35.22 minor isomer], 31.96, 31.85, 29.17, 22.84, 21.49 [19.97 minor isomer], 14.35; LC–MS (ESI+) <i>m</i>/<i>z</i> 437.25 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 437.2547, found 437.2548.</div></div><div id="sec6_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-Isopropyl-2-(4-cyclohexylphenoxy)-<i>N</i>-((3-pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ah</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5o</b> (79 mg, 0.31 mmol) and <b>10f</b> (57 mg, 0.26 mmol) using triethylamine (53 mg, 0.52 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ah</b> (88 mg, 78%) as a sticky solid. HPLC 97.00% (<i>t</i><sub>R</sub> = 17.0 min, 70% MeOH in 0.1% TFA water 30 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.27 (s, 1H), 8.78–8.72 (m, 1H), 8.30 (appdt, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.42–7.39 (m, 1H), 7.12 (d, <i>J</i> = 8.7 Hz, 2H, [7.06 minor isomer]), 6.88 (d, <i>J</i> = 8.7 Hz, 2H, [6.80 minor isomer]), 4.78 (s, 2H, [4.89 minor isomer]), 4.71 (s, 2H, [4.81 minor isomer]), 4.46–4.39 (m, 1H), 2.48–2.38 (m, 2H), 1.83–1.71 (m, 4H), 1.38–1.24 (brm, 11H, and around 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.17 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.26 [177.47 minor isomer], 168.57, 166.66 [166.88 minor isomer ], 156.11 [155.86 minor isomer], 152.20 [152.49 minor isomer], 148.91 [148.86 minor isomer], 141.82, 141.75, 134.96, 128.03, 123.86, 114.60 [114.50 minor isomer], 67.88 [69.03 minor isomer], 48.98 [47.07 minor isomer], 43.88, 37.30 [38.66 minor isomer], 34.85, 27.13 [29.93 minor isomer], 26.36, 21.51 [19.99 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 435.24 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 435.2391, found 435.2395.</div></div><div id="sec6_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-Isopropyl-2-(4-isopropylphenoxy)-<i>N</i>-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ai</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5p</b> (61 mg, 0.29 mmol) and <b>10f</b> (52 mg, 0.24 mmol) using triethylamine (49 mg, 0.48 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ai</b> (77 mg, 81%) as a sticky white solid. HPLC 99.1% (<i>t</i><sub>R</sub> = 6.7 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.27 (s, 1H), 8.77–8.70 (m, 1H), 8.30 (dt, <i>J</i> = 8.0,1.8 Hz, 1H), 8.40 (appdd, <i>J</i> = 7.7, 5.0 Hz, 1H), 7.14 (d, <i>J</i> = 8.6 Hz, 2H, [7.08 minor isomer]), 6.89 (d, <i>J</i> = 8.6 Hz, 2H, [6.81 minor isomer]), 4.79 (s, 2H, [4.89 minor isomer]), 4.71 (s, 2H, [4.81 minor isomer]), 4.45–4.39 (m, 1H), 2.88–2.78 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.17 minor isomer]), 1.20 (d, <i>J</i> = 6.9 Hz, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.26 [177.47 minor isomer], 168.56, 166.65 [166.88 minor isomer], 156.11 [155.88 minor isomer], 152.22 [152.52 minor isomer], 148.91, 142.44, 134.96, 127.66, 123.81 [123.91 minor isomer], 123.25, 114.64 [114.53 minor isomer], 67.89 [69.01 minor isomer], 48.98 [47.06 minor isomer], 37.30 [38.65 minor isomer], 33.49, 24.37, 21.50 [19.99 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 395.20 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 395.2078, found 395.2074.</div></div><div id="sec6_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-Isopropyl-2-(4-<i>tert</i>-butylphenoxy)-<i>N</i>-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11aj</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5r</b> (63 mg, 0.28 mmol) and <b>10f</b> (50 mg, 0.23 mmol) using triethylamine (47 mg, 0.46 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11aj</b> (78 mg, 83%) as a sticky colorless solid. HPLC 97.96% (<i>t</i><sub>R</sub> = 9.1 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.28 (s, 1H), 8.73 (brs, 1H), 8.20 (appd, <i>J</i> = 8.0 Hz, 1H), 7.40 (appdd, <i>J</i> = 7.7, 4.9 Hz, 1H), 7.29 (d, <i>J</i> = 8.7 Hz, 2H, [7.24 minor isomer shown]), 6.89 (d, <i>J</i> = 8.7 Hz, 2H, [6.81 minor isomer]), 4.78 (s, 2H, [4.89 minor isomer]), 4.71 (s, 2H, [4.83 minor isomer]), 4.43–4.37 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]), 1.27 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.27 [177.48 minor isomer], 168.62, [168.53 minor isomer], 166.64 [166.86 minor isomer], 155.76 [155.53 minor isomer], 152.23 [152.52 minor isomer], 148.89, 144.69, 134.97, 126.64 [126.60 minor isomer], 123.87, 123.26, 114.26 [114.15 minor isomer], 67.75 [68.86 minor isomer], 48.98 [47.00 minor isomer], 37.32 [38.62 minor isomer], 34.35, 31.70 [31.67 minor isomer], 21.52 [20.01 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 409.22 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 409.2234, found 409.2233.</div></div><div id="sec6_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-Isopropyl-2-(4-isobutylphenoxy)-<i>N</i>-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ak</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5q</b> (74 mg, 0.32 mmol) and <b>10f</b> (59 mg, 0.27 mmol mmol) using triethylamine (55 mg, 0.54 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ak</b> (97 mg, 88%) as a white solid. Mp 121.5–123.7 °C. HPLC 98.3% (<i>t</i><sub>R</sub> = 10.8 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.27 (s, 1H), 8.74 (brs, 1H), 8.29 (d, <i>J</i> = 7.8 Hz, 1H), 7.41(brm, 1H), 7.05 (d, <i>J</i> = 8.6 Hz, 2H, [7.00 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.79 minor isomer]), 4.79 (s, 2H, [4.90 minor isomer]), 4.71 (s, 2H, [4.81 minor isomer]), 4.47–4.40 (m, 1H), 2.40 (d, <i>J</i> = 7.2 Hz, 2H, partially overlapped, [2.36 minor isomer partially overlapped]), 1.85–1.73 (m, 1H), 1.31 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]), 0.87 (d, <i>J</i> = 6.6 Hz, 6H, [0.85 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.24, 168.59, 166.72, 156.15 [155.92 minor isomer], 152.14, 148.89, 135.26 [135.34 minor isomer], 134.93, 130.35, 114.46 [114.37 minor isomer], 67.93 [69.06 minor isomer], 48.98 [47.06 minor isomer], 44.73, 37.30 [38.65 minor isomer], 30.53 [30.49 minor isomer], 22.52, 21.51 [19.98 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 409.23 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 409.2234, found 409.2231.</div></div><div id="sec6_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-Isopropyl-2-(4-propylphenoxy)-<i>N</i>-((3-(pyrimidin-5-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11al</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5k</b> (46 mg, 0.22 mmol) and <b>10h</b> (40 mg, 0.18 mmol) using triethylamine (36 mg, 0.36 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11al</b> (58 mg, 81%) as a white solid. Mp 92.7–94.0 °C. HPLC 97.2% (<i>t</i><sub>R</sub> = 12.1 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.39–9.28 (m, 3H), 7.09 (d, <i>J</i> = 8.5 Hz, 2H, [7.01 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.75 minor isomer]), 4.78 (s, 2H, [4.92 minor isomer]), 4.70 (s, 2H), 4.49–4.41 (m, 1H), 2.52 (t, <i>J</i> = 7.6 Hz, 2H, [2.45 minor isomer]), 1.64–1.47 (m, 2H), 1.32 (d, <i>J</i> = 6.8 Hz, 6H, [1.17 minor isomer]), 0.91 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.87, 168.67, 164.52, 160.62 [160.82 minor isomer], 155.72 [156.04 minor isomer], 136.33, 129.71, 121.78, 114.54 [114.40 minor isomer], 67.83, 49.03 [49.00 minor isomer], 37.34 [38.87 minor isomer], 24.92, 21.53 [20.05 minor isomer], 14.02; LC–MS (ESI+) <i>m</i>/<i>z</i> 396.20 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub>(M + H)<sup>+</sup> 396.2030, found 396.2031.</div></div><div id="sec6_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-Isopropyl-2-(4-propylphenoxy)-<i>N</i>-((3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11am</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5k</b> (77 mg, 0.36 mmol) and <b>10j</b> (66 mg, 0.30 mmol) using triethylamine (61 mg, 0.60 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11am</b> (101 mg, 85%) as a colorless sticky solid. HPLC 97.3% (<i>t</i><sub>R</sub> = 11.1 min, 50% MeOH in 0.1% TFA water 30 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.29 (appd, <i>J</i> = 1.4 Hz, 1H, [9.26 minor isomer]), 8.73–8.70 (m, 2H), 7.08 (d, <i>J</i> = 8.6 Hz, 2H, [7.01 minor isomer]), 6.86 (d, <i>J</i> = 8.6 Hz, 2H, [6.77 minor isomer]), 4.78 (s, 2H, [4.94 minor isomer]), 4.76 (s, 2H, [4.79 minor isomer]), 4.46–4.36 (m, 1H), 2.50 (t, <i>J</i> = 7.8 Hz, 2H, [2.45 minor isomer]), 1.63–1.51 (m, 2H), 1.30 (d, <i>J</i> = 6.6 Hz, 6H, [1.15 minor isomer]), 0.90 (t, <i>J</i> = 7.5 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.00, 168.64, 166.65 [166.86 minor isomer], 156.08 [155.82 minor isomer], 146.96, [146.67 minor isomer], 145.02 [145.09 minor isomer], 144.62, 142.47, 136.29, 129.72 [129.67 minor isomer], 114.58 [114.50 minor isomer], 67.92 [ 69.16 minor isomer], 49.02 [47.08 minor isomer], 37.35 [38.85 minor isomer], 24.92, 21.49 [19.96 minor isomer], 14.02; LC–MS (ESI+) <i>m</i>/<i>z</i> 396.19 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub>(M + H)<sup>+</sup> 396.2030, found 396.2028.</div></div><div id="sec6_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2(-4-Butylphenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl)methylecetamide (<b>11an</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5l</b> (54 mg, 0.24 mmol) and <b>10j</b> (44 mg, 0.20 mmol) using triethylamine (41 mg, 0.40 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11an</b> (64 mg, 78%) as a yellow/green sticky solid. HPLC 97.97% (<i>t</i><sub>R</sub> = 9.7 min, 70% MeOH in 0.1% TFA water 30 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.30 (d, <i>J</i> = 1.4 Hz, 1H), 9.27 (brs, 1H), 8.74–8.71 (m, 1H), 7.09 (d, <i>J</i> = 8.6 Hz, 2H, [7.02 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.78 minor isomer]), 4.80 (s, 2H, [4.95 minor isomer]), 4.76 (s, 2H, [4.80 minor isomer]), 4.48–4.39 (m, 1H), 2.53 (t, <i>J</i> = 7.7 Hz, 2H, [2.47 minor isomer]), 1.63–1.48 (m, 3H), 1.37–1.14 [m, 10H and around 1.30 (d, <i>J</i> = 6.7 Hz, 6H, [1.16 minor isomer]), 0.90 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.00, 168.64, 166.64, 156.05 [155.78 minor isomer], 146.65 [146.94 minor isomer], 145.00 [145.08 minor isomer], 144.61, 142.47 [142.08 minor isomer], 136.49 [136.57 minor isomer], 129.65 [129.80 minor isomer], 114.60 [114.53 minor isomer], 67.93 [69.17 minor isomer], 49.01 [47.13 minor isomer], 37.34 [38.85 minor isomer], 34.94, 34.00, 22.52 [21.11 minor isomer], 21.47 [19.95 minor isomer shown], 14.17; LC–MS (ESI+) <i>m</i>/<i>z</i> 410.222 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub>(M + H)<sup>+</sup> 410.2187, found 410.2185.</div></div><div id="sec6_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-Isopropyl-2-(4-propylphenoxy)-<i>N</i>-((3-(pyrimidin-2-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ao</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5k</b> (46 mg, 0.22 mmol) and <b>10i</b> (40 mg, 0.18 mmol) using triethylamine (36 mg, 0.36 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ao</b> (63 mg, 88%) as a colorless sticky solid; HPLC 97.9% (<i>t</i><sub>R</sub> = 7.1 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (d, <i>J</i> = 4.9 Hz, 2H), 7.45 (t, <i>J</i> = 4.9 Hz, 1H, [7.48 minor isomer]), 7.10 (d, <i>J</i> = 8.6 Hz, 2H, [7.04 minor isomer]), 6.88 (d, <i>J</i> = 8.6 Hz, 2H, [6.81 minor isomer]), 4.83 (s, 2H, [4.99 minor isomer]), 4.80 (s, 2H, [4.81 minor isomer]), 4.44–4.34 (m, 1H), 2.52 (t, <i>J</i> = 7.7 Hz, 2H, partially overlapped [2.48 minor isomer, partially overlapped]), 1.66–1.51 (m, 2H, [1.46–1.38 minor isomer]), 1.28 (d, <i>J</i> = 6.6 Hz, 2H, [1.14 minor isomer]), 0.92 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.04, 168.62 [167.47 minor isomer], 167.85, 158.19 [158.27 minor isomer], 156.27, 156.09, 136.24, 129.73, 122.37, 114.59, 67.97 [69.02 minor isomer], 49.02 [47.00 minor isomer], 37.36 [38.85 minor isomer], 37.34, 24.93, 21.42 [19.90 minor isomer], 14.02; LC–MS (ESI+) <i>m</i>/<i>z</i> 396.19 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub>(M + H)<sup>+</sup> 396.2030, found 396.2025.</div></div><div id="sec6_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-Isopropyl-2-(4-propylphenoxy)-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ap</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5k</b> (140 mg, 0.66 mmol) and <b>10a</b> (127 mg, 0.55 mmol) using triethylamine (111 mg, 1.10 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ap</b> (195 mg, 87%) as a white solid. Mp 121.7–122.3 °C. HPLC 99.3% (<i>t</i><sub>R</sub> = 11.1 min, 45% MeOH in 0.1% TFA water 30 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.90 (d, <i>J</i> = 8.2 Hz, 2H), 7.29–7.20 (m, 2H), 7.07 (d, <i>J</i> = 8.6 Hz, 2H, [7.03 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.82 minor isomer]), 4.77 (s, 2H, [4.83 minor isomer]), 4.69 (s, 2H, [4.82 minor isomer]), 4.45–4.34 (m, 1H), 2.54–2.46 (m, 2H), 2.39 (s, 3H, [2.40 minor isomer]), 1.60–1.50 (m, 2H), 1.29 (d, <i>J</i> = 6.6 Hz, 6H, [1.13 minor isomer]), 0.91 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.43 [δ 176.57 minor isomer]), 168.56 [168.80 minor isomer]), 168.50, 156.18 [155.99 minor isomer]), 141.66 [142.14 minor isomer]), 136.16, 129.69 [129.83 minor isomer]), 127.65, 124.09 [123.58 minor isomer]), 114.64 [114.59 minor isomer]), 67.99 [68.74 minor isomer]), 48.94 [46.89 minor isomer]), 37.37 [38.41 minor isomer]), 37.22, 24.92, 21.82, 21.47 [19.98 minor isomer]), 14.03; LC–MS (ESI+) <i>m</i>/<i>z</i> 408.22 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>30</sub>N<sub>3</sub>O<sub>3</sub>(M + H)<sup>+</sup> 408.2282, found 408.2279.</div></div><div id="sec6_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>tert</i>-Butyl 4-(2-(Isopropyl((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)amino)-2-oxoethoxy)benzoate (<b>11aq</b>)</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl 4-hydroxybenzoate (<b>27</b>, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for <b>27</b>) (27 mg, 0.14 mmol), <b>15</b> (41 mg, 0.14 mmol), and potassium carbonate (97 mg, 0.70 mmol) in acetonitrile (20 mL) was heated under reflux overnight. Acetonitile was evaporated, and the residue was dissolved in ethyl acetate (20 mL) and washed with water (20 mL × 2). The organic phase was dried (MgSO<sub>4</sub>) and the product obtained was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11aq</b> (51 mg, 80% as a white solid). Mp 143.0–144.4 °C. HPLC 99.7% (<i>t</i><sub>R</sub> = 14.1 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.97 (d, <i>J</i> = 8.8 Hz, 2H, [8.01 minor isomer]), 7.94 (d, <i>J</i> = 8.8 Hz, 2H, [7.88 minor isomer]), 7.50–7.38 (m, 3H), 6.96 (d, <i>J</i> = 8.9 Hz, 2H, overlapped, [6.93 minor isomer, overlapped]), 4.86 (s, 2H, [4.91 minor isomer]), 4.69 (s, 2H, [4.78 minor isomer]), 4.41–4.31 (m, 1H), 1.55 (s, 9H), 1.29 (d, <i>J</i> = 6.6 Hz, 6H, [1.14 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) 176.14 [176.24 minor isomer], 168.32, 167.60 [167.68 minor isomer], 165.40 [165.65 minor isomer], 161.11 [161.06 minor isomer], 159.73, 131.60 [131.64 minor isomer], 131.51 [131.45 minor isomer], 128.77 [128.96 minor isomer], 127.45 [126.50 minor isomer], 125.51 [125.46 minor isomer], 124.25, 114.96, 114.11 [114.06 minor isomer], 80.74 [80.51 minor isomer], 67.30 [67.84 minor isomer], 48.78 (46.83 minor isomer), 36.98 [38.22 minor isomer], 28.24 [29.70 minor isomer], 21.24 [19.75 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 469.26 (M + NH<sub>4</sub>)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>30</sub>N<sub>3</sub>O<sub>5</sub> (M + H)<sup>+</sup> 452.2180, found 452.2191.</div></div><div id="sec6_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-(4-Fluorophenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-(pyridin-3-yl)1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11ar</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5f</b> (93 mg, 0.49 mmol) and <b>10f</b> (90 mg, 0.41 mmol) using triethylamine (83 mg, 0.82 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11ar</b> (132 mg, 87%) as a white solid. Mp 83.8–84.6 °C. HPLC 100% (<i>t</i><sub>R</sub> = 10.8 min, 30% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4.5:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.25 (s, 1H), 8.73 (d, <i>J</i> = 4.1 Hz, 1H, [8.76 minor isomer]), 8.25 (dt, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.40 (dd, <i>J</i> = 7.9, 4.9 Hz, 1H, partially overlapped, [7.43 minor isomer]), 7.05–6.83 (m, 4H, [6.88–6.78 minor isomer]), 4.79 (s, 2H, [4.81 minor isomer]), 4.71 (s, 2H, [4.86 minor isomer]), 4.47–4.35 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) 176.97 [177.10 minor isomer], 168.06, 166.25 [166.62 minor isomer], 157. 72 (d, <i>J</i> = 239 Hz), 153.93 (d, <i>J</i> = 2.06 Hz), 151.39 [152.19 minor isomer], 148.07 [148.41 minor isomer], 135.18 [134.86 minor isomer], 123.80, 123.16, 116.03 (d, <i>J</i> = 23 Hz), 115.75 (d, <i>J</i> = 8 Hz), 67.91 [68.67 minor isomer], 48.72 [46.89 minor isomer], 37.03 [38.34 minor isomer], 21.26 [19.75 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −122.60 [−122.53 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 371.15 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> 371.1514, found 371.1517.</div></div><div id="sec6_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-(4-Chlorophenoxy)-<i>N</i>-isopropyl-<i>N</i>-((3-(pyridin-3-yl)1,2,4-oxadiazol-5-yl)methyl)acetamide (<b>11as</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5d</b> (66 mg, 0.32 mmol) and <b>10f</b> (59 mg, 0.27 mmol) using triethylamine (55 mg, 0.54 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>11as</b> (91 mg, 87%) as a white solid. Mp 118.1–119.9 °C. HPLC 99.0% (<i>t</i><sub>R</sub> = 10.4 min, 35% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.25 (s, 1H), 8.73 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H, overlapped [8.76 minor isomer, overlapped]), 8.24 (dt, <i>J</i> = 7.9, 1.9 Hz, 1H), 7.41 (dd, <i>J</i> = 8.0, 4.9 Hz, 1H), 7.22 (d, <i>J</i> = 9.0 Hz, 2H, [7.18 minor isomer]), 6.90 (d, <i>J</i> = 9.0 Hz, 2H, [6.83 minor isomer]), 4.80 (s, 2H, [4.85 minor isomer]), 4.70 (s, 2H, [4.83 minor isomer]), 4.48–4.31 (m, 1H), 1.32 (d, <i>J</i> = 6.6 Hz, 6H, [1.17 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) 176.74, 167.82, 166.35, 156.39, 152.39 [152.03 minor isomer], 148.59 [148.55 minor isomer], 134.59, 129.51 [129.47 minor isomer], 126.68, 123.63 [122.89 minor isomer], 115.89 [115.83 minor isomer], 67.59 [68.57 minor isomer], 48.75 [46.93 minor isomer], 37.03 [38.38 minor isomer], 21.24 [18.67 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 387.03 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>20</sub>ClN<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> 387.1218, found 387.1212.</div></div><div id="sec6_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-Isobutyl-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>12a</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (95 mg, 0.52 mmol) and <b>10m</b> (106 mg, 0.43 mmol) using triethylamine (87 mg, 0.86 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>12a</b> (147 mg, 87%) as a white solid. Mp 78.4–79.8 °C. HPLC 99.1% (<i>t</i><sub>R</sub> = 11.8 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed approximately 2:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (d, <i>J</i> = 8.2 Hz, 2H), 7.30–7.25 (m, 2H), 7.08 (d, <i>J</i> = 8.3 Hz, 2H, [7.04 minor isomer]), 6.86 (d, <i>J</i> = 8.6 Hz, 2H, [6.81 minor isomer]), 4.85 (s, 2H, [4.93 minor isomer]), 4.79 (s, 2H, [4.86 minor isomer]), 3.36–3.34 (m, 2H), 2.41 (s, 3H, [2.42 minor isomer]), 2.27 (s, 3H, [2.24 minor isomer]), 2.06–1.94 (m, 1H), 1.01 (d, <i>J</i> = 6.6 Hz, 6H, [0.86 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 175.43 [175.48 minor isomer], 169.22 [169.08 minor isomer], 168.61 [168.79 minor isomer], 156.04 [155.63 minor isomer], 141.82 [142.15 minor isomer], 131.21 [131.33 minor isomer], 130.24, 129.74 [129.84 minor isomer], 127.66 [127.67 minor isomer], 123.92 [123.53 minor isomer], 114.82 [114.54 minor isomer], 67.23 [68.55 minor isomer], 55.50 [54.51 minor isomer], 42.10 [43.59 minor isomer], 27.73 [26.86 minor isomer], 21.85, 20.75 [20.70 minor isomer], 20.28 [20.15 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 394.20 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 394.2125, found 394.2127.</div></div><div id="sec6_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>N</i>-Ethyl-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>12b</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (51 mg, 0.28 mmol) and <b>10l</b> (50 mg, 0.23 mmol) using triethylamine (47 mg, 0.46 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>12b</b> (69 mg, 82%) as a white solid. Mp 97.4–100.1 °C. HPLC 99.6% (<i>t</i><sub>R</sub> = 9.0 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 2:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (d, <i>J</i> = 8.1 Hz, 2H, partially overlapped, [7.89 minor isomer]), 7.31–7.27 (m, 2H), 7.09 (d, <i>J</i> = 8.2 Hz, 2H, [7.03 minor isomer]), 6.87 (d, <i>J</i> = 8.6 Hz, 2H, [6.79 minor isomer]), 4.84 (s, 2H, [4.91 minor isomer]), 4.78 (s, 2H, [4.82 minor isomer]), 3.63 (q, <i>J</i> = 7.1 Hz, 2H, partially overlapped, [3.59 minor isomer overlapped]), 2.41 (s, 3H, [2.42 minor isomer]), 2.29 (s, 3H, [2.24 minor isomer]), 1.29 (t, <i>J</i> = 7.1 Hz, 3H, [1.16 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 175.56 [175.49 minor isomer], 168.86 [168.80 minor isomer], 168.66 [168.48 minor isomer], 156.00 [155.65 minor isomer], 141.85 [142.12 minor isomer], 131.27 [131.32 minor isomer], 130.30 [130.27 minor isomer], 129.75 [129.82 minor isomer], 127.66, 123.89 [123.56 minor isomer], 114.72 [114.52 minor isomer], 67.61 [68.52 minor isomer], 43.31 [42.97 minor isomer], 41.30 [42.72 minor isomer], 21.83, 20.74 [20.68 minor isomer], 14.14 [12.56 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 366.19 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 366.1812, found 366.1810.</div></div><div id="sec6_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>N</i>-Methyl-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>12c</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (67 mg, 0.36 mmol) and <b>10k</b> (61 mg, 0.30 mmol) using triethylamine (61 mg, 0.60 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>12c</b> (100 mg, 95%) as a white solid. Mp 99.1–100.9 °C. HPLC 96.7% (<i>t</i><sub>R</sub> = 7.4 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 2:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (d, <i>J</i> = 8.3 Hz, 2H, overlapped, [7.90 minor isomer, overlapped]), 7.30–7.26 (m, 2H), 7.08 (d, <i>J</i> = 8.1 Hz, 2H, [7.03 minor isomer]), 6.87 (d, <i>J</i> = 8.8 Hz, 2H, [6.78 minor isomer]), 4.87 (s, 2H [4.94 minor isomer]), 4.78 (s, 2H, [4.82 minor isomer]), 3.28 (s, 3H, [3.12 minor isomer]), 2.41 (s, 3H, [2.42 minor isomer)], 2.28 (s, 3H, [2.23 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 175.13 [175.03 minor isomer], 169.08 [168.92 minor isomer shown], 168.80 [168.68 minor isomer shown], 155.58 [155.89 minor isomer], 141.91 [142.12 minor isomer], 131.32 [131.38 minor isomer], 130.29, 129.77 [129.82 minor isomer], 127.65, 123.82 [123.54 minor isomer], 114.76, [114.44 minor isomer], 67.53 [67.49 minor isomer], 43.98 [45.45 minor isomer], 35.77 [35.22 minor isomer], 21.85 [21.83 minor isomer], 20.75 [20.74 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 352.17 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 352.1657, found 352.1658.</div></div><div id="sec6_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i>-((3-<i>p</i>-Tolyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>12d</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (58 mg, 0.31 mmol) and <b>10n</b> (49 mg, 0.26 mmol) using triethylamine (54 mg, 0.53 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>12d</b> (69 mg, 79%) as a white solid. Mp 113.7–115.5 °C. HPLC 99.9% (<i>t</i><sub>R</sub> = 6.5 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94 (d, <i>J</i> = 8.2 Hz, 2H), 7.28 (d, <i>J</i> = 8.2 Hz, 2H), 7.12 (d, <i>J</i> = 8.2 Hz, 2H), 6.87 (d, <i>J</i> = 8.6 Hz, 2H), 4.84 (d, <i>J</i> = 5.9 Hz, 2H), 4.59 (s, 2H), 2.42 (s, 3H), 2.31 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 175.46, 169.14, 168.66, 155.20, 142.02, 131.98, 130.49, 129.82, 127.64, 123.67, 114.82, 67.70, 35.46, 21.85, 20.77; LC–MS (ESI+) <i>m</i>/<i>z</i> 360.14 (M + Na)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 338.1499, found 338.1505.</div></div><div id="sec6_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> <i>N</i>-<i>tert</i>-Butyl-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl-2-(<i>p</i>-tolyloxy)acetamide (<b>12e</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (40 mg, 0.22 mmol) and <b>10o</b> (44 mg, 0.18 mmol) using triethylamine (36 mg, 0.36 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>12e</b> (53 mg, 75%) as a white solid. Mp 129.1–130.0 °C. HPLC 96.2% (<i>t</i><sub>R</sub> = 18.3 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91 (d, <i>J</i> = 8.2 Hz, 2H), 7.27 (m, 2H), 7.02 (m, 2H), 6.78 (d, <i>J</i> = 8.6 Hz, 2H), 4.95 (s, 2H), 4.76 (s, 2H), 2.42 (s, 3H), 2.24 (s, 3H), 1.47 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.97, 169.45, 168.78, 155.88, 142.11, 131.07, 130.17, 129.81, 127.66, 123.62, 114.55, 69.81, 59.15, 40.71, 28.47, 21.86, 20.72; LC–MS (ESI+) <i>m</i>/<i>z</i> 394.22 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 394.2125, found 394.2114.</div></div><div id="sec6_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> <i>N</i>-Cyclopropyl-<i>N</i>-((3-<i>p</i>-tolyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>12f</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (74 mg, 0.40 mmol) and <b>10p</b> (76 mg, 0.33 mmol) using triethylamine (67 mg, 0.66 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>12f</b> (98 mg, 79%) as a white solid. Mp 113.8–115.2 °C. HPLC 94.8% (<i>t</i><sub>R</sub> = 6.2 min, 70% MeOH in 0.1% TFA water 20 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.93 (d, <i>J</i> = 8.0 Hz, 2H), 7.31–7.23 (m, 2H), 7.06 (d, <i>J</i> = 8.2 Hz, 2H), 6.86 (d, <i>J</i> = 8.3 Hz, 2H), 4.97 (s, 2H), 4.88 (s, 2H), 3.10–3.02 (m, 1H), 2.42 (s, 3H), 2.26 (s, 3H), 1.05–0.91 (m, 4H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 175.92, 171.51, 168.61, 156.24, 141.86, 131.02, 130.19, 129.75, 127.65, 123.91, 114.81, 67.14, 43.44, 29.96, 21.82, 20.72, 9.29; LC–MS (ESI+) <i>m</i>/<i>z</i> 378.18 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 378.1812, found 378.1811.</div></div><div id="sec6_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-Isopropyl-3-(4-methylbenzyl)-1-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)urea (<b>14</b>)</h4><div class="NLM_p last">A solution of <b>10d</b> (70 mg, 0.32 mmol), 4-methylbenzyl isocyanate <b>13</b> (47 mg, 0.32 mmol), and triethylamine (40 mg, 0.39 mmol) was heated under reflux in benzene overnight (14–15 h). The organics were evaporated, and the residue was dissolved in ethyl acetate (20 mL) and washed with HCl (4 M, 3 × 10 mL) and water (2 × 20 mL). The organic phase was dried (MgSO<sub>4</sub>), evaporated, and the crude product obtained was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to obtain pure <b>14</b> (91 mg, 78%) as a white solid. Mp 87.6–89.1 °C. HPLC 96.26% (<i>t</i><sub>R</sub> = 14.98 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 30 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98–7.95 (m, 2H), 7.44–7.49 (m, 1H), 7.49–7.44 (m, 2H), 7.24 (d, <i>J</i> = 8.0 Hz, 2H), 7.13 (d, <i>J</i> = 7.8 Hz, 2H), 5.52 (apparent t, 1H), 4.63 (s, 2H), 4.43 (d, <i>J</i> = 4.7 Hz, 2H), 4.40–4.34 (m, 1H), 2.33 (s, 3H), 1.22 (d, <i>J</i> = 6.8 Hz, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.63, 168.47, 158.01, 137.13, 136.32, 131.58, 129.52, 129.03, 128.03, 127.71, 126.53, 47.12, 45.27, 37.62, 21.36, 20.96; LC–MS (ESI+) <i>m</i>/<i>z</i> 365.20 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 365.1972, found 365.1988.</div></div><div id="sec6_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>-Isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-2-(<i>p</i>-tolylamino)acetamide (<b>16</b>)</h4><div class="NLM_p last">A solution of <i>p</i>-toluidine (19 mg, 0.18 mmol), <b>15</b> (65 mg, 0.22 mmol), and sodium acetate (18 mg, 0.22 mmol) in ethanol (20 mL) was refluxed for 15 h. Ethanol was evaporated and the product was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to obtain <b>16</b> as a yellow-brown sticky solid (51 mg, 78%). HPLC 96.59% (<i>t</i><sub>R</sub> = 12.2 min, 45% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 4:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.07–8.04 (m, 2H), 7.54–7.44 (m, 3H), 7.01 (d, <i>J</i> = 8.1 Hz, 2H), 6.59 (d, <i>J</i> = 8.3 Hz, 2H), 4.76 (s, 2H, [4.71 minor isomer]), 4.29–4.16 (m, 1H, [4.98–4.90 minor isomer]), 4.05 (s, 2H), 2.25 (s, 3H, [2.23 minor isomer]), 1.34 (d, <i>J</i> = 6.6 Hz, 6H, [1.18 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.66 [176.22 minor isomer], 169.91 [169.69 minor isomer], 168.65 [168.92 minor isomer], 145.14, 131.43 [131.83 minor isomer], 130.01 [130.14 minor isomer], 129.00 [129.18 minor isomer], 127.74 [127.70 minor isomer], 127.33, 126.82, 113.51 [113.65 minor isomer], 47.98 [49.59 minor isomer], 46.18 [46.74 minor isomer], 37.25 [37.44 minor isomer], 21.32 [19.96 minor isomer], 20.65 [20.14 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 365.19 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub>(M + H)<sup>+</sup> 365.1972, found 365.1978.</div></div><div id="sec6_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>N</i>-Isopropyl-<i>N</i>-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)-3-(4-(trifluoromethyl)phenyl)propanamide (<b>19a</b>)</h4><div class="NLM_p last">This compound was prepared from <b>18a</b> (131 mg, 0.55 mmol) and <b>10d</b> (100 mg, 0.46 mmol) using triethylamine (93 mg, 0.92 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>19a</b> (169 mg, 88%) as a white solid. Mp 96.1–97.7 °C. HPLC 98.5% (<i>t</i><sub>R</sub> = 5.27 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06 (dd, <i>J</i> = 7.9, 1.7 Hz, 2H, overlapped [8.03 minor isomer overlapped]), 7.56–7.42 (m, 5H), 7.37 (d, <i>J</i> = 8.1 Hz, 2H, [7.33 minor isomer]), 4.70 (s, 2H, [4.61 minor isomer]), 4.25–4.18 (m, 1H, [4.97 minor isomer]), 3.08 (t, <i>J</i> = 7.6 Hz, 2H, [3.02 minor isomer]), 2.79 (t, <i>J</i> = 7.6 Hz, 2H, [2.71 minor isomer]), 1.24 (d, <i>J</i> = 6.7 Hz, 6H, [1.12 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.07 [176.66 minor isomer], 171.92 [172.02 minor isomer], 168.58, 145.48, 131.40 [131.84 minor isomer], 129.19, 129.07, 129.00 [128.88 minor isomer], 127.70 [127.67 minor isomer], 126.94, 125.64 (q, <i>J</i> = 3.76 Hz), 124.50 (q, <i>J</i> = 271 Hz), 48.78 [45.82 minor isomer], 37.16 [38.72 minor isomer], 34.81 [35.30 minor isomer], 31.09 [31.17 minor isomer], 21.33 [20.20 minor isomer]; <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −62.75 [−62.78 minor isomer]; LC–MS (ESI+) <i>m</i>/<i>z</i> 418.18 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub> (M + H)<sup>+</sup> 418.1737, found 418.1745.</div></div><div id="sec6_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Benzofuran-2-carboxylic Acid Isopropyl-(3-pyridin-3-yl[1,2,4]oxadiazol-5-yl)methyl)amide (<b>19b</b>)</h4><div class="NLM_p last">This compound was prepared from <b>18b</b> (63 mg, 0.35 mmol) and <b>10f</b> (63 mg, 0.29 mmol using triethylamine (59 mg, 0.58 mmol) in a similar manner as described for compound <b>11u</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>19b</b> (86 mg, 82%) as a sticky colorless solid. HPLC 96.1% (<i>t</i><sub>R</sub> = 4.1 min, 70% MeOH in 0.1% TFA water 20 min); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.27 (s, 1H), 8.71 (appd, <i>J</i> = 4.0 Hz, 1H), 8.32 (d, <i>J</i> = 7.9 Hz, 1H), 7.63 (d, <i>J</i> = 7.7 Hz, 1H), 7.46–7.38 (m, 3H, [7.57–7.46 minor isomer]), 7.31–7.25 (m, 2H), 5.03–4.93 (m, 1H), 4.89 (brs, 2H), 1.37 (d, <i>J</i> = 3.1 Hz, 6H, [7.50 minor isomer]). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.69, 161.31, 154.93, 152.05, 148.69, 135.19, 127.05 [126.98 minor isomer], 123.98 [123.95 minor isomer], 122.63 [123.26 minor isomer] 113.13, 112.13, 49.89, 38.21, 22.78, 21.66; LC–MS (ESI+) <i>m</i>/<i>z</i> 363.16 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>(M + H)<sup>+</sup> 363.1452, found 363.1455.</div></div><div id="sec6_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>N</i>-Isopropyl-<i>N</i>-(2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl)-2-(<i>p</i>-tolyloxy)acetamide (<b>23</b>)</h4><div class="NLM_p last">This compound was prepared from <b>5a</b> (56 mg, 0.55 mmol) and <b>22</b> (106 mg, 0.46 mmol, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for the synthesis of <b>22</b>) using triethylamine (93 mg, 0.92 mmol) in a similar manner as described for compound <b>1</b>. The crude product obtained was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to afford pure <b>23</b> (152 mg, 87%) as a sticky colorless solid. HPLC 97.51% (<i>t</i><sub>R</sub> = 22.7 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 30 min). The <sup>1</sup>H NMR showed 3:1 ratio of atropisomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.07–8.02 (m, 2H), 7.52–7.44 (m, 3H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 6.85 (d, <i>J</i> = 8.6 Hz, 2H), 4.69 (s, 2H), 4.29–4.20 (m, 2H, [4.55–4.44 minor isomer]), 3.72 (t, <i>J</i> = 7.4 Hz, 2H, [3.89 minor isomer]), 3.28 (t, <i>J</i> = 7.4 Hz, 2H), 2.28, (s, 3H, [2.26 minor isomer]), 1.28 (d, <i>J</i> = 6.7 Hz, 6H, [1.20 minor isomer]); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.76, 168.50, 168.40, 155.99, 131.37 [131.18 minor isomer], 130.29, 129.05, 127.66 [126.99 minor isomer], 114.59 [114.67 minor isomer], 68.31 [68.99 minor isomer], 48.80 [47.87 minor isomer shown], 38.56 [41.31 minor isomer], 26.18 [28.64 minor isomer], 21.36 [20.45 minor isomer], 20.72; LC–MS (ESI+) <i>m</i>/<i>z</i> 380.20 (M + H)<sup>+</sup>; HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub>(M + H)<sup>+</sup> 380.1969, found 380.1965.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82"><a href="/doi/suppl/10.1021/jm400221d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">(i) Synthetic protocols and characterization for libraries <b>5</b> and <b>10</b> and compounds <b>15</b>, <b>18a</b>,<b>b</b>, <b>20</b>–<b>27</b> (except <b>23</b>); (ii) scanned NMR spectra, HPLC, HRMS, and LC–MS reports for <b>1</b>, <b>11x</b>, <b>11aa</b>, <b>11ab</b>, <b>11ac</b>, <b>11ad</b>, <b>11ae</b>, <b>11af</b>, <b>11ah</b>, <b>11al</b>, <b>11am</b>, <b>11an</b>, <b>11ao</b>, <b>11ap</b>, <b>12d</b>, <b>12e</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400221d/suppl_file/jm400221d_si_001.pdf">jm400221d_si_001.pdf (5.76 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400221d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harshani R. Lawrence</span> - <span class="hlFld-Affiliation affiliation">†Drug
Discovery Department, ‡Molecular Oncology Department, §Chemical Biology Core, and ∥Proteomics Core, Moffitt Cancer Center, 12902 Magnolia
Drive, Tampa, Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">⊥Department
of Oncologic Sciences and ¶Department of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d39bb2a1a0bbb2bdbafd9fb2a4a1b6bdb0b693bebcb5b5baa7a7fdbca1b4"><span class="__cf_email__" data-cfemail="e2aa8390918a838c8bccae839590878c8187a28f8d84848b9696cc8d9085">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sevil Ozcan</span> - <span class="hlFld-Affiliation affiliation">†Drug
Discovery Department, ‡Molecular Oncology Department, §Chemical Biology Core, and ∥Proteomics Core, Moffitt Cancer Center, 12902 Magnolia
Drive, Tampa, Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">⊥Department
of Oncologic Sciences and ¶Department of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aslamuzzaman Kazi</span> - <span class="hlFld-Affiliation affiliation">†Drug
Discovery Department, ‡Molecular Oncology Department, §Chemical Biology Core, and ∥Proteomics Core, Moffitt Cancer Center, 12902 Magnolia
Drive, Tampa, Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">⊥Department
of Oncologic Sciences and ¶Department of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Marsilio</span> - <span class="hlFld-Affiliation affiliation">†Drug
Discovery Department, ‡Molecular Oncology Department, §Chemical Biology Core, and ∥Proteomics Core, Moffitt Cancer Center, 12902 Magnolia
Drive, Tampa, Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">⊥Department
of Oncologic Sciences and ¶Department of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bin Fang</span> - <span class="hlFld-Affiliation affiliation">†Drug
Discovery Department, ‡Molecular Oncology Department, §Chemical Biology Core, and ∥Proteomics Core, Moffitt Cancer Center, 12902 Magnolia
Drive, Tampa, Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">⊥Department
of Oncologic Sciences and ¶Department of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wayne C. Guida</span> - <span class="hlFld-Affiliation affiliation">†Drug
Discovery Department, ‡Molecular Oncology Department, §Chemical Biology Core, and ∥Proteomics Core, Moffitt Cancer Center, 12902 Magnolia
Drive, Tampa, Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">⊥Department
of Oncologic Sciences and ¶Department of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Koomen</span> - <span class="hlFld-Affiliation affiliation">†Drug
Discovery Department, ‡Molecular Oncology Department, §Chemical Biology Core, and ∥Proteomics Core, Moffitt Cancer Center, 12902 Magnolia
Drive, Tampa, Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">⊥Department
of Oncologic Sciences and ¶Department of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saïd M. Sebti</span> - <span class="hlFld-Affiliation affiliation">†Drug
Discovery Department, ‡Molecular Oncology Department, §Chemical Biology Core, and ∥Proteomics Core, Moffitt Cancer Center, 12902 Magnolia
Drive, Tampa, Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">⊥Department
of Oncologic Sciences and ¶Department of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e8389-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by NCI Grant 1PO1 CA118210-03 (S.M.S.). We acknowledge Dr. Kenyon Daniel (Mofffiit Chemical Biology Core-Screening and Modeling Unit) for helpful discussions and Nan Sun (Chemical Biology Core-Screening Unit) for technical assistance. We also thank the Chemistry Unit of the Moffitt Chemical Biology Core for technical assistance and maintenance of the NMR, mass spectrometry, and HPLC instruments. The Moffitt Proteomics Facility is supported in part by the U.S. Army Medical Research and Materiel Command under Award W81XWH-08-2-0101 for a National Functional Genomics Center. The Moffitt Proteomics and Chemical Biology Core facilities are supported by the National Cancer Institute under Award P30-CA076292 as a Cancer Center Support Grant and by the Moffitt Foundation.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i85" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i85"> Abbreviations Used</h2><tr><td class="NLM_term">CT-L</td><td class="NLM_def"><p class="first last">chymotrypsin-like</p></td></tr><tr><td class="NLM_term">T-L</td><td class="NLM_def"><p class="first last">trypsin-like</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PGPH-L</td><td class="NLM_def"><p class="first last">postglutamyl-peptide-hydrolysis-like</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">LC–MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–tandem mass spectrometry</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">AMC</td><td class="NLM_def"><p class="first last">7-amino-4-methylcoumarin</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hochstrasser, M.</span><span> </span><span class="NLM_article-title">Ubiquitin, proteasomes, and the regulation of intracellular protein degradation</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2F0955-0674%2895%2980031-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=7612274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2MXkslWhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=215-223&author=M.+Hochstrasser&title=Ubiquitin%2C+proteasomes%2C+and+the+regulation+of+intracellular+protein+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin, proteasomes, and the regulation of intracellular protein degradation</span></div><div class="casAuthors">Hochstrasser, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-23</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 68 refs.  Rapid degrdn. of specific proteins by ubiquitin/proteasome-dependent pathways is a component of many cellular regulatory mechanisms.  Recent work has shown that protein ubiquitination and deubiquitination are both mediated by large families of enzymes and that proteolysis can be modulated by alterations of the proteasome itself.  The complexity of the ubiquitin system is reflected in the broad range of processes it regulates; these include key steps in cell cycle progression, processing of foreign proteins for presentation by class 1 MHC mols., and the control of cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtYy_aXiC_ILVg90H21EOLACvtfcHk0lh9MqHfqKqL9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslWhtLY%253D&md5=e2e2a135307fee97e04f90097519605c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0955-0674%2895%2980031-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0955-0674%252895%252980031-X%26sid%3Dliteratum%253Aachs%26aulast%3DHochstrasser%26aufirst%3DM.%26atitle%3DUbiquitin%252C%2520proteasomes%252C%2520and%2520the%2520regulation%2520of%2520intracellular%2520protein%2520degradation%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D1995%26volume%3D7%26spage%3D215%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Yamasaki, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span> </span><span class="NLM_article-title">Cell cycle, proteolysis and cancer</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2Fj.ceb.2004.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=15530772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVOrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=623-628&author=L.+Yamasakiauthor=M.+Pagano&title=Cell+cycle%2C+proteolysis+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, proteolysis and cancer</span></div><div class="casAuthors">Yamasaki, Lili; Pagano, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">623-628</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Research in the past 15 years has shown that the mammalian cell cycle is controlled by the action of cyclin-dependent kinases (CDKs).  A crucial substrate of the CDKs in G1-phase is the retinoblastoma tumor suppressor (pRB), which restrains proliferation largely by repressing the activity of the E2F transcription factors.  More recent work has shown that the cell cycle is also a tale of two classes of ubiquitin ligases, referred to as SCF and APC/C ligases.  CDKs, E2F and ubiquitin ligases reciprocally regulate each other, resulting in complex feedback loops.  Perturbation of this network of mol. machines is assocd. with proliferative diseases, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLzkzLO5drSrVg90H21EOLACvtfcHk0lh9MqHfqKqL9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVOrtb8%253D&md5=6d0378298b12ab5cbbdc7e54a5672514</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2004.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2004.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DYamasaki%26aufirst%3DL.%26aulast%3DPagano%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520proteolysis%2520and%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2004%26volume%3D16%26spage%3D623%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Coux, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span> </span><span class="NLM_article-title">Structure and functions of the 20S and 26S proteasomes</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1146%2Fannurev.bi.65.070196.004101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=8811196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK28XktFamurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=801-847&author=O.+Couxauthor=K.+Tanakaauthor=A.+L.+Goldberg&title=Structure+and+functions+of+the+20S+and+26S+proteasomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and functions of the 20S and 26S proteasomes</span></div><div class="casAuthors">Coux, Olivier; Tanaka, Keiji; Goldberg, Alfred L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">801-847</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 287 refs., of recent progress with respect to biochem. mechanisms and intracellular functions of the 20 S and 26 S proteasomes (multicatalytic proteinases).  The proteasome is an essential component of the ATP-dependent proteolytic pathway in eukaryotic cells and is responsible for the degrdn. of most cellular proteins.  The 20 S (700-kDa) proteasome contains multiple peptidase activities that function through a new type of proteolytic mechanism involving a threonine active site.  The 26 S (2000-kDa) complex, which degrades ubiquitinated proteins, contains in addn. to the 20 S proteasome a 19 S regulatory complex composed of multiple ATPases and components necessary for binding protein substrates.  The proteasome has been highly conserved during eukaryotic evolution, and simpler forms are even found in archaebacteria and eubacteria.  Major advances have been achieved recently in the knowledge about the mol. organization of the 20 S and 19 S particles, their subunits, the proteasome's role in MHC-class 1 antigen presentation, and regulators of its activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCV4euIYQJHLVg90H21EOLACvtfcHk0lh9MqHfqKqL9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktFamurc%253D&md5=546ea9ad61ac1cf74667da7e5075484c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.65.070196.004101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.65.070196.004101%26sid%3Dliteratum%253Aachs%26aulast%3DCoux%26aufirst%3DO.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DStructure%2520and%2520functions%2520of%2520the%252020S%2520and%252026S%2520proteasomes%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1996%26volume%3D65%26spage%3D801%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A. L.</span><span> </span><span class="NLM_article-title">The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=40-51&author=A.+Ciechanoverauthor=A.+Orianauthor=A.+L.+Schwartz&title=The+ubiquitin-mediated+proteolytic+pathway%3A+mode+of+action+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DOrian%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DA.%2BL.%26atitle%3DThe%2520ubiquitin-mediated%2520proteolytic%2520pathway%253A%2520mode%2520of%2520action%2520and%2520clinical%2520implications%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2000%26spage%3D40%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span> </span><span class="NLM_article-title">The ubiquitin–proteasome proteolytic pathway</span> <span class="citation_source-journal">Cell (Cambridge, MA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2F0092-8674%2894%2990396-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=7923371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2cXmsFWqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1994&pages=13-21&author=A.+Ciechanover&title=The+ubiquitin%E2%80%93proteasome+proteolytic+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin-proteasome proteolytic pathway</span></div><div class="casAuthors">Ciechanover, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-21</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A review, with 61 refs., on the components, mechanisms of action, and cellular physiol. of the ubiquitin-proteasome pathway, including enzymes of the system, recognition of substrates, and cellular substrates of the ubiquitin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKZUwFZmTaxrVg90H21EOLACvtfcHk0ljlWcXo5HAT2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsFWqtb4%253D&md5=4430ea222235ad39b0bc0f2799685f67</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2894%2990396-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252894%252990396-4%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DThe%2520ubiquitin%25E2%2580%2593proteasome%2520proteolytic%2520pathway%26jtitle%3DCell%2520%2528Cambridge%252C%2520MA%252C%2520U.%2520S.%2529%26date%3D1994%26volume%3D79%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Baumeister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuhl, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seemuller, E.</span><span> </span><span class="NLM_article-title">The proteasome: paradigm of a self-compartmentalizing protease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2FS0092-8674%2800%2980929-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=9476896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK1cXhtFGisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=367-880&author=W.+Baumeisterauthor=J.+Walzauthor=F.+Zuhlauthor=E.+Seemuller&title=The+proteasome%3A+paradigm+of+a+self-compartmentalizing+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The proteasome: paradigm of a self-compartmentalizing protease</span></div><div class="casAuthors">Baumeister, Wolfgang; Walz, Jochen; Zuhl, Frank; Seemuller, Erika</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-380</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with ∼100 refs. on advances in understanding the structure of the proteasome and its mechanism of action which shaped the concept of self-compartmentalization and the proteasome became the paradigm of this form of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tVahAhrt17Vg90H21EOLACvtfcHk0ljlWcXo5HAT2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtFGisLY%253D&md5=0a865caef4357214337a03025ba611d6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980929-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980929-0%26sid%3Dliteratum%253Aachs%26aulast%3DBaumeister%26aufirst%3DW.%26aulast%3DWalz%26aufirst%3DJ.%26aulast%3DZuhl%26aufirst%3DF.%26aulast%3DSeemuller%26aufirst%3DE.%26atitle%3DThe%2520proteasome%253A%2520paradigm%2520of%2520a%2520self-compartmentalizing%2520protease%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D367%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditzel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bochtler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartunik, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span> </span><span class="NLM_article-title">Structure of 20S proteasome from yeast at 2.4 .ANG. resolution</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1038%2F386463a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=9087403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2sXisVSqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=1997&pages=463-471&author=M.+Grollauthor=L.+Ditzelauthor=J.+Loeweauthor=D.+Stockauthor=M.+Bochtlerauthor=H.+D.+Bartunikauthor=R.+Huber&title=Structure+of+20S+proteasome+from+yeast+at+2.4+.ANG.+resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of 20S proteasome from yeast at 2.4 Å resolution</span></div><div class="casAuthors">Groll, Michael; Ditzel, Lars; Loewe, Jan; Stock, Daniela; Bochtler, Matthias; Bartunik, Hans D.; Huber, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">6624</span>),
    <span class="NLM_cas:pages">463-471</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structure of the 20S proteasome from the yeast Saccharomyces cerevisiae shows that its 28 protein subunits are arranged as an (α1...α7,β1...β7)2 complex in four stacked rings and occupy unique locations.  The interior of the particle, which harbors the active sites, is only accessible by some very narrow side entrances.  The β-type subunits are synthesized as proproteins before being proteolytically processed for assembly into the particle.  The pro forms of three of the seven different β-type subunits, β1-PRE3, β2/PUP1 and β5/PRE2, are cleaved between the threonine at position 1 and the last glycine of the pro-sequence, with release of the active-site residue Thr 1.  These three β-type subunits have inhibitor-binding sites, indicating that PRE2 has a chymotrypsin-like and a trypsin-like activity and that PRE3 has peptidylglutamyl peptide hydrolytic specificity.  Other β-type subunits are processed to an intermediate form, indicating that an addnl. nonspecific endopeptidase activity may exist which is important for peptide hydrolysis and for the generation of ligands for class I mols. of the major histocompatibility complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUP7-BUWwo-bVg90H21EOLACvtfcHk0ljlWcXo5HAT2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVSqsr0%253D&md5=1796bb267e45cc5cdd2c97ecb426f39b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F386463a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F386463a0%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DDitzel%26aufirst%3DL.%26aulast%3DLoewe%26aufirst%3DJ.%26aulast%3DStock%26aufirst%3DD.%26aulast%3DBochtler%26aufirst%3DM.%26aulast%3DBartunik%26aufirst%3DH.%2BD.%26aulast%3DHuber%26aufirst%3DR.%26atitle%3DStructure%2520of%252020S%2520proteasome%2520from%2520yeast%2520at%25202.4%2520.ANG.%2520resolution%26jtitle%3DNature%2520%2528London%2529%26date%3D1997%26volume%3D386%26spage%3D463%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span> </span><span class="NLM_article-title">Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1695</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2Fj.bbamcr.2004.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=15571807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1695&publication_year=2004&pages=33-44&author=M.+Grollauthor=R.+Huber&title=Inhibitors+of+the+eukaryotic+20S+proteasome+core+particle%3A+a+structural+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach</span></div><div class="casAuthors">Groll, Michael; Huber, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1695</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">33-44</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome pathway is particularly important for the regulated degrdn. of various proteins which control a vast array of biol. processes.  Therefore, proteasome inhibitors are promising candidates for anti-tumoral or anti-inflammatory drugs.  N-Acetyl-Leu-Leu-Norleucinal (Ac-LLN-al, also termed calpain inhibitor I) was one of the first proteasome inhibitors discovered and has been widely used to study the 20S proteasome core particle (CP) function in vivo, despite its lack of specificity.  Vinyl sulfones, like Ac-PRLN-vs, show covalent binding of the β-carbon atom of the vinyl sulfone group to the Thr1Oγ only of subunit β2.  However, vinyl sulfones have similar limitations as peptide aldehydes as they have been reported also to bind and block intracellular cysteine proteases.  A more specific proteasome inhibitor is the natural product lactacystin, which can be isolated from Streptomyces.  It was found that this compd. forms an ester bond only to the Thr1Oγ of the chymotrypsin-like active subunit β5 due to specific P1 interactions.  In contrast to most other proteasome inhibitors, the natural α',β'-epoxyketone peptide epoxomicin binds specifically to the small class of N-terminal nucleophilic (Ntn) hydrolases (CPs belong to this protease family) with the formation of a morpholino adduct.  All previously described proteasome inhibitors bind covalently to the proteolytic active sites.  However, as the proteasome is involved in a variety of biol. important functions, it is of particular interest to block the CP only for limited time in order to reduce cytotoxic effects.  Recently, the binding mode of the natural specific proteasome inhibitor TMC-95 obtained from Apiospora montagnei was investigated.  The crystal structure revealed that the TMC-95 blocks the active sites of the CP noncovalently in the low nanomolar range.  This review summarizes the current structural knowledge of inhibitory compds. bound to the CP, showing the proteasome as a potential target for drug development in medical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKy_YEOh4O87Vg90H21EOLACvtfcHk0ljRXmBGjnHZ4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzM&md5=657de84e4dd5ce34c5112505543fbd29</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2004.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2004.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DR.%26atitle%3DInhibitors%2520of%2520the%2520eukaryotic%252020S%2520proteasome%2520core%2520particle%253A%2520a%2520structural%2520approach%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2004%26volume%3D1695%26spage%3D33%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kisselev, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: from research tools to drug candidates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2FS1074-5521%2801%2900056-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=11514224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=739-758&author=A.+F.+Kisselevauthor=A.+L.+Goldberg&title=Proteasome+inhibitors%3A+from+research+tools+to+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: from research tools to drug candidates</span></div><div class="casAuthors">Kisselev, A. F.; Goldberg, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">739-758</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The 26S proteasome is a 2.4 MDa multifunctional ATP-dependent proteolytic complex, which degrades the majority of cellular polypeptides by an unusual enzyme mechanism.  Several groups of proteasome inhibitors have been developed and are now widely used as research tools to study the role of the ubiquitin-proteasome pathway in various cellular processes, and two inhibitors are now in clin. trials for treatment of multiple cancers and stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTXBSmAzp9vLVg90H21EOLACvtfcHk0ljRXmBGjnHZ4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7g%253D&md5=b729e5f56c402172aca5b139df61c09e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900056-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900056-4%26sid%3Dliteratum%253Aachs%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DProteasome%2520inhibitors%253A%2520from%2520research%2520tools%2520to%2520drug%2520candidates%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D739%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Borissenko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span> </span><span class="NLM_article-title">20S proteasome and its inhibitors: crystallographic knowledge for drug development</span> <span class="citation_source-journal">Chem. Rev. (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0502504" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvF2kuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2007&pages=687-717&author=L.+Borissenkoauthor=M.+Groll&title=20S+proteasome+and+its+inhibitors%3A+crystallographic+knowledge+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development</span></div><div class="casAuthors">Borissenko, Ljudmila; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">687-717</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The aim of this review is to discuss the latest insights on the structure and function of the proteasome, highlighting the structural features that det. its activity and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwElwBj8JBKrVg90H21EOLACvtfcHk0ljRXmBGjnHZ4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvF2kuro%253D&md5=af2e998e5443f598a46ffef71118a119</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fcr0502504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0502504%26sid%3Dliteratum%253Aachs%26aulast%3DBorissenko%26aufirst%3DL.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3D20S%2520proteasome%2520and%2520its%2520inhibitors%253A%2520crystallographic%2520knowledge%2520for%2520drug%2520development%26jtitle%3DChem.%2520Rev.%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2007%26volume%3D107%26spage%3D687%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigstad, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sappal, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J. L.</span><span> </span><span class="NLM_article-title">Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2010&pages=461-476&author=C.+Blackburnauthor=K.+M.+Gigstadauthor=P.+Halesauthor=K.+Garciaauthor=M.+Jonesauthor=F.+J.+Bruzzeseauthor=C.+Barrettauthor=J.+X.+Liuauthor=T.+A.+Soucyauthor=D.+S.+Sappalauthor=N.+Bumpauthor=E.+J.+Olhavaauthor=P.+Flemingauthor=L.+R.+Dickauthor=C.+Tsuauthor=M.+D.+Sintchakauthor=J.+L.+Blank&title=Characterization+of+a+new+series+of+non-covalent+proteasome+inhibitors+with+exquisite+potency+and+selectivity+for+the+20S+%CE%B25-subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DGigstad%26aufirst%3DK.%2BM.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DBruzzese%26aufirst%3DF.%2BJ.%26aulast%3DBarrett%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DSoucy%26aufirst%3DT.%2BA.%26aulast%3DSappal%26aufirst%3DD.%2BS.%26aulast%3DBump%26aufirst%3DN.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DBlank%26aufirst%3DJ.%2BL.%26atitle%3DCharacterization%2520of%2520a%2520new%2520series%2520of%2520non-covalent%2520proteasome%2520inhibitors%2520with%2520exquisite%2520potency%2520and%2520selectivity%2520for%2520the%252020S%2520%25CE%25B25-subunit%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D430%26spage%3D461%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Genin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.2174%2F156802610790725515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=20166955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1ent7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=232-256&author=E.+Geninauthor=M.+Reboud-Ravauxauthor=J.+Vidal&title=Proteasome+inhibitors%3A+recent+advances+and+new+perspectives+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry</span></div><div class="casAuthors">Genin, E.; Reboud-Ravaux, M.; Vidal, J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">232-256</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The search for proteasome inhibitors began fifteen years ago.  These inhibitors proved to be powerful tools for investigating many important cellular processes regulated by the ubiquitin-proteasome pathway.  Targeting the proteasome pathway can also lead to new treatments for disorders like cancer, muscular dystrophies, inflammation and immune diseases.  This is already true for cancer; the FDA approved bortezomib, a potent proteasome inhibitor, for treating multiple myeloma in 2003, and mantle cell lymphoma in 2006.  The chem. structures identified in some of the early proteasome inhibitors have led to the development of new anti-cancer drugs (CEP-18770, Carfilzomib, NPI-0052).  All these mols. are covalent bonding inhibitors that react with the catalytic Thr1-Oγ of the three types of active site.  This review covers recent developments in medicinal chem. of natural and synthetic proteasome inhibitors.  Advances in non-covalent inhibitors that have no reactive group will be highlighted as they should minimize side-effects.  New structures and new modes of action have been recently identified that open the door to new drug candidates for treating a range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv2fNL-WAY3LVg90H21EOLACvtfcHk0lgXRmkKU-5_Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1ent7Y%253D&md5=ef6b9b743b0c4f4981ad9138beceb90d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F156802610790725515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790725515%26sid%3Dliteratum%253Aachs%26aulast%3DGenin%26aufirst%3DE.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DJ.%26atitle%3DProteasome%2520inhibitors%253A%2520recent%2520advances%2520and%2520new%2520perspectives%2520in%2520medicinal%2520chemistry%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2010%26volume%3D10%26spage%3D232%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macherla, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manam, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. C.</span><span> </span><span class="NLM_article-title">Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5420</span><span class="NLM_x">–</span> <span class="NLM_lpage">5428</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900559x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5420-5428&author=M.+Grollauthor=K.+A.+McArthurauthor=V.+R.+Macherlaauthor=R.+R.+Manamauthor=B.+C.+Potts&title=Snapshots+of+the+fluorosalinosporamide%2F20S+complex+offer+mechanistic+insights+for+fine+tuning+proteasome+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm900559x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900559x%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DMcArthur%26aufirst%3DK.%2BA.%26aulast%3DMacherla%26aufirst%3DV.%2BR.%26aulast%3DManam%26aufirst%3DR.%2BR.%26aulast%3DPotts%26aufirst%3DB.%2BC.%26atitle%3DSnapshots%2520of%2520the%2520fluorosalinosporamide%252F20S%2520complex%2520offer%2520mechanistic%2520insights%2520for%2520fine%2520tuning%2520proteasome%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5420%26epage%3D5428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of a′,b′-epoxyketone proteasome inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja993588m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=1237-1238&author=M.+Grollauthor=K.+B.+Kimauthor=N.+Kairiesauthor=R.+Huberauthor=C.+M.+Crews&title=Crystal+structure+of+epoxomicin%3A20S+proteasome+reveals+a+molecular+basis+for+selectivity+of+a%E2%80%B2%2Cb%E2%80%B2-epoxyketone+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja993588m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja993588m%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DKairies%26aufirst%3DN.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520epoxomicin%253A20S%2520proteasome%2520reveals%2520a%2520molecular%2520basis%2520for%2520selectivity%2520of%2520a%25E2%2580%25B2%252Cb%25E2%2580%25B2-epoxyketone%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D1237%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kupperman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee Edmund, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannerman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J.</span><span> </span><span class="NLM_article-title">Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1970</span><span class="NLM_x">–</span> <span class="NLM_lpage">1980</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1158%2F0008-5472.CAN-09-2766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=20160034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFWisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1970-1980&author=E.+Kuppermanauthor=C.+Lee+Edmundauthor=Y.+Caoauthor=B.+Bannermanauthor=M.+Fitzgeraldauthor=A.+Bergerauthor=J.+Yuauthor=Y.+Yangauthor=P.+Halesauthor=F.+Bruzzeseauthor=J.+Liuauthor=J.+Blankauthor=K.+Garciaauthor=C.+Tsuauthor=L.+Dickauthor=P.+Flemingauthor=L.+Yuauthor=M.+Manfrediauthor=M.+Rolfeauthor=J.+Bolen&title=Evaluation+of+the+proteasome+inhibitor+MLN9708+in+preclinical+models+of+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer</span></div><div class="casAuthors">Kupperman, Erik; Lee, Edmund C.; Cao, Yueying; Bannerman, Bret; Fitzgerald, Michael; Berger, Allison; Yu, Jie; Yang, Yu; Bruzzese, Frank; Liu, Jane; Blank, Jonathan; Garcia, Khristofer; Tsu, Christopher; Dick, Larry; Fleming, Paul; Yu, Li; Manfredi, Mark; Rolfe, Mark; Bolen, Joe</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1970-1980</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The proteasome was validated as an oncol. target following the clin. success of VELCADE (bortezomib) for injection for the treatment of multiple myeloma and recurring mantle cell lymphoma.  Consequently, several groups are pursuing the development of addnl. small-mol. proteasome inhibitors for both hematol. and solid tumor indications.  Here, we describe MLN9708, a selective, orally bioavailable, second-generation proteasome inhibitor that is in phase I clin. development.  MLN9708 has a shorter proteasome dissocn. half-life and improved pharmacokinetics, pharmacodynamics, and antitumor activity compared with bortezomib.  MLN9708 has a larger blood vol. distribution at steady state, and anal. of 20S proteasome inhibition and markers of the unfolded protein response confirmed that MLN9708 has greater pharmacodynamic effects in tissues than bortezomib.  MLN9708 showed activity in both solid tumor and hematol. preclin. xenograft models, and we found a correlation between greater pharmacodynamic responses and improved antitumor activity.  Moreover, antitumor activity was shown via multiple dosing routes, including oral gavage.  Taken together, these data support the clin. development of MLN9708 for both hematol. and solid tumor indications.  Cancer Res; 70(5); 1970-80.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjauqAFEgDA7Vg90H21EOLACvtfcHk0lgXRmkKU-5_Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFWisro%253D&md5=45636404582fc0eb66581c6c19420458</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2766%26sid%3Dliteratum%253Aachs%26aulast%3DKupperman%26aufirst%3DE.%26aulast%3DLee%2BEdmund%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DBannerman%26aufirst%3DB.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DBruzzese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DDick%26aufirst%3DL.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DManfredi%26aufirst%3DM.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520the%2520proteasome%2520inhibitor%2520MLN9708%2520in%2520preclinical%2520models%2520of%2520human%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1970%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kupperman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannerman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J.</span><span> </span><span class="NLM_article-title">Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">3853</span><div class="note"><p class="first last"> [Erratum to document cited in CA152:517050]</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3853&author=E.+Kuppermanauthor=E.+C.+Leeauthor=Y.+Caoauthor=B.+Bannermanauthor=M.+Fitzgeraldauthor=A.+Bergerauthor=J.+Yuauthor=Y.+Yangauthor=P.+Halesauthor=F.+Bruzzeseauthor=J.+Liuauthor=J.+Blankauthor=K.+Garciaauthor=C.+Tsuauthor=L.+Dickauthor=P.+Flemingauthor=L.+Yuauthor=M.+Manfrediauthor=M.+Rolfeauthor=J.+Bolen&title=Evaluation+of+the+proteasome+inhibitor+MLN9708+in+preclinical+models+of+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKupperman%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DE.%2BC.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DBannerman%26aufirst%3DB.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DBruzzese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DDick%26aufirst%3DL.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DManfredi%26aufirst%3DM.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520the%2520proteasome%2520inhibitor%2520MLN9708%2520in%2520preclinical%2520models%2520of%2520human%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D3853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dick Lawrence, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming Paul, E.</span><span> </span><span class="NLM_article-title">Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=243-249&author=R.+Dick+Lawrenceauthor=E.+Fleming+Paul&title=Building+on+bortezomib%3A+second-generation+proteasome+inhibitors+as+anti-cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDick%2BLawrence%26aufirst%3DR.%26aulast%3DFleming%2BPaul%26aufirst%3DE.%26atitle%3DBuilding%2520on%2520bortezomib%253A%2520second-generation%2520proteasome%2520inhibitors%2520as%2520anti-cancer%2520therapy%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D243%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dorsey, B. D.; Menta, E.; Bernardini, R.; Bernareggi, A.; Casara, P. G.; D’Arasmo, G.; Ferretti, E.; De Munari, S.; Oliva, A.; Iqbal, M.; Chatterjee, S.; Ruggeri, B.; Ator, M. A.; Williams, M.; Mallamo, J. P.</span><span> </span><span class="NLM_article-title">CEP-18770: Discovery of a Potent, Selective and Orally Active Proteasome Inhibitor for the Treatment of Cancer</span>. Presented at Frontiers in CNS and Oncology Medicinal Chemistry, ACS-EFMC, Siena, Italy, October 7–9,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>COMC-027.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+D.+Dorsey&author=E.+Menta&author=R.+Bernardini&author=A.+Bernareggi&author=P.+G.+Casara&author=G.+D%E2%80%99Arasmo&author=E.+Ferretti&author=S.+De+Munari&author=A.+Oliva&author=M.+Iqbal&author=S.+Chatterjee&author=B.+Ruggeri&author=M.+A.+Ator&author=M.+Williams&author=J.+P.+Mallamo&title=CEP-18770%3A+Discovery+of+a+Potent%2C+Selective+and+Orally+Active+Proteasome+Inhibitor+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DCEP-18770%253A%2520Discovery%2520of%2520a%2520Potent%252C%2520Selective%2520and%2520Orally%2520Active%2520Proteasome%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Piva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giai, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coscia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massaia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allievi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescalli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Giovine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Feudis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strepponi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roato, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferracini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussolati, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camussi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones-Bolin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernareggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inghirami, G.</span><span> </span><span class="NLM_article-title">CEP-18770: a novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">2765</span><span class="NLM_x">–</span> <span class="NLM_lpage">2775</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=2765-2775&author=R.+Pivaauthor=B.+Ruggeriauthor=M.+Williamsauthor=G.+Costaauthor=I.+Tamagnoauthor=D.+Ferreroauthor=V.+Giaiauthor=M.+Cosciaauthor=S.+Peolaauthor=M.+Massaiaauthor=G.+Pezzoniauthor=C.+Allieviauthor=N.+Pescalliauthor=M.+Cassinauthor=S.+di+Giovineauthor=P.+Nicoliauthor=P.+de+Feudisauthor=I.+Strepponiauthor=I.+Roatoauthor=R.+Ferraciniauthor=B.+Bussolatiauthor=G.+Camussiauthor=S.+Jones-Bolinauthor=K.+Hunterauthor=H.+Zhaoauthor=A.+Neriauthor=A.+Palumboauthor=C.+Berkersauthor=H.+Ovaaauthor=A.+Bernareggiauthor=G.+Inghirami&title=CEP-18770%3A+a+novel%2C+orally+active+proteasome+inhibitor+with+a+tumor-selective+pharmacologic+profile+competitive+with+bortezomib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiva%26aufirst%3DR.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DCosta%26aufirst%3DG.%26aulast%3DTamagno%26aufirst%3DI.%26aulast%3DFerrero%26aufirst%3DD.%26aulast%3DGiai%26aufirst%3DV.%26aulast%3DCoscia%26aufirst%3DM.%26aulast%3DPeola%26aufirst%3DS.%26aulast%3DMassaia%26aufirst%3DM.%26aulast%3DPezzoni%26aufirst%3DG.%26aulast%3DAllievi%26aufirst%3DC.%26aulast%3DPescalli%26aufirst%3DN.%26aulast%3DCassin%26aufirst%3DM.%26aulast%3Ddi%2BGiovine%26aufirst%3DS.%26aulast%3DNicoli%26aufirst%3DP.%26aulast%3Dde%2BFeudis%26aufirst%3DP.%26aulast%3DStrepponi%26aufirst%3DI.%26aulast%3DRoato%26aufirst%3DI.%26aulast%3DFerracini%26aufirst%3DR.%26aulast%3DBussolati%26aufirst%3DB.%26aulast%3DCamussi%26aufirst%3DG.%26aulast%3DJones-Bolin%26aufirst%3DS.%26aulast%3DHunter%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DNeri%26aufirst%3DA.%26aulast%3DPalumbo%26aufirst%3DA.%26aulast%3DBerkers%26aufirst%3DC.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DBernareggi%26aufirst%3DA.%26aulast%3DInghirami%26aufirst%3DG.%26atitle%3DCEP-18770%253A%2520a%2520novel%252C%2520orally%2520active%2520proteasome%2520inhibitor%2520with%2520a%2520tumor-selective%2520pharmacologic%2520profile%2520competitive%2520with%2520bortezomib%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sterz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Metzler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahne, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamottke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heider, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terpos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sezer, O.</span><span> </span><span class="NLM_article-title">The potential of proteasome inhibitors in cancer therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=879-895&author=J.+Sterzauthor=I.+von+Metzlerauthor=J.-C.+Hahneauthor=B.+Lamottkeauthor=J.+Rademacherauthor=U.+Heiderauthor=E.+Terposauthor=O.+Sezer&title=The+potential+of+proteasome+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSterz%26aufirst%3DJ.%26aulast%3Dvon%2BMetzler%26aufirst%3DI.%26aulast%3DHahne%26aufirst%3DJ.-C.%26aulast%3DLamottke%26aufirst%3DB.%26aulast%3DRademacher%26aufirst%3DJ.%26aulast%3DHeider%26aufirst%3DU.%26aulast%3DTerpos%26aufirst%3DE.%26aulast%3DSezer%26aufirst%3DO.%26atitle%3DThe%2520potential%2520of%2520proteasome%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D879%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernareggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassara, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arasmo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferretti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allievi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strepponi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7010589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1068-1072&author=B.+D.+Dorseyauthor=M.+Iqbalauthor=S.+Chatterjeeauthor=E.+Mentaauthor=R.+Bernardiniauthor=A.+Bernareggiauthor=P.+G.+Cassaraauthor=G.+D%E2%80%99Arasmoauthor=E.+Ferrettiauthor=M.+S.+Deauthor=A.+Olivaauthor=G.+Pezzoniauthor=C.+Allieviauthor=I.+Strepponiauthor=B.+Ruggeriauthor=M.+A.+Atorauthor=M.+Williamsauthor=J.+P.+Mallamo&title=Discovery+of+a+potent%2C+selective%2C+and+orally+active+proteasome+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer</span></div><div class="casAuthors">Dorsey, Bruce D.; Iqbal, Mohamed; Chatterjee, Sankar; Menta, Ernesto; Bernardini, Raffaella; Bernareggi, Alberto; Cassara, Paolo G.; D'Arasmo, Germano; Ferretti, Edmondo; De Munari, Sergio; Oliva, Ambrogio; Pezzoni, Gabriella; Allievi, Cecilia; Strepponi, Ivan; Ruggeri, Bruce; Ator, Mark A.; Williams, Michael; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1068-1072</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome pathway plays a central role in regulation of the prodn. and destruction of cellular proteins.  These pathways mediate proliferation and cell survival, particularly in malignant cells.  The successful development of the 20S human proteasome inhibitor bortezomib for the treatment of relapsed and refractory multiple myeloma has established this targeted intervention as an effective therapeutic strategy.  Herein, the potent, selective, and orally bioavailable threonine-derived 20S human proteasome inhibitor that has been advanced to preclin. development, [(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid 20 (CEP-18770), is disclosed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkNeu3d81vbVg90H21EOLACvtfcHk0liBGDRqDTIrsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKls78%253D&md5=cfc22ee09c2a4f4d9c695010187c4693</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm7010589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7010589%26sid%3Dliteratum%253Aachs%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DIqbal%26aufirst%3DM.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DMenta%26aufirst%3DE.%26aulast%3DBernardini%26aufirst%3DR.%26aulast%3DBernareggi%26aufirst%3DA.%26aulast%3DCassara%26aufirst%3DP.%2BG.%26aulast%3DD%25E2%2580%2599Arasmo%26aufirst%3DG.%26aulast%3DFerretti%26aufirst%3DE.%26aulast%3DDe%26aufirst%3DM.%2BS.%26aulast%3DOliva%26aufirst%3DA.%26aulast%3DPezzoni%26aufirst%3DG.%26aulast%3DAllievi%26aufirst%3DC.%26aulast%3DStrepponi%26aufirst%3DI.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520proteasome%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1068%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fuchs, O.</span><span> </span><span class="NLM_article-title">Proteasome inhibition as a therapeutic strategy in patients with multiple myeloma</span> <span class="citation_source-journal">Mult. Myeloma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlOmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=101-125&author=O.+Fuchs&title=Proteasome+inhibition+as+a+therapeutic+strategy+in+patients+with+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition as a therapeutic strategy in patients with multiple myeloma</span></div><div class="casAuthors">Fuchs, Ota</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Myeloma</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-125</span>CODEN:
                <span class="NLM_cas:coden">69MVM2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Nova Science Publishers, Inc.</span>)
        </div><div class="casAbstract">A review.  Multiple myeloma (MM) is the second most frequent hematol. malignancy and remains fatal despite all available therapies, because of chemotherapeutic resistance.  Novel targeted drugs for the treatment of MM are therefore needed to improve outcome of MM patients.  Bortezomib (PS-341, Velcade; Millennium Pharmaceuticals, Cambridge MA), a dipeptidyl boronic acid that reversibly inhibits the chymotrypsin-like activity in the 20S core of the 26S mammalian proteasome, is the first proteasome inhibitor that was approved by the US Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products (EMEA) for patients with relapsed and refractory MM who had received at least one prior therapy and who had already undergone or are unsuitable for the transplantation of bone marrow.  Phase I-III trials based on previous preclin. studies showed very good antimyeloma activity.  Bortezomib acts by disrupting various cell signaling pathways, thereby leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis.  The main action of bortezomib is the inhibition of the key transcription factor, nuclear factor-kappaB (NF-κB) activation.  Activation of NF-κB has been noted in MM cells.  Bortezomib interferes with NF-κB-mediated cell survival, tumor growth and angiogenesis.  Several studies have shown that cancer cells are more sensitive than normal cells to the proapoptotic effects of bortezomib, perhaps due to their loss of checkpoint mechanisms for DNA repair.  The accumulation of misfolded proteins in the endoplasmic reticulum (ER) leads to the induction of the unfolded protein response, provoking apoptosis.  Proteasome inhibitors induce ER-mediated apoptosis.  The increased susceptibility of MM cells to ER stress is caused by the large amts. of Igs produced by MM cells.  The clin. success of bortezomib is encouraging.  Bortezomib is relatively well tolerated, causing manageable nonhematol. and hematol. toxicity.  However, the overall response rate was 40-50% and bortezomib resistance was also obsd.  Response rates may be improved with combination therapy (bortezomib with dexamethasone, thalidomide, lenalidomide, arsenic trioxide, cisplatin, doxorubicin, cyclophosphamide, etoposide or with melphalan and prednisone).  Clin. evaluation of addnl. proteasome inhibitors of the next generation with greater efficacy is also needed.  Three such proteasome inhibitors (carfilzomib, salinosporamide A and threonine boronic acid-derived proteasome inhibitor CEP-18770) have been recently tested in preclin. models of MM.  Carfilzomib (PR-171; Proteolix), an epoxyketone related to epoxomicin inhibits the chymotrypsin-like proteasome activity as bortezomib does.  However, carfilzomib is an irreversible inhibitor of all three proteasome proteolytic sites.  Salinosporamide A (NPI-0052), a compd. related to lactacystin binds irreversibly to the 20S proteasome and acts predominantly through caspase-8 activation.  CEP-18770 is a reversible inhibitor of the chymotrypsin-like proteasome activity as bortezomib but it inhibits also the tryptic and peptidyl glutamyl activities of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEgVHeWnqC_rVg90H21EOLACvtfcHk0liBGDRqDTIrsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlOmtrc%253D&md5=cb6b1732f8d4e3adc619ecb6591e1567</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DO.%26atitle%3DProteasome%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520in%2520patients%2520with%2520multiple%2520myeloma%26jtitle%3DMult.%2520Myeloma%26date%3D2009%26spage%3D101%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuteboom, S. T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palladino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethna, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. C.</span><span> </span><span class="NLM_article-title">From natural products to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent</span> <span class="citation_source-journal">Nat. Prod. Chem. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlCjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=355-373&author=K.+S.+Lamauthor=G.+K.+Lloydauthor=S.+T.+C.+Neuteboomauthor=M.+A.+Palladinoauthor=K.+M.+Sethnaauthor=M.+A.+Spearauthor=B.+C.+Potts&title=From+natural+products+to+clinical+trials%3A+NPI-0052+%28salinosporamide+A%29%2C+a+marine+actinomycete-derived+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">From natural products to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent</span></div><div class="casAuthors">Lam, Kin S.; Lloyd, G. Kenneth; Neuteboom, Saskia T. C.; Palladino, Michael A.; Sethna, Kobi M.; Spear, Matthew A.; Potts, Barbara C.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Chemistry for Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-373</span>CODEN:
                <span class="NLM_cas:coden">69MGLO</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The unique aspects of developing a marine actinomycete-derived therapeutic agent, NPI-0052, are highlighted.  Salinosporamide A (designated as NPI-0052) was first isolated from the fermn. broth of Salinispora tropica strain CNB392.  This highly potent 20S proteasome inhibitor is currently undergoing Phase I clin. studies for the treatment of various hematol. and solid tumor malignancies.  An account is given of events from the early mechanism of action and preclin. studies that supported its entry into clin. trials in cancer patients, to the current strategy for its continued development as an anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzGil7yTcC7Vg90H21EOLACvtfcHk0liBGDRqDTIrsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlCjug%253D%253D&md5=1498e5081a2ba9e7eff273ecb2124899</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DLloyd%26aufirst%3DG.%2BK.%26aulast%3DNeuteboom%26aufirst%3DS.%2BT.%2BC.%26aulast%3DPalladino%26aufirst%3DM.%2BA.%26aulast%3DSethna%26aufirst%3DK.%2BM.%26aulast%3DSpear%26aufirst%3DM.%2BA.%26aulast%3DPotts%26aufirst%3DB.%2BC.%26atitle%3DFrom%2520natural%2520products%2520to%2520clinical%2520trials%253A%2520NPI-0052%2520%2528salinosporamide%2520A%2529%252C%2520a%2520marine%2520actinomycete-derived%2520anticancer%2520agent%26jtitle%3DNat.%2520Prod.%2520Chem.%2520Drug%2520Discovery%26date%3D2010%26spage%3D355%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zhou, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aujay, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demo, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laidig, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchamuel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenk, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shwonek, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3038</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801329v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3028-3038&author=H.-J.+Zhouauthor=M.+A.+Aujayauthor=M.+K.+Bennettauthor=M.+Dajeeauthor=S.+D.+Demoauthor=Y.+Fangauthor=M.+N.+Hoauthor=J.+Jiangauthor=C.+J.+Kirkauthor=G.+J.+Laidigauthor=E.+R.+Lewisauthor=Y.+Luauthor=T.+Muchamuelauthor=F.+Parlatiauthor=E.+Ringauthor=K.+D.+Shenkauthor=J.+Shieldsauthor=P.+J.+Shwonekauthor=T.+Stantonauthor=C.+M.+Sunauthor=C.+Sylvainauthor=T.+M.+Wooauthor=J.+Yang&title=Design+and+synthesis+of+an+orally+bioavailable+and+selective+peptide+epoxyketone+proteasome+inhibitor+%28PR-047%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)</span></div><div class="casAuthors">Zhou, Han-Jie; Aujay, Monette A.; Bennett, Mark K.; Dajee, Maya; Demo, Susan D.; Fang, Ying; Ho, Mark N.; Jiang, Jing; Kirk, Christopher J.; Laidig, Guy J.; Lewis, Evan R.; Lu, Yan; Muchamuel, Tony; Parlati, Francesco; Ring, Eileen; Shenk, Kevin D.; Shields, Jamie; Shwonek, Peter J.; Stanton, Timothy; Sun, Congcong M.; Sylvain, Catherine; Woo, Tina M.; Yang, Jinfu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3028-3038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epoxypeptides such as I are prepd. as carfilzomib analogs and proteasome inhibitors for use as antitumor agents; the inhibition of human 20S proteasomes and of the growth of multidrug-resistant and nonresistant cancer cells by selected compds. and their stabilities in simulated gastric and intestinal fluids and in liver microsomes are detd.  I selectively inhibits chymotrypsin-like activity of both the constitutive proteasome (β5) and immunoproteasome (LMP7) and demonstrated an abs. bioavailability of up to 39% in rodents and dogs.  I is well tolerated with repeated oral administration at doses resulting in >80% proteasome inhibition in most tissues and elicited an antitumor response equiv. to i.v. administered carfilzomib in multiple human tumor xenograft and mouse syngeneic models.  I is prepd. in eight steps (longest linear sequence) from Cbz-L-phenylalanine, Boc-O-methyl-L-serine, 2-methyl-5-thiazolecarboxylic acid, and isopropenylmagnesium bromide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouNBIBwb8w47Vg90H21EOLACvtfcHk0li_am_p1nWc9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFemtLw%253D&md5=688c8d0942539bab2e50617d083bf89a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm801329v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801329v%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.-J.%26aulast%3DAujay%26aufirst%3DM.%2BA.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26aulast%3DDajee%26aufirst%3DM.%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DM.%2BN.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DLaidig%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DRing%26aufirst%3DE.%26aulast%3DShenk%26aufirst%3DK.%2BD.%26aulast%3DShields%26aufirst%3DJ.%26aulast%3DShwonek%26aufirst%3DP.%2BJ.%26aulast%3DStanton%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DC.%2BM.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DWoo%26aufirst%3DT.%2BM.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520orally%2520bioavailable%2520and%2520selective%2520peptide%2520epoxyketone%2520proteasome%2520inhibitor%2520%2528PR-047%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3028%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkers, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploegh, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome</span> <span class="citation_source-journal">Structure (Cambridge, MA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2Fj.str.2005.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=16531229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=451-456&author=M.+Grollauthor=C.+R.+Berkersauthor=H.+L.+Ploeghauthor=H.+Ovaa&title=Crystal+structure+of+the+boronic+acid-based+proteasome+inhibitor+bortezomib+in+complex+with+the+yeast+20S+proteasome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Boronic Acid-Based Proteasome Inhibitor Bortezomib in Complex with the Yeast 20S Proteasome</span></div><div class="casAuthors">Groll, Michael; Berkers, Celia R.; Ploegh, Hidde L.; Ovaa, Huib</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-456</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The dipeptide boronic acid bortezomib, also termed VELCADE is a proteasome inhibitor now in use for the treatment of multiple myeloma, and its use for the treatment of other malignancies is being explored.  We detd. the crystal structure of the yeast 20S proteasome in complex with bortezomib to establish the specificity and binding mode of bortezomib to the proteasome's different catalytically active sites.  This structure should enable the rational design of new boronic acid derivs. with improved affinities and specificities for individual active subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpusGzFSuveALVg90H21EOLACvtfcHk0li_am_p1nWc9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ylsL8%253D&md5=d5b4e46e5a9f5259cce758770302b4fe</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2005.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2005.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520the%2520boronic%2520acid-based%2520proteasome%2520inhibitor%2520bortezomib%2520in%2520complex%2520with%2520the%2520yeast%252020S%2520proteasome%26jtitle%3DStructure%2520%2528Cambridge%252C%2520MA%252C%2520U.%2520S.%2529%26date%3D2006%26volume%3D14%26spage%3D451%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. C. M.</span><span> </span><span class="NLM_article-title">Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of β-lactone ring opening and a mechanism for irreversible binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">5136</span><span class="NLM_x">–</span> <span class="NLM_lpage">5141</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja058320b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=5136-5141&author=M.+Grollauthor=R.+Huberauthor=B.+C.+M.+Potts&title=Crystal+structures+of+salinosporamide+A+%28NPI-0052%29+and+B+%28NPI-0047%29+in+complex+with+the+20S+proteasome+reveal+important+consequences+of+%CE%B2-lactone+ring+opening+and+a+mechanism+for+irreversible+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja058320b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja058320b%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DPotts%26aufirst%3DB.%2BC.%2BM.%26atitle%3DCrystal%2520structures%2520of%2520salinosporamide%2520A%2520%2528NPI-0052%2529%2520and%2520B%2520%2528NPI-0047%2529%2520in%2520complex%2520with%2520the%252020S%2520proteasome%2520reveal%2520important%2520consequences%2520of%2520%25CE%25B2-lactone%2520ring%2520opening%2520and%2520a%2520mechanism%2520for%2520irreversible%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D5136%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Schmidtke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzhutter, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giuli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groettrup, M.</span><span> </span><span class="NLM_article-title">How an inhibitor of the HIV-I protease modulates proteasome activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">35734</span><span class="NLM_x">–</span> <span class="NLM_lpage">35740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=35734-35740&author=G.+Schmidtkeauthor=H.-G.+Holzhutterauthor=M.+Bogyoauthor=N.+Kairiesauthor=M.+Grollauthor=R.+De+Giuliauthor=S.+Emchauthor=M.+Groettrup&title=How+an+inhibitor+of+the+HIV-I+protease+modulates+proteasome+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidtke%26aufirst%3DG.%26aulast%3DHolzhutter%26aufirst%3DH.-G.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DKairies%26aufirst%3DN.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DDe%2BGiuli%26aufirst%3DR.%26aulast%3DEmch%26aufirst%3DS.%26aulast%3DGroettrup%26aufirst%3DM.%26atitle%3DHow%2520an%2520inhibitor%2520of%2520the%2520HIV-I%2520protease%2520modulates%2520proteasome%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D35734%26epage%3D35740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Structure-based optimization of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1331-1334&author=P.+Furetauthor=P.+Imbachauthor=P.+Fuerstauthor=M.+Langauthor=M.+Nooraniauthor=J.+Zimmermannauthor=C.+Garcia-Echeverria&title=Structure-based+optimization+of+2-aminobenzylstatine+derivatives%3A+potent+and+selective+inhibitors+of+the+chymotrypsin-like+activity+of+the+human+20S+proteasome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DImbach%26aufirst%3DP.%26aulast%3DFuerst%26aufirst%3DP.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DNoorani%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DStructure-based%2520optimization%2520of%25202-aminobenzylstatine%2520derivatives%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520chymotrypsin-like%2520activity%2520of%2520the%2520human%252020S%2520proteasome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1331%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeppler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laumen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia Echeverria, C.</span><span> </span><span class="NLM_article-title">Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4810</span><span class="NLM_x">–</span> <span class="NLM_lpage">4813</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049660v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4810-4813&author=P.+Furetauthor=P.+Imbachauthor=M.+Nooraniauthor=J.+Koepplerauthor=K.+Laumenauthor=M.+Langauthor=V.+Guagnanoauthor=P.+Fuerstauthor=J.+Roeselauthor=J.+Zimmermannauthor=C.+Garcia+Echeverria&title=Entry+into+a+new+class+of+potent+proteasome+inhibitors+having+high+antiproliferative+activity+by+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm049660v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049660v%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DImbach%26aufirst%3DP.%26aulast%3DNoorani%26aufirst%3DM.%26aulast%3DKoeppler%26aufirst%3DJ.%26aulast%3DLaumen%26aufirst%3DK.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DFuerst%26aufirst%3DP.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DGarcia%2BEcheverria%26aufirst%3DC.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520potent%2520proteasome%2520inhibitors%2520having%2520high%2520antiproliferative%2520activity%2520by%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4810%26epage%3D4813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapostolou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felten, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderesse, R.</span><span> </span><span class="NLM_article-title">Development of lipopeptides for inhibiting 20S proteasomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3277</span><span class="NLM_x">–</span> <span class="NLM_lpage">3281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3277-3281&author=N.+Basseauthor=D.+Papapostolouauthor=M.+Paganoauthor=M.+Reboud-Ravauxauthor=E.+Bernardauthor=A.-S.+Feltenauthor=R.+Vanderesse&title=Development+of+lipopeptides+for+inhibiting+20S+proteasomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DPapapostolou%26aufirst%3DD.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26aulast%3DBernard%26aufirst%3DE.%26aulast%3DFelten%26aufirst%3DA.-S.%26aulast%3DVanderesse%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520lipopeptides%2520for%2520inhibiting%252020S%2520proteasomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3277%26epage%3D3281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kohno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsubara, S.</span><span> </span><span class="NLM_article-title">Structures of TMC-95A-D: novel proteasome inhibitors from <i>Apiospora montagnei</i> Sacc. TC 1093</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo991375%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=990-995&author=J.+Kohnoauthor=Y.+Koguchiauthor=M.+Nishioauthor=K.+Nakaoauthor=M.+Kurodaauthor=R.+Shimizuauthor=T.+Ohnukiauthor=S.+Komatsubara&title=Structures+of+TMC-95A-D%3A+novel+proteasome+inhibitors+from+Apiospora+montagnei+Sacc.+TC+1093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo991375%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo991375%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKohno%26aufirst%3DJ.%26aulast%3DKoguchi%26aufirst%3DY.%26aulast%3DNishio%26aufirst%3DM.%26aulast%3DNakao%26aufirst%3DK.%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DShimizu%26aufirst%3DR.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DKomatsubara%26aufirst%3DS.%26atitle%3DStructures%2520of%2520TMC-95A-D%253A%2520novel%2520proteasome%2520inhibitors%2520from%2520Apiospora%2520montagnei%2520Sacc.%2520TC%25201093%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D990%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Formicola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier-Durand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet-Delpon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milcent, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongeri, S.</span><span> </span><span class="NLM_article-title">Novel fluorinated pseudopeptides as proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=83-86&author=L.+Formicolaauthor=X.+Marechalauthor=N.+Basseauthor=M.+Bouvier-Durandauthor=D.+Bonnet-Delponauthor=T.+Milcentauthor=M.+Reboud-Ravauxauthor=S.+Ongeri&title=Novel+fluorinated+pseudopeptides+as+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFormicola%26aufirst%3DL.%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DBouvier-Durand%26aufirst%3DM.%26aulast%3DBonnet-Delpon%26aufirst%3DD.%26aulast%3DMilcent%26aufirst%3DT.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26aulast%3DOngeri%26aufirst%3DS.%26atitle%3DNovel%2520fluorinated%2520pseudopeptides%2520as%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D83%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujol, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span> </span><span class="NLM_article-title">Noncovalent inhibition of 20S proteasome by pegylated dimerized inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=322-327&author=X.+Marechalauthor=A.+Pujolauthor=N.+Richyauthor=E.+Geninauthor=N.+Basseauthor=M.+Reboud-Ravauxauthor=J.+Vidal&title=Noncovalent+inhibition+of+20S+proteasome+by+pegylated+dimerized+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DPujol%26aufirst%3DA.%26aulast%3DRichy%26aufirst%3DN.%26aulast%3DGenin%26aufirst%3DE.%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DJ.%26atitle%3DNoncovalent%2520inhibition%2520of%252020S%2520proteasome%2520by%2520pegylated%2520dimerized%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D322%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier-Durand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villoutreix, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span> </span><span class="NLM_article-title">Novel organic proteasome inhibitors identified by virtual and in vitro screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9011092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=509-513&author=N.+Basseauthor=M.+Montesauthor=X.+Marechalauthor=L.+Qinauthor=M.+Bouvier-Durandauthor=E.+Geninauthor=J.+Vidalauthor=B.+O.+Villoutreixauthor=M.+Reboud-Ravaux&title=Novel+organic+proteasome+inhibitors+identified+by+virtual+and+in+vitro+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm9011092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9011092%26sid%3Dliteratum%253Aachs%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DMontes%26aufirst%3DM.%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DBouvier-Durand%26aufirst%3DM.%26aulast%3DGenin%26aufirst%3DE.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DVilloutreix%26aufirst%3DB.%2BO.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26atitle%3DNovel%2520organic%2520proteasome%2520inhibitors%2520identified%2520by%2520virtual%2520and%2520in%2520vitro%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D509%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, J.</span><span> </span><span class="NLM_article-title">Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2001&pages=543-548&author=M.+Grollauthor=Y.+Koguchiauthor=R.+Huberauthor=J.+Kohno&title=Crystal+structure+of+the+20+S+proteasome%3ATMC-95A+complex%3A+a+non-covalent+proteasome+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DKoguchi%26aufirst%3DY.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DKohno%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520the%252020%2520S%2520proteasome%253ATMC-95A%2520complex%253A%2520a%2520non-covalent%2520proteasome%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2001%26volume%3D311%26spage%3D543%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallastegui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span> </span><span class="NLM_article-title">20S proteasome inhibition: designing noncovalent linear peptide mimics of the natural product TMC-95A</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1701</span><span class="NLM_x">–</span> <span class="NLM_lpage">1705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1701-1705&author=M.+Grollauthor=N.+Gallasteguiauthor=X.+Marechalauthor=R.+V.+Leauthor=N.+Basseauthor=N.+Richyauthor=E.+Geninauthor=R.+Huberauthor=L.+Moroderauthor=J.+Vidalauthor=M.+Reboud-Ravaux&title=20S+proteasome+inhibition%3A+designing+noncovalent+linear+peptide+mimics+of+the+natural+product+TMC-95A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DLe%26aufirst%3DR.%2BV.%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DRichy%26aufirst%3DN.%26aulast%3DGenin%26aufirst%3DE.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DMoroder%26aufirst%3DL.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26atitle%3D20S%2520proteasome%2520inhibition%253A%2520designing%2520noncovalent%2520linear%2520peptide%2520mimics%2520of%2520the%2520natural%2520product%2520TMC-95A%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1701%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siciliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assfalg-Machleidt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbradt, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroder, L.</span><span> </span><span class="NLM_article-title">Binding mode of TMC-95A analogues to eukaryotic 20S proteasome</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1256-1266&author=M.+Kaiserauthor=M.+Grollauthor=C.+Sicilianoauthor=I.+Assfalg-Machleidtauthor=E.+Weyherauthor=J.+Kohnoauthor=A.+G.+Milbradtauthor=C.+Rennerauthor=R.+Huberauthor=L.+Moroder&title=Binding+mode+of+TMC-95A+analogues+to+eukaryotic+20S+proteasome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DSiciliano%26aufirst%3DC.%26aulast%3DAssfalg-Machleidt%26aufirst%3DI.%26aulast%3DWeyher%26aufirst%3DE.%26aulast%3DKohno%26aufirst%3DJ.%26aulast%3DMilbradt%26aufirst%3DA.%2BG.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DMoroder%26aufirst%3DL.%26atitle%3DBinding%2520mode%2520of%2520TMC-95A%2520analogues%2520to%2520eukaryotic%252020S%2520proteasome%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1256%26epage%3D1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Gallastegui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arciniega, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillebrand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span> </span><span class="NLM_article-title">Hydroxyureas as noncovalent proteasome inhibitors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=247-249&author=N.+Gallasteguiauthor=P.+Beckauthor=M.+Arciniegaauthor=R.+Huberauthor=S.+Hillebrandauthor=M.+Groll&title=Hydroxyureas+as+noncovalent+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3DBeck%26aufirst%3DP.%26aulast%3DArciniega%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DHillebrand%26aufirst%3DS.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DHydroxyureas%2520as%2520noncovalent%2520proteasome%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D247%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Meiners, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyken, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stangl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloetzel, P.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, E.</span><span> </span><span class="NLM_article-title">Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">21517</span><span class="NLM_x">–</span> <span class="NLM_lpage">21525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1074%2Fjbc.M301032200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=12676932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVemsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=21517-21525&author=S.+Meinersauthor=D.+Heykenauthor=A.+Wellerauthor=A.+Ludwigauthor=K.+Stanglauthor=P.-M.+Kloetzelauthor=E.+Krueger&title=Inhibition+of+proteasome+activity+induces+concerted+expression+of+proteasome+genes+and+de+novo+formation+of+mammalian+proteasomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Proteasome Activity Induces Concerted Expression of Proteasome Genes and de Novo Formation of Mammalian Proteasomes</span></div><div class="casAuthors">Meiners, Silke; Heyken, Dirk; Weller, Andrea; Ludwig, Antje; Stangl, Karl; Kloetzel, Peter-M.; Krueger, Elke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21517-21525</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The 26 S proteasome is a high mol. mass proteinase complex that is built by at least 32 different protein subunits.  Such protease complexes in bacteria and yeast are systems that undergo a highly sophisticated network of gene expression regulation.  However, regulation of mammalian proteasome gene expression has been neglected so far as a possible control mechanism for the amt. of proteasomes in the cell.  Here, we show that treatment of cells with proteasome inhibitors and the concomitant impairment of proteasomal enzyme activity induce a transient and concerted up-regulation of all mammalian 26 S proteasome subunit mRNAs.  Proteasome inhibition in combination with inhibition of transcription revealed that the obsd. up-regulation is mediated by coordinated transcriptional activation of the proteasome genes and not by post-transcriptional events.  Our expts. also demonstrate that inhibitor-induced proteasome gene activation results in enhanced de novo protein synthesis of all subunits and in increased de novo formation of proteasomes.  This phenomenon is accompanied by enhanced expression of the proteasome maturation factor POMP.  Thus, our expts. present the first evidence that the amt. of proteasomes in mammalia is regulated at the transcriptional level and that there exists an autoregulatory feedback mechanism that allows the compensation of reduced proteasome activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbyNxj9qhUXLVg90H21EOLACvtfcHk0ljdwRNOMbfXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVemsrk%253D&md5=2dba4af89533fe1720299bef5653e451</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M301032200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M301032200%26sid%3Dliteratum%253Aachs%26aulast%3DMeiners%26aufirst%3DS.%26aulast%3DHeyken%26aufirst%3DD.%26aulast%3DWeller%26aufirst%3DA.%26aulast%3DLudwig%26aufirst%3DA.%26aulast%3DStangl%26aufirst%3DK.%26aulast%3DKloetzel%26aufirst%3DP.-M.%26aulast%3DKrueger%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520proteasome%2520activity%2520induces%2520concerted%2520expression%2520of%2520proteasome%2520genes%2520and%2520de%2520novo%2520formation%2520of%2520mammalian%2520proteasomes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D21517%26epage%3D21525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5576</span><span class="NLM_x">–</span> <span class="NLM_lpage">5592</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5576-5592&author=H.+R.+Lawrenceauthor=A.+Kaziauthor=Y.+Luoauthor=R.+Kendigauthor=Y.+Geauthor=S.+Jainauthor=K.+Danielauthor=D.+Santiagoauthor=W.+C.+Guidaauthor=S.+M.+Sebti&title=Synthesis+and+biological+evaluation+of+naphthoquinone+analogs+as+a+novel+class+of+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DKendig%26aufirst%3DR.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DDaniel%26aufirst%3DK.%26aulast%3DSantiago%26aufirst%3DD.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520naphthoquinone%2520analogs%2520as%2520a%2520novel%2520class%2520of%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5576%26epage%3D5592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span> </span><span class="NLM_article-title">Discovery and synthesis of hydronaphthoquinones as novel proteasome inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1978</span><span class="NLM_x">–</span> <span class="NLM_lpage">1998</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201118h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1978-1998&author=Y.+Geauthor=A.+Kaziauthor=F.+Marsilioauthor=Y.+Luoauthor=S.+Jainauthor=W.+Brooksauthor=K.+G.+Danielauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=H.+R.+Lawrence&title=Discovery+and+synthesis+of+hydronaphthoquinones+as+novel+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm201118h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201118h%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DY.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DBrooks%26aufirst%3DW.%26aulast%3DDaniel%26aufirst%3DK.%2BG.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520hydronaphthoquinones%2520as%2520novel%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1978%26epage%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ozcan, S.; Aslamuzzaman, K.; Marsilio, F.; Daniel, K.; Brooks, W.; Guida, W.; Lawrence, H.; Sebti, S.</span><span> </span><span class="NLM_article-title">Identification of a Novel Class of Compounds as Proteasome Inhibitors: Synthesis and Structure Activity Relationship Studies of PI-1833 Library</span>.  <span class="citation_source-book">Book of Abstracts</span>, 102nd Annual Meeting of the American Association of Cancer Research, Orlando, FL, April 15, 2011; <span class="NLM_publisher-name">American Association of Cancer Research</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Abstract 1359.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Ozcan&author=K.+Aslamuzzaman&author=F.+Marsilio&author=K.+Daniel&author=W.+Brooks&author=W.+Guida&author=H.+Lawrence&author=S.+Sebti&title=Book+of+Abstracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOzcan%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Class%2520of%2520Compounds%2520as%2520Proteasome%2520Inhibitors%253A%2520Synthesis%2520and%2520Structure%2520Activity%2520Relationship%2520Studies%2520of%2520PI-1833%2520Library%26btitle%3DBook%2520of%2520Abstracts%26pub%3DAmerican%2520Association%2520of%2520Cancer%2520Research%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Villoutreix, B.; Reboud-Ravaux, M.; Basse, N.; Vidal, J.; Montes, M.</span><span> </span><span class="NLM_article-title">Nitrogen Heterocyclic Derivatives as Proteasome Modulators</span>. US 2011/0257176A1, Oct 20,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Villoutreix&author=M.+Reboud-Ravaux&author=N.+Basse&author=J.+Vidal&author=M.+Montes&title=Nitrogen+Heterocyclic+Derivatives+as+Proteasome+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVilloutreix%26aufirst%3DB.%26atitle%3DNitrogen%2520Heterocyclic%2520Derivatives%2520as%2520Proteasome%2520Modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Villoutreix, B.; Reboud-Ravaux, M.; Basse, N.; Vidal, J.; Montes, M.</span><span> </span><span class="NLM_article-title">Nitrogen Heterocycle Derivatives as Proteasome Modulators</span>. WO2010001365A1, Jan 7,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=B.+Villoutreix&author=M.+Reboud-Ravaux&author=N.+Basse&author=J.+Vidal&author=M.+Montes&title=Nitrogen+Heterocycle+Derivatives+as+Proteasome+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVilloutreix%26aufirst%3DB.%26atitle%3DNitrogen%2520Heterocycle%2520Derivatives%2520as%2520Proteasome%2520Modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagayoshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sappal, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigstad, K. M.</span><span> </span><span class="NLM_article-title">Optimization of a series of dipeptides with a P3 [small beta]-neopentyl asparagine residue as non-covalent inhibitors of the chymotrypsin-like activity of human 20S proteasome</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=710-719&author=C.+Blackburnauthor=C.+Barrettauthor=J.+L.+Blankauthor=F.+J.+Bruzzeseauthor=N.+Bumpauthor=L.+R.+Dickauthor=P.+Flemingauthor=K.+Garciaauthor=P.+Halesauthor=M.+Jonesauthor=J.+X.+Liuauthor=M.+Nagayoshiauthor=D.+S.+Sappalauthor=M.+D.+Sintchakauthor=C.+Tsuauthor=C.+Xiaauthor=X.+Zhouauthor=K.+M.+Gigstad&title=Optimization+of+a+series+of+dipeptides+with+a+P3+%5Bsmall+beta%5D-neopentyl+asparagine+residue+as+non-covalent+inhibitors+of+the+chymotrypsin-like+activity+of+human+20S+proteasome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DC.%26aulast%3DBlank%26aufirst%3DJ.%2BL.%26aulast%3DBruzzese%26aufirst%3DF.%2BJ.%26aulast%3DBump%26aufirst%3DN.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DNagayoshi%26aufirst%3DM.%26aulast%3DSappal%26aufirst%3DD.%2BS.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DGigstad%26aufirst%3DK.%2BM.%26atitle%3DOptimization%2520of%2520a%2520series%2520of%2520dipeptides%2520with%2520a%2520P3%2520%255Bsmall%2520beta%255D-neopentyl%2520asparagine%2520residue%2520as%2520non-covalent%2520inhibitors%2520of%2520the%2520chymotrypsin-like%2520activity%2520of%2520human%252020S%2520proteasome%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D710%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Baciocchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzalunga, O.</span><span> </span><span class="NLM_article-title">Lignin peroxidase-catalyzed oxidation of nonphenolic trimeric lignin model compounds: fragmentation reactions in the intermediate radical cations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">9061</span><span class="NLM_x">–</span> <span class="NLM_lpage">9069</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo035052w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=9061-9069&author=E.+Baciocchiauthor=C.+Fabbriauthor=O.+Lanzalunga&title=Lignin+peroxidase-catalyzed+oxidation+of+nonphenolic+trimeric+lignin+model+compounds%3A+fragmentation+reactions+in+the+intermediate+radical+cations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo035052w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo035052w%26sid%3Dliteratum%253Aachs%26aulast%3DBaciocchi%26aufirst%3DE.%26aulast%3DFabbri%26aufirst%3DC.%26aulast%3DLanzalunga%26aufirst%3DO.%26atitle%3DLignin%2520peroxidase-catalyzed%2520oxidation%2520of%2520nonphenolic%2520trimeric%2520lignin%2520model%2520compounds%253A%2520fragmentation%2520reactions%2520in%2520the%2520intermediate%2520radical%2520cations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D9061%26epage%3D9069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Spurg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldvogel, S. R.</span><span> </span><span class="NLM_article-title">High-yielding cleavage of (aryloxy) acetates</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=337-342&author=A.+Spurgauthor=S.+R.+Waldvogel&title=High-yielding+cleavage+of+%28aryloxy%29+acetates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpurg%26aufirst%3DA.%26aulast%3DWaldvogel%26aufirst%3DS.%2BR.%26atitle%3DHigh-yielding%2520cleavage%2520of%2520%2528aryloxy%2529%2520acetates%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2008%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Shah, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arfan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qadir, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal Choudhary, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanDerveer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed Mesaik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soomro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabeen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, I. U.</span><span> </span><span class="NLM_article-title">Synthesis of new bergenin derivatives as potent inhibitors of inflammatory mediators NO and TNF-α</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2744</span><span class="NLM_x">–</span> <span class="NLM_lpage">2747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2744-2747&author=M.+R.+Shahauthor=M.+Arfanauthor=H.+Aminauthor=Z.+Hussainauthor=M.+I.+Qadirauthor=M.+Iqbal+Choudharyauthor=D.+VanDerveerauthor=M.+Ahmed+Mesaikauthor=S.+Soomroauthor=A.+Jabeenauthor=I.+U.+Khan&title=Synthesis+of+new+bergenin+derivatives+as+potent+inhibitors+of+inflammatory+mediators+NO+and+TNF-%CE%B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%2BR.%26aulast%3DArfan%26aufirst%3DM.%26aulast%3DAmin%26aufirst%3DH.%26aulast%3DHussain%26aufirst%3DZ.%26aulast%3DQadir%26aufirst%3DM.%2BI.%26aulast%3DIqbal%2BChoudhary%26aufirst%3DM.%26aulast%3DVanDerveer%26aufirst%3DD.%26aulast%3DAhmed%2BMesaik%26aufirst%3DM.%26aulast%3DSoomro%26aufirst%3DS.%26aulast%3DJabeen%26aufirst%3DA.%26aulast%3DKhan%26aufirst%3DI.%2BU.%26atitle%3DSynthesis%2520of%2520new%2520bergenin%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520inflammatory%2520mediators%2520NO%2520and%2520TNF-%25CE%25B1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2744%26epage%3D2747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Wrzesien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D.</span><span> </span><span class="NLM_article-title">Synthesis of SERS active nanoparticles for detection of biomolecules</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=1230-1240&author=J.+Wrzesienauthor=D.+Graham&title=Synthesis+of+SERS+active+nanoparticles+for+detection+of+biomolecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWrzesien%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DD.%26atitle%3DSynthesis%2520of%2520SERS%2520active%2520nanoparticles%2520for%2520detection%2520of%2520biomolecules%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D1230%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Joseph, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanujam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, C. P.</span><span> </span><span class="NLM_article-title">Lower rim 1,3-di{bis(2-picolyl)}amide derivative of calix[4]arene (L) as ratiometric primary sensor toward Ag+ and the complex of Ag+ as secondary sensor toward Cys: experimental, computational, and microscopy studies and INHIBIT logic gate properties of L</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">8181</span><span class="NLM_x">–</span> <span class="NLM_lpage">8190</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo901676s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=8181-8190&author=R.+Josephauthor=B.+Ramanujamauthor=A.+Acharyaauthor=C.+P.+Rao&title=Lower+rim+1%2C3-di%7Bbis%282-picolyl%29%7Damide+derivative+of+calix%5B4%5Darene+%28L%29+as+ratiometric+primary+sensor+toward+Ag%2B+and+the+complex+of+Ag%2B+as+secondary+sensor+toward+Cys%3A+experimental%2C+computational%2C+and+microscopy+studies+and+INHIBIT+logic+gate+properties+of+L"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo901676s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901676s%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DR.%26aulast%3DRamanujam%26aufirst%3DB.%26aulast%3DAcharya%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DC.%2BP.%26atitle%3DLower%2520rim%25201%252C3-di%257Bbis%25282-picolyl%2529%257Damide%2520derivative%2520of%2520calix%255B4%255Darene%2520%2528L%2529%2520as%2520ratiometric%2520primary%2520sensor%2520toward%2520Ag%252B%2520and%2520the%2520complex%2520of%2520Ag%252B%2520as%2520secondary%2520sensor%2520toward%2520Cys%253A%2520experimental%252C%2520computational%252C%2520and%2520microscopy%2520studies%2520and%2520INHIBIT%2520logic%2520gate%2520properties%2520of%2520L%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D8181%26epage%3D8190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Gezginci, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span> </span><span class="NLM_article-title">Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1560</span><span class="NLM_x">–</span> <span class="NLM_lpage">1563</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000350w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1560-1563&author=M.%E2%80%89H.+Gezginciauthor=A.%E2%80%89R.+Martinauthor=S.%E2%80%89G.+Franzblau&title=Antimycobacterial+activity+of+substituted+isosteres+of+pyridine-+and+pyrazinecarboxylic+acids.+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm000350w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000350w%26sid%3Dliteratum%253Aachs%26aulast%3DGezginci%26aufirst%3DM.%25E2%2580%2589H.%26aulast%3DMartin%26aufirst%3DA.%25E2%2580%2589R.%26aulast%3DFranzblau%26aufirst%3DS.%25E2%2580%2589G.%26atitle%3DAntimycobacterial%2520activity%2520of%2520substituted%2520isosteres%2520of%2520pyridine-%2520and%2520pyrazinecarboxylic%2520acids.%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1560%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Ji, J.; Lee, C.-L.; Sippy, K. B.; Li, T.; Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Oxadiazole Derivatives as Neuronal Nicotinic Acetylcholine Receptor Ligands and a4b2 pos. Allosteric Modulators and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases</span>. 2008-134678 20080269236, 20080606,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Ji&author=C.-L.+Lee&author=K.+B.+Sippy&author=T.+Li&author=M.+Gopalakrishnan&title=Oxadiazole+Derivatives+as+Neuronal+Nicotinic+Acetylcholine+Receptor+Ligands+and+a4b2+pos.+Allosteric+Modulators+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%26atitle%3DOxadiazole%2520Derivatives%2520as%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Ligands%2520and%2520a4b2%2520pos.%2520Allosteric%2520Modulators%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Sindkhedkar, M. D.; Desai, V. N.; Loriya, R. M.; Patel, M. V.; Trivedi, B. K.; Bora, R. O.; Diwakar, S. D.; Jadhav, G. R.; Pawar, S. S.</span><span> </span><span class="NLM_article-title">Preparation of Erythromycin Macrolides and Ketolides Having Antimicrobial Activity</span>. 2007-IB2405 2008023248, 20070822,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+D.+Sindkhedkar&author=V.+N.+Desai&author=R.+M.+Loriya&author=M.+V.+Patel&author=B.+K.+Trivedi&author=R.+O.+Bora&author=S.+D.+Diwakar&author=G.+R.+Jadhav&author=S.+S.+Pawar&title=Preparation+of+Erythromycin+Macrolides+and+Ketolides+Having+Antimicrobial+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSindkhedkar%26aufirst%3DM.%2BD.%26atitle%3DPreparation%2520of%2520Erythromycin%2520Macrolides%2520and%2520Ketolides%2520Having%2520Antimicrobial%2520Activity%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Romeiro, L. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, M. d. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Silva, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, A. L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nascimento, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibirica, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C. A. M.</span><span> </span><span class="NLM_article-title">Discovery of LASSBio-772, a 1,3-benzodioxole <i>N</i>-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking properties</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3000</span><span class="NLM_x">–</span> <span class="NLM_lpage">3012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2Fj.ejmech.2011.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=21549456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVOrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3000-3012&author=L.+A.+S.+Romeiroauthor=M.+d.+S.+Ferreiraauthor=L.+L.+da+Silvaauthor=H.+C.+Castroauthor=A.+L.+P.+Mirandaauthor=C.+L.+M.+Silvaauthor=F.+Noelauthor=J.+B.+Nascimentoauthor=C.+V.+Araujoauthor=E.+Tibiricaauthor=E.+J.+Barreiroauthor=C.+A.+M.+Fraga&title=Discovery+of+LASSBio-772%2C+a+1%2C3-benzodioxole+N-phenylpiperazine+derivative+with+potent+alpha+1A%2FD-adrenergic+receptor+blocking+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-Adrenergic receptor blocking properties</span></div><div class="casAuthors">Romeiro, Luiz A. S.; Ferreira, Marcos da Silva; da Silva, Leandro L.; Castro, Helena C.; Miranda, Ana L. P.; Silva, Claudia L. M.; Noel, Francois; Nascimento, Jessica B.; Araujo, Claudia V.; Tibirica, Eduardo; Barreiro, Eliezer J.; Fraga, Carlos A. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3000-3012</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We described herein the discovery of 1-(2-(benzo[d] [1,3]dioxol-6-yl)ethyl)-4-(2-methoxyphenyl) piperazine (LASSBio-772), as a novel potent and selective alpha 1A/1D adrenoceptor (AR) antagonist selected after screening of functionalized N-phenylpiperazine derivs. in phenylephrine-induced vasoconstriction of rabbit aorta rings.  The affinity of LASSBio-772 for alpha 1A and alpha 1B AR subtypes was detd. through displacement of [3H]prazosin binding.  We obtained Ki values of 0.14 nM for the alpha 1A-AR, similar to that displayed by tamsulosin (K i = 0.13 nM) and 5.55 nM for the alpha 1B-AR, representing a 40-fold higher affinity for alpha 1A-AR.  LASSBio-772 also presented high affinity (K B = 0.025 nM) for the alpha 1D-AR subtype in the functional rat aorta assay, showing to be equipotent to tamsulosin (K B = 0.017 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2o5fIs2Ji_rVg90H21EOLACvtfcHk0lgDuUWusThIGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVOrtr8%253D&md5=2a62b6c9dd4252c69b030b23da8c559f</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DRomeiro%26aufirst%3DL.%2BA.%2BS.%26aulast%3DFerreira%26aufirst%3DM.%2Bd.%2BS.%26aulast%3Dda%2BSilva%26aufirst%3DL.%2BL.%26aulast%3DCastro%26aufirst%3DH.%2BC.%26aulast%3DMiranda%26aufirst%3DA.%2BL.%2BP.%26aulast%3DSilva%26aufirst%3DC.%2BL.%2BM.%26aulast%3DNoel%26aufirst%3DF.%26aulast%3DNascimento%26aufirst%3DJ.%2BB.%26aulast%3DAraujo%26aufirst%3DC.%2BV.%26aulast%3DTibirica%26aufirst%3DE.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DFraga%26aufirst%3DC.%2BA.%2BM.%26atitle%3DDiscovery%2520of%2520LASSBio-772%252C%2520a%25201%252C3-benzodioxole%2520N-phenylpiperazine%2520derivative%2520with%2520potent%2520alpha%25201A%252FD-adrenergic%2520receptor%2520blocking%2520properties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3000%26epage%3D3012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Weingarth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raouafi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jouvelet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodenhausen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boujlel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schollhorn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekely, P.</span><span> </span><span class="NLM_article-title">Revealing molecular self-assembly and geometry of non-covalent halogen bonding by solid-state NMR spectroscopy</span> <span class="citation_source-journal">Chem. Commun. (Cambridge, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">5981</span><span class="NLM_x">–</span> <span class="NLM_lpage">5983</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1039%2Fb813237b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=19030559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSqtbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=5981-5983&author=M.+Weingarthauthor=N.+Raouafiauthor=B.+Jouveletauthor=L.+Dumaauthor=G.+Bodenhausenauthor=K.+Boujlelauthor=B.+Schollhornauthor=P.+Tekely&title=Revealing+molecular+self-assembly+and+geometry+of+non-covalent+halogen+bonding+by+solid-state+NMR+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing molecular self-assembly and geometry of non-covalent halogen bonding by solid-state NMR spectroscopy</span></div><div class="casAuthors">Weingarth, Markus; Raouafi, Noureddine; Jouvelet, Benjamin; Duma, Luminita; Bodenhausen, Geoffrey; Boujlel, Khaled; Schollhorn, Bernd; Tekely, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">5981-5983</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report a new spectroscopic fingerprint of intermol. contacts in halogen bond-driven self-assembling aggregates and a precise detn. of intermol. N···I distances in microcryst. samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSwnZRkFpOJLVg90H21EOLACvtfcHk0lgDuUWusThIGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSqtbzL&md5=27725228a7c33a19219fec32d29b681a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2Fb813237b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb813237b%26sid%3Dliteratum%253Aachs%26aulast%3DWeingarth%26aufirst%3DM.%26aulast%3DRaouafi%26aufirst%3DN.%26aulast%3DJouvelet%26aufirst%3DB.%26aulast%3DDuma%26aufirst%3DL.%26aulast%3DBodenhausen%26aufirst%3DG.%26aulast%3DBoujlel%26aufirst%3DK.%26aulast%3DSchollhorn%26aufirst%3DB.%26aulast%3DTekely%26aufirst%3DP.%26atitle%3DRevealing%2520molecular%2520self-assembly%2520and%2520geometry%2520of%2520non-covalent%2520halogen%2520bonding%2520by%2520solid-state%2520NMR%2520spectroscopy%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2008%26spage%3D5981%26epage%3D5983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Fenteany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1126%2Fscience.7732382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=7732382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVGitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1995&pages=726-731&author=G.+Fenteanyauthor=R.+F.+Standaertauthor=W.+S.+Laneauthor=S.+Choiauthor=E.+J.+Coreyauthor=S.+L.+Schreiber&title=Inhibition+of+proteasome+activities+and+subunit-specific+amino-terminal+threonine+modification+by+lactacystin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin</span></div><div class="casAuthors">Fenteany, Gabriel; Standaert, Robert F.; Lane, William S.; Choi, Soongyu; Corey, E. J.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">5211</span>),
    <span class="NLM_cas:pages">726-31</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">3H-labeled lactacystin was used to identify the 20 S proteasome as its specific cellular target.  Three distinct peptidase activities of this enzyme complex (trypsin-like, chymotrypsin-like, and peptidylglutamylpeptide hydrolyzing activities) were inhibited by lactacystin, the 1st 2 irreversibly and all at different rates.  None of 5 other proteases were inhibited, and the ability of lactacystin analogs to inhibit cell cycle progression and induce neurite outgrowth correlated with their ability to inhibit the proteasome.  Lactacystin appeared to modify covalently the highly conserved N-terminal Thr residue of the mammalian proteasome subunit X (also called MB1), a close homolog of the LMP7 proteasome subunit encoded by the major histocompatibility complex.  This Thr residue may therefore play a catalytic role, and subunit X/MB1 may be a core component of an N-terminal-Thr protease activity of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2_DiZBqzR7Vg90H21EOLACvtfcHk0ljHC8RC1lS25g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVGitrg%253D&md5=6e3cf44432ad42b1aa17d246873292b9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1126%2Fscience.7732382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7732382%26sid%3Dliteratum%253Aachs%26aulast%3DFenteany%26aufirst%3DG.%26aulast%3DStandaert%26aufirst%3DR.%2BF.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DInhibition%2520of%2520proteasome%2520activities%2520and%2520subunit-specific%2520amino-terminal%2520threonine%2520modification%2520by%2520lactacystin%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1995%26volume%3D268%26spage%3D726%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Fenteany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Lactacystin, proteasome function, and cell fate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">8545</span><span class="NLM_x">–</span> <span class="NLM_lpage">8548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=8545-8548&author=G.+Fenteanyauthor=S.+L.+Schreiber&title=Lactacystin%2C+proteasome+function%2C+and+cell+fate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFenteany%26aufirst%3DG.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DLactacystin%252C%2520proteasome%2520function%252C%2520and%2520cell%2520fate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D8545%26epage%3D8548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljHC8RC1lS25g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Eng, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, J. R.,  III.</span><span> </span><span class="NLM_article-title">An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database</span> <span class="citation_source-journal">J. Am. Soc. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks">[<a href="/doi/10.1016/1044-0305%2894%2980016-2" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2MXhvF2htLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=976-989&author=J.+K.+Engauthor=A.+L.+McCormackauthor=J.+R.+Yates&title=An+approach+to+correlate+tandem+mass+spectral+data+of+peptides+with+amino+acid+sequences+in+a+protein+database"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database</span></div><div class="casAuthors">Eng, Jimmy K.; McCormack, Ashley L.; Yates, John R., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society for Mass Spectrometry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">976-89</span>CODEN:
                <span class="NLM_cas:coden">JAMSEF</span>;
        ISSN:<span class="NLM_cas:issn">1044-0305</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A method to correlate the uninterpreted tandem mass spectra of peptides produced under low energy (10-50 eV) collision conditions with amino acid sequences in the Genpept database has been developed.  In this method the protein database is searched to identify linear amino acid sequences within a mass tolerance of ±1 u of the precursor ion mol. wt.  A cross-correlation function is then used to provide a measurement of similarity between the mass-to-charge ratios for the fragment ions predicted from amino acid sequences obtained from the database and the fragment ions obsd. in the tandem mass spectrum.  In general, a difference >0.1 between the normalized cross-correlation functions of the first- and second-ranked search results indicates a successful match between sequence and spectrum.  Searches of species-specific protein databases with tandem mass spectra acquired from peptides obtained from the enzymically digested total proteins of E. coli and S. cerevisiae cells allowed matching of the spectra to amino acid sequences within proteins of these organisms.  The approach described in this manuscript provides a convenient method to interpret tandem mass spectra with known sequences in a protein database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-W7KmqWaYm7Vg90H21EOLACvtfcHk0ljHC8RC1lS25g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhvF2htLw%253D&md5=1a47bd23e76df9208ffdab41baed1880</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F1044-0305%2894%2980016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1044-0305%252894%252980016-2%26sid%3Dliteratum%253Aachs%26aulast%3DEng%26aufirst%3DJ.%2BK.%26aulast%3DMcCormack%26aufirst%3DA.%2BL.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26atitle%3DAn%2520approach%2520to%2520correlate%2520tandem%2520mass%2520spectral%2520data%2520of%2520peptides%2520with%2520amino%2520acid%2520sequences%2520in%2520a%2520protein%2520database%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D1994%26volume%3D5%26spage%3D976%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruikshank, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destree, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melandri, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plamondon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. L.</span><span> </span><span class="NLM_article-title">Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=182-188&author=L.+R.+Dickauthor=A.+A.+Cruikshankauthor=A.+T.+Destreeauthor=L.+Grenierauthor=T.+A.+McCormackauthor=F.+D.+Melandriauthor=S.+L.+Nunesauthor=V.+J.+Palombellaauthor=L.+A.+Parentauthor=L.+Plamondonauthor=R.+L.+Stein&title=Mechanistic+studies+on+the+inactivation+of+the+proteasome+by+lactacystin+in+cultured+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DCruikshank%26aufirst%3DA.%2BA.%26aulast%3DDestree%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DMcCormack%26aufirst%3DT.%2BA.%26aulast%3DMelandri%26aufirst%3DF.%2BD.%26aulast%3DNunes%26aufirst%3DS.%2BL.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DParent%26aufirst%3DL.%2BA.%26aulast%3DPlamondon%26aufirst%3DL.%26aulast%3DStein%26aufirst%3DR.%2BL.%26atitle%3DMechanistic%2520studies%2520on%2520the%2520inactivation%2520of%2520the%2520proteasome%2520by%2520lactacystin%2520in%2520cultured%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D182%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ming Li, Wei Li, Cheng-Dong Lin, Jia-Hui Wang, <span class="NLM_string-name hlFld-ContribAuthor">Li-Rong Wen</span>. </span><span class="cited-content_cbyCitation_article-title">One Base for Two Shots: Metal-Free Substituent-Controlled Synthesis of Two Kinds of Oxadiazine Derivatives from Alkynylbenziodoxolones and Amidoximes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (11)
                                     , 6904-6915. <a href="https://doi.org/10.1021/acs.joc.9b00659" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00659%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne%252BBase%252Bfor%252BTwo%252BShots%25253A%252BMetal-Free%252BSubstituent-Controlled%252BSynthesis%252Bof%252BTwo%252BKinds%252Bof%252BOxadiazine%252BDerivatives%252Bfrom%252BAlkynylbenziodoxolones%252Band%252BAmidoximes%26aulast%3DLi%26aufirst%3DMing%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13032019%26date%3D23052019%26date%3D14052019%26volume%3D84%26issue%3D11%26spage%3D6904%26epage%3D6915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huang-Chi Du, Madison C. Bangs, Nicholas Simmons, <span class="NLM_string-name hlFld-ContribAuthor">Martin M. Matzuk</span>. </span><span class="cited-content_cbyCitation_article-title">Multistep Synthesis of 1,2,4-Oxadiazoles via DNA-Conjugated Aryl Nitrile Substrates. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (5)
                                     , 1304-1308. <a href="https://doi.org/10.1021/acs.bioconjchem.9b00188" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.9b00188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.9b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.9b00188%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DMultistep%252BSynthesis%252Bof%252B1%25252C2%25252C4-Oxadiazoles%252Bvia%252BDNA-Conjugated%252BAryl%252BNitrile%252BSubstrates%26aulast%3DDu%26aufirst%3DHuang-Chi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11032019%26date%3D04042019%26date%3D10042019%26date%3D09042019%26volume%3D30%26issue%3D5%26spage%3D1304%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fábio
S. Fernandes, Manoel T. Rodrigues, Jr., Lucas A. Zeoly, Caroline Conti, Célio F.
F. Angolini, Marcos Nogueira Eberlin, <span class="NLM_string-name hlFld-ContribAuthor">Fernando Coelho</span>. </span><span class="cited-content_cbyCitation_article-title">Vinyl-1,2,4-oxadiazoles Behave as Nucleophilic Partners in Morita–Baylis–Hillman Reactions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (24)
                                     , 15118-15127. <a href="https://doi.org/10.1021/acs.joc.8b02402" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02402%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DVinyl-1%25252C2%25252C4-oxadiazoles%252BBehave%252Bas%252BNucleophilic%252BPartners%252Bin%252BMorita%2525E2%252580%252593Baylis%2525E2%252580%252593Hillman%252BReactions%26aulast%3DFernandes%26aufirst%3DF%25C3%25A1bio%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19092018%26date%3D04122018%26date%3D23112018%26volume%3D83%26issue%3D24%26spage%3D15118%26epage%3D15127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Perez</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Francesco  Parlati</span>, <span class="hlFld-ContribAuthor ">Matthieu  Rouffet</span>, <span class="hlFld-ContribAuthor ">Yuyong  Ma</span>, <span class="hlFld-ContribAuthor ">Andrew L.  Mackinnon</span>, <span class="hlFld-ContribAuthor ">Tsui-Fen  Chou</span>, <span class="hlFld-ContribAuthor ">Raymond J.  Deshaies</span>, and <span class="hlFld-ContribAuthor ">Seth M.  Cohen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of an Inhibitor of the Proteasome Subunit Rpn11. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (4)
                                     , 1343-1361. <a href="https://doi.org/10.1021/acs.jmedchem.6b01379" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01379</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01379%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ban%252BInhibitor%252Bof%252Bthe%252BProteasome%252BSubunit%252BRpn11%26aulast%3DPerez%26aufirst%3DChristian%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20092016%26date%3D13022017%26date%3D23022017%26volume%3D60%26issue%3D4%26spage%3D1343%26epage%3D1361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrey  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Andrey V.  Bogolubsky</span>, <span class="hlFld-ContribAuthor ">Sergey E.  Pipko</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Grishchenko</span>, <span class="hlFld-ContribAuthor ">Dmytro V.  Ushakov</span>, <span class="hlFld-ContribAuthor ">Anton V.  Zhemera</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Viniychuk</span>, <span class="hlFld-ContribAuthor ">Anzhelika I.  Konovets</span>, <span class="hlFld-ContribAuthor ">Olga A.  Zaporozhets</span>, <span class="hlFld-ContribAuthor ">Pavel K.  Mykhailiuk</span>, and <span class="hlFld-ContribAuthor ">Yurii S.  Moroz</span>  . </span><span class="cited-content_cbyCitation_article-title">Expanding Synthesizable Space of Disubstituted 1,2,4-Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2016,</strong> <em>18 </em>
                                    (10)
                                     , 616-624. <a href="https://doi.org/10.1021/acscombsci.6b00103" title="DOI URL">https://doi.org/10.1021/acscombsci.6b00103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.6b00103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.6b00103%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DExpanding%252BSynthesizable%252BSpace%252Bof%252BDisubstituted%252B1%25252C2%25252C4-Oxadiazoles%26aulast%3DTolmachev%26aufirst%3DAndrey%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12072016%26date%3D18082016%26date%3D07092016%26date%3D10102016%26date%3D22082016%26volume%3D18%26issue%3D10%26spage%3D616%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George  Kokotos</span>, <span class="hlFld-ContribAuthor ">Astrid J.  Feuerherm</span>, <span class="hlFld-ContribAuthor ">Efrosini  Barbayianni</span>, <span class="hlFld-ContribAuthor ">Ishita  Shah</span>, <span class="hlFld-ContribAuthor ">Mari  Sæther</span>, <span class="hlFld-ContribAuthor ">Victoria  Magrioti</span>, <span class="hlFld-ContribAuthor ">Thuy  Nguyen</span>, <span class="hlFld-ContribAuthor ">Violetta  Constantinou-Kokotou</span>, <span class="hlFld-ContribAuthor ">Edward A.  Dennis</span>, and <span class="hlFld-ContribAuthor ">Berit  Johansen</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibition of Group IVA Cytosolic Phospholipase A2 by Thiazolyl Ketones in Vitro, ex Vivo, and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (18)
                                     , 7523-7535. <a href="https://doi.org/10.1021/jm500192s" title="DOI URL">https://doi.org/10.1021/jm500192s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500192s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500192s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252BGroup%252BIVA%252BCytosolic%252BPhospholipase%252BA2%252Bby%252BThiazolyl%252BKetones%252Bin%252BVitro%25252C%252Bex%252BVivo%25252C%252Band%252Bin%252BVivo%26aulast%3DKokotos%26aufirst%3DGeorge%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11022014%26date%3D03092014%26date%3D25092014%26date%3D25082014%26volume%3D57%26issue%3D18%26spage%3D7523%26epage%3D7535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Ke  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Fang-Fang  Lai</span>, <span class="hlFld-ContribAuthor ">Xiao-Guang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Yan  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of dipeptides as novel non-covalent 20S proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Asian Natural Products Research</span><span> <strong>2021,</strong> <em>23 </em>
                                    (5)
                                     , 436-451. <a href="https://doi.org/10.1080/10286020.2021.1910241" title="DOI URL">https://doi.org/10.1080/10286020.2021.1910241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10286020.2021.1910241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10286020.2021.1910241%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Asian%2520Natural%2520Products%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bdipeptides%252Bas%252Bnovel%252Bnon-covalent%252B20S%252Bproteasome%252Binhibitors%26aulast%3DYang%26aufirst%3DYa-Jun%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D5%26spage%3D436%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Yang</span>, <span class="hlFld-ContribAuthor ">Ke  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Wu</span>, <span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Fangfang  Lai</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (21)
                                     , 127508. <a href="https://doi.org/10.1016/j.bmcl.2020.127508" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127508%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Btriaryl%252Bcompounds%252Bas%252Bnovel%252B20S%252Bproteasome%252Binhibitors%26aulast%3DYang%26aufirst%3DYajun%26date%3D2020%26volume%3D30%26issue%3D21%26spage%3D127508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Benassi</span>, <span class="hlFld-ContribAuthor ">Filippo  Doria</span>, <span class="hlFld-ContribAuthor ">Valentina  Pirota</span>. </span><span class="cited-content_cbyCitation_article-title">Groundbreaking Anticancer Activity of Highly Diversified Oxadiazole Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (22)
                                     , 8692. <a href="https://doi.org/10.3390/ijms21228692" title="DOI URL">https://doi.org/10.3390/ijms21228692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21228692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21228692%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DGroundbreaking%252BAnticancer%252BActivity%252Bof%252BHighly%252BDiversified%252BOxadiazole%252BScaffolds%26aulast%3DBenassi%26aufirst%3DAlessandra%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D22%26spage%3D8692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Tongliang  Zhou</span>, <span class="hlFld-ContribAuthor ">Dandan  Xi</span>, <span class="hlFld-ContribAuthor ">Xiaona  Li</span>, <span class="hlFld-ContribAuthor ">Zirui  Lü</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasome. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112160. <a href="https://doi.org/10.1016/j.ejmech.2020.112160" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112160%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Btripeptidyl%252Bfurylketones%252Bas%252Bselective%252Binhibitors%252Bagainst%252Bthe%252B%2525CE%2525B25%252Bsubunit%252Bof%252Bhuman%252B20S%252Bproteasome%26aulast%3DSun%26aufirst%3DQi%26date%3D2020%26volume%3D192%26spage%3D112160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guedes</span>, <span class="hlFld-ContribAuthor ">Aniceto</span>, <span class="hlFld-ContribAuthor ">Andrade</span>, <span class="hlFld-ContribAuthor ">Salvador</span>, <span class="hlFld-ContribAuthor ">Guedes</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Patterns of Proteasome Inhibitors: Lessons Learned from Two Decades of Drug Design. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (21)
                                     , 5326. <a href="https://doi.org/10.3390/ijms20215326" title="DOI URL">https://doi.org/10.3390/ijms20215326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20215326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20215326%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DChemical%252BPatterns%252Bof%252BProteasome%252BInhibitors%25253A%252BLessons%252BLearned%252Bfrom%252BTwo%252BDecades%252Bof%252BDrug%252BDesign%26aulast%3DGuedes%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D21%26spage%3D5326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xudong  Cao</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Yao</span>, <span class="hlFld-ContribAuthor ">Fei  Dou</span>, <span class="hlFld-ContribAuthor ">Yifang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinli  Qiu</span>, <span class="hlFld-ContribAuthor ">Song  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiangqing  Xu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Bi‐Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Yin  Chen</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Sigma‐1 (σ
              1
              ) Receptor Ligands Based on Phenyl‐1,2,4‐oxadiazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (3)
                                     , e1800599. <a href="https://doi.org/10.1002/cbdv.201800599" title="DOI URL">https://doi.org/10.1002/cbdv.201800599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800599%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BSigma%2525E2%252580%2525901%252B%252528%2525CF%252583%252B1%252B%252529%252BReceptor%252BLigands%252BBased%252Bon%252BPhenyl%2525E2%252580%2525901%25252C2%25252C4%2525E2%252580%252590oxadiazole%252BDerivatives%26aulast%3DCao%26aufirst%3DXudong%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D3%26spage%3De1800599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wiliam  Caneschi</span>, <span class="hlFld-ContribAuthor ">Karine Braga  Enes</span>, <span class="hlFld-ContribAuthor ">Camille  Carvalho de Mendonça</span>, <span class="hlFld-ContribAuthor ">Fábio  de Souza Fernandes</span>, <span class="hlFld-ContribAuthor ">Fabio Balbino  Miguel</span>, <span class="hlFld-ContribAuthor ">Jefferson  da Silva Martins</span>, <span class="hlFld-ContribAuthor ">Mireille  Le Hyaric</span>, <span class="hlFld-ContribAuthor ">Roberto Rosas  Pinho</span>, <span class="hlFld-ContribAuthor ">Lucas Mattos  Duarte</span>, <span class="hlFld-ContribAuthor ">Marcone Augusto  Leal de Oliveira</span>, <span class="hlFld-ContribAuthor ">Hélio F.  Dos Santos</span>, <span class="hlFld-ContribAuthor ">Miriam Teresa  Paz Lopes</span>, <span class="hlFld-ContribAuthor ">Dalton  Dittz</span>, <span class="hlFld-ContribAuthor ">Heveline  Silva</span>, <span class="hlFld-ContribAuthor ">Mara Rubia  Costa Couri</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>165 </em>, 18-30. <a href="https://doi.org/10.1016/j.ejmech.2019.01.001" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bevaluation%252Bof%252Bnew%252Blipophilic%252B1%25252C2%25252C4%252Band%252B1%25252C3%25252C4-oxadiazoles%26aulast%3DCaneschi%26aufirst%3DWiliam%26date%3D2019%26volume%3D165%26spage%3D18%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Yu</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Duidui  Hong</span>, <span class="hlFld-ContribAuthor ">Xiaotuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jieyu  Liu</span>, <span class="hlFld-ContribAuthor ">Daqiang  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>161 </em>, 543-558. <a href="https://doi.org/10.1016/j.ejmech.2018.10.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bphenol%252Bether%252Bderivatives%252Bas%252Bnon-covalent%252Bproteasome%252Binhibitors%26aulast%3DYu%26aufirst%3DJianjun%26date%3D2019%26volume%3D161%26spage%3D543%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruda de Luna Almeida  Santos</span>, <span class="hlFld-ContribAuthor ">Lin  Bai</span>, <span class="hlFld-ContribAuthor ">Pradeep K.  Singh</span>, <span class="hlFld-ContribAuthor ">Naoka  Murakami</span>, <span class="hlFld-ContribAuthor ">Hao  Fan</span>, <span class="hlFld-ContribAuthor ">Wenhu  Zhan</span>, <span class="hlFld-ContribAuthor ">Yingrong  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiuju  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaiming  Zhang</span>, <span class="hlFld-ContribAuthor ">Jean Pierre  Assker</span>, <span class="hlFld-ContribAuthor ">Carl F.  Nathan</span>, <span class="hlFld-ContribAuthor ">Huilin  Li</span>, <span class="hlFld-ContribAuthor ">Jamil  Azzi</span>, <span class="hlFld-ContribAuthor ">Gang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-01760-5" title="DOI URL">https://doi.org/10.1038/s41467-017-01760-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-01760-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-01760-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructure%252Bof%252Bhuman%252Bimmunoproteasome%252Bwith%252Ba%252Breversible%252Band%252Bnoncompetitive%252Binhibitor%252Bthat%252Bselectively%252Binhibits%252Bactivated%252Blymphocytes%26aulast%3DSantos%26aufirst%3DRuda%2Bde%2BLuna%2BAlmeida%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanner J.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Theresa A.  Lansdell</span>, <span class="hlFld-ContribAuthor ">Amila A.  Dissanayake</span>, <span class="hlFld-ContribAuthor ">Lauren M.  Azevedo</span>, <span class="hlFld-ContribAuthor ">Jacob  Claes</span>, <span class="hlFld-ContribAuthor ">Aaron L.  Odom</span>, <span class="hlFld-ContribAuthor ">Jetze J.  Tepe</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted quinolines as noncovalent proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (11)
                                     , 2441-2450. <a href="https://doi.org/10.1016/j.bmc.2016.04.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252Bquinolines%252Bas%252Bnoncovalent%252Bproteasome%252Binhibitors%26aulast%3DMcDaniel%26aufirst%3DTanner%2BJ.%26date%3D2016%26volume%3D24%26issue%3D11%26spage%3D2441%26epage%3D2450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Adib</span>, <span class="hlFld-ContribAuthor ">Sara  Saeedi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Soheilizad</span>, <span class="hlFld-ContribAuthor ">Maryam  Bayanati</span>, <span class="hlFld-ContribAuthor ">Mahmood  Tajbakhsh</span>, <span class="hlFld-ContribAuthor ">Massoud  Amanlou</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient One-Pot Synthesis of 3-Aryl-5-(Dialkoxymethyl)-1,2,4-Oxadiazoles under Solvent-Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2016,</strong> <em>40 </em>
                                    (5)
                                     , 314-317. <a href="https://doi.org/10.3184/174751916X14608135651135" title="DOI URL">https://doi.org/10.3184/174751916X14608135651135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751916X14608135651135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751916X14608135651135%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DAn%252BEfficient%252BOne-Pot%252BSynthesis%252Bof%252B3-Aryl-5-%252528Dialkoxymethyl%252529-1%25252C2%25252C4-Oxadiazoles%252Bunder%252BSolvent-Free%252BConditions%26aulast%3DAdib%26aufirst%3DMehdi%26date%3D2016%26date%3D2019%26volume%3D40%26issue%3D5%26spage%3D314%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Han Gary  Teng</span>, <span class="hlFld-ContribAuthor ">William T.  Berger</span>, <span class="hlFld-ContribAuthor ">Natasha M.  Nesbitt</span>, <span class="hlFld-ContribAuthor ">Kunal  Kumar</span>, <span class="hlFld-ContribAuthor ">Trent E.  Balius</span>, <span class="hlFld-ContribAuthor ">Robert C.  Rizzo</span>, <span class="hlFld-ContribAuthor ">Peter J.  Tonge</span>, <span class="hlFld-ContribAuthor ">Iwao  Ojima</span>, <span class="hlFld-ContribAuthor ">Subramanyam  Swaminathan</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5489-5495. <a href="https://doi.org/10.1016/j.bmc.2015.07.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DComputer-aided%252Bidentification%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Binhibitors%252Bfor%252Bbotulinum%252Bneurotoxin%252Bserotype%252BA%26aulast%3DTeng%26aufirst%3DYu-Han%2BGary%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5489%26epage%3D5495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  Villoutreix</span>, <span class="hlFld-ContribAuthor ">Melaine  Kuenemann</span>, <span class="hlFld-ContribAuthor ">David  Lagorce</span>, <span class="hlFld-ContribAuthor ">Olivier  Sperandio</span>, <span class="hlFld-ContribAuthor ">Maria  Miteva</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Approaches Assisting the Rational Design of Low Molecular Weight Protein–Protein Interaction Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 441-482. <a href="https://doi.org/10.1201/b18799-21" title="DOI URL">https://doi.org/10.1201/b18799-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/b18799-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2Fb18799-21%26sid%3Dliteratum%253Aachs%26atitle%3DIn%252BSilico%252BApproaches%252BAssisting%252Bthe%252BRational%252BDesign%252Bof%252BLow%252BMolecular%252BWeight%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BModulators%26aulast%3DVilloutreix%26aufirst%3DBruno%26date%3D2015%26date%3D2015%26spage%3D441%26epage%3D482%26pub%3DCRC%2520Press%26atitle%3DIn%252BSilico%252BDrug%252BDiscovery%252Band%252BDesign%26aulast%3DCavasotto%26aufirst%3DClaudio%26date%3D2015%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>, <span class="hlFld-ContribAuthor ">Melaine A.  Kuenemann</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Poyet</span>, <span class="hlFld-ContribAuthor ">Heriberto  Bruzzoni-Giovanelli</span>, <span class="hlFld-ContribAuthor ">Céline  Labbé</span>, <span class="hlFld-ContribAuthor ">David  Lagorce</span>, <span class="hlFld-ContribAuthor ">Olivier  Sperandio</span>, <span class="hlFld-ContribAuthor ">Maria A.  Miteva</span>. </span><span class="cited-content_cbyCitation_article-title">Drug-Like ProteinProtein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2014,</strong> <em>33 </em>
                                    (6-7)
                                     , 414-437. <a href="https://doi.org/10.1002/minf.201400040" title="DOI URL">https://doi.org/10.1002/minf.201400040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201400040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201400040%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DDrug-Like%252BProtein%2525EF%2525A3%2525BFProtein%252BInteraction%252BModulators%25253A%252BChallenges%252Band%252BOpportunities%252Bfor%252BDrug%252BDiscovery%252Band%252BChemical%252BBiology%26aulast%3DVilloutreix%26aufirst%3DBruno%2BO.%26date%3D2014%26date%3D2014%26volume%3D33%26issue%3D6-7%26spage%3D414%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aslamuzzaman  Kazi</span>, <span class="hlFld-ContribAuthor ">Sevil  Ozcan</span>, <span class="hlFld-ContribAuthor ">Awet  Tecleab</span>, <span class="hlFld-ContribAuthor ">Ying  Sun</span>, <span class="hlFld-ContribAuthor ">Harshani R.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Saïd M.  Sebti</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of PI-1840, a Novel Noncovalent and Rapidly Reversible Proteasome Inhibitor with Anti-tumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2014,</strong> <em>289 </em>
                                    (17)
                                     , 11906-11915. <a href="https://doi.org/10.1074/jbc.M113.533950" title="DOI URL">https://doi.org/10.1074/jbc.M113.533950</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M113.533950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M113.533950%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPI-1840%25252C%252Ba%252BNovel%252BNoncovalent%252Band%252BRapidly%252BReversible%252BProteasome%252BInhibitor%252Bwith%252BAnti-tumor%252BActivity%26aulast%3DKazi%26aufirst%3DAslamuzzaman%26date%3D2014%26volume%3D289%26issue%3D17%26spage%3D11906%26epage%3D11915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>, <span class="hlFld-ContribAuthor ">David  Lagorce</span>, <span class="hlFld-ContribAuthor ">Céline M.  Labbé</span>, <span class="hlFld-ContribAuthor ">Olivier  Sperandio</span>, <span class="hlFld-ContribAuthor ">Maria A.  Miteva</span>. </span><span class="cited-content_cbyCitation_article-title">One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2013,</strong> <em>18 </em>
                                    (21-22)
                                     , 1081-1089. <a href="https://doi.org/10.1016/j.drudis.2013.06.013" title="DOI URL">https://doi.org/10.1016/j.drudis.2013.06.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2013.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2013.06.013%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DOne%252Bhundred%252Bthousand%252Bmouse%252Bclicks%252Bdown%252Bthe%252Broad%25253A%252Bselected%252Bonline%252Bresources%252Bsupporting%252Bdrug%252Bdiscovery%252Bcollected%252Bover%252Ba%252Bdecade%26aulast%3DVilloutreix%26aufirst%3DBruno%2BO.%26date%3D2013%26volume%3D18%26issue%3D21-22%26spage%3D1081%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structures of clinically advanced covalent proteasome inhibitors. (B) Structures of noncovalent small molecule proteasome inhibitors: hydroxyurea pharmacophore<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and peptidic pharmacophore from Millennium.<a onclick="showRef(event, 'ref11 ref45'); return false;" href="javascript:void(0);" class="ref ref11 ref45">(11, 45)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modifications and library synthesis around <b>1</b> for design of new proteasome inhibitors and SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Compound <b>1</b> and Libraries <b>11</b> and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl bromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 14 h; (b) <i>tert</i>-butyl bromoacetate, DMF, 80 °C, 14 h; (c) ethyl bromoacetate, K<sub>2</sub>CO<sub>3,</sub> DMF, rt, 14 h; (d) NaOH, THF, reflux, 2 h (R = ethyl); (e) CF<sub>3</sub>COOH, DCM, rt, 2 h (R = <sup><i>t</i></sup>Bu); (f) SOCl<sub>2</sub>, benzene, reflux, 3 h; (g) NH<sub>2</sub>OH.HCl, Na<sub>2</sub>CO<sub>3,</sub> water, 70 °C, 14 h; (h) chloroacetyl chloride, acetone, rt, 30 min; (i) toluene, reflux, 2 h; (j) alkylamine, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 30 min; (k) Et<sub>3</sub>N, THF, rt, 15 min.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (l) Et<sub>3</sub>N, benzene, reflux, 14 h, 78%; (m) chloroacetyl chloride, Et<sub>3</sub>N, THF, rt, 15 min, 80%; (n) <i>p</i>-methylaniline, NaOAc, ethanol, reflux, 15 h, 78%; (f) SOCl<sub>2</sub>, benzene, reflux, 3 h, 94%; (k) Et<sub>3</sub>N, THF, rt, 15 min, 88% (<b>19a</b>), 82% (<b>19b</b>), 87%, (<b>23</b>); (o) DCM, rt, 14 h, 76%; (i) toluene, reflux, 2 h, 81%; (j) isopropylamine, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 30 min, 86%.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) LC–MS/MS analysis of tryptic digests from proteasome CT-L subunit after incubation with vehicle. LC–MS/MS analysis of Thr-1 containing peptide from the proteasome CT-L subunit β5 after tryptic digestion is shown. Singly charged unmodified peptide was observed at <i>m</i>/<i>z</i> 781.4401, which represents a mass error of 6.9 ppm. The tandem mass spectrum was matched to peptide TTTLAFK. The b ions (labeled in red) contain the N-terminus of the peptide, and y ions (labeled in blue) contain the C-terminus of the peptide. The number associated with each ion indicates the number of amino acids in that fragment (for example, y4 contains LAFK from C-terminus of the peptide). (B) LC–MS/MS analysis of tryptic digests from proteasome CT-L subunit after incubation with compound <b>1</b>. The Thr-1 containing peptide did not show any modification. Both intact mass spectrum and tandem mass spectrum indicate unmodified Thr-1 containing peptide. (C) LC–MS/MS analysis of tryptic digests from proteasome CT-L subunit after incubation with lactacystin shows <i>clasto</i>-lactacystin-modified Thr-1 containing peptide. Doubly charged lactacystin-Thr modified peptide was detected at <i>m</i>/<i>z</i> 497.7795, which represents a mass error 6.1 ppm. The tandem mass spectrum confirms the modification of the peptide by lactacystin. (D) Structure of the unmodified TTTLAFK tryptic peptide. (E) Structure of the <i>clasto</i>-lactacystin modified peptide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Recovery of CT-L activity upon dialysis of the 20S proteasome–compound complexes after preincubation with lead <b>1</b> and lactacystin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/medium/jm-2013-00221d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Lead <b>11ad</b> is more potent at inhibiting proteasomal CT-L activity in intact human MDA-MB-468 cancer cells compared to the parent compound <b>1</b>. (B) Lead <b>11ad</b> is more potent at inhibiting proliferation/survival of human MDA-MB-468 cells compared to the parent hit <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-10/jm400221d/production/images/large/jm-2013-00221d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400221d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hochstrasser, M.</span><span> </span><span class="NLM_article-title">Ubiquitin, proteasomes, and the regulation of intracellular protein degradation</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2F0955-0674%2895%2980031-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=7612274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2MXkslWhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=215-223&author=M.+Hochstrasser&title=Ubiquitin%2C+proteasomes%2C+and+the+regulation+of+intracellular+protein+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin, proteasomes, and the regulation of intracellular protein degradation</span></div><div class="casAuthors">Hochstrasser, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-23</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 68 refs.  Rapid degrdn. of specific proteins by ubiquitin/proteasome-dependent pathways is a component of many cellular regulatory mechanisms.  Recent work has shown that protein ubiquitination and deubiquitination are both mediated by large families of enzymes and that proteolysis can be modulated by alterations of the proteasome itself.  The complexity of the ubiquitin system is reflected in the broad range of processes it regulates; these include key steps in cell cycle progression, processing of foreign proteins for presentation by class 1 MHC mols., and the control of cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtYy_aXiC_ILVg90H21EOLACvtfcHk0liHRBBnc_BEIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslWhtLY%253D&md5=e2e2a135307fee97e04f90097519605c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0955-0674%2895%2980031-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0955-0674%252895%252980031-X%26sid%3Dliteratum%253Aachs%26aulast%3DHochstrasser%26aufirst%3DM.%26atitle%3DUbiquitin%252C%2520proteasomes%252C%2520and%2520the%2520regulation%2520of%2520intracellular%2520protein%2520degradation%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D1995%26volume%3D7%26spage%3D215%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Yamasaki, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span> </span><span class="NLM_article-title">Cell cycle, proteolysis and cancer</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2Fj.ceb.2004.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=15530772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVOrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=623-628&author=L.+Yamasakiauthor=M.+Pagano&title=Cell+cycle%2C+proteolysis+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, proteolysis and cancer</span></div><div class="casAuthors">Yamasaki, Lili; Pagano, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">623-628</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Research in the past 15 years has shown that the mammalian cell cycle is controlled by the action of cyclin-dependent kinases (CDKs).  A crucial substrate of the CDKs in G1-phase is the retinoblastoma tumor suppressor (pRB), which restrains proliferation largely by repressing the activity of the E2F transcription factors.  More recent work has shown that the cell cycle is also a tale of two classes of ubiquitin ligases, referred to as SCF and APC/C ligases.  CDKs, E2F and ubiquitin ligases reciprocally regulate each other, resulting in complex feedback loops.  Perturbation of this network of mol. machines is assocd. with proliferative diseases, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLzkzLO5drSrVg90H21EOLACvtfcHk0liHRBBnc_BEIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVOrtb8%253D&md5=6d0378298b12ab5cbbdc7e54a5672514</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2004.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2004.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DYamasaki%26aufirst%3DL.%26aulast%3DPagano%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520proteolysis%2520and%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2004%26volume%3D16%26spage%3D623%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Coux, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span> </span><span class="NLM_article-title">Structure and functions of the 20S and 26S proteasomes</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1146%2Fannurev.bi.65.070196.004101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=8811196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK28XktFamurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=801-847&author=O.+Couxauthor=K.+Tanakaauthor=A.+L.+Goldberg&title=Structure+and+functions+of+the+20S+and+26S+proteasomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and functions of the 20S and 26S proteasomes</span></div><div class="casAuthors">Coux, Olivier; Tanaka, Keiji; Goldberg, Alfred L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">801-847</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 287 refs., of recent progress with respect to biochem. mechanisms and intracellular functions of the 20 S and 26 S proteasomes (multicatalytic proteinases).  The proteasome is an essential component of the ATP-dependent proteolytic pathway in eukaryotic cells and is responsible for the degrdn. of most cellular proteins.  The 20 S (700-kDa) proteasome contains multiple peptidase activities that function through a new type of proteolytic mechanism involving a threonine active site.  The 26 S (2000-kDa) complex, which degrades ubiquitinated proteins, contains in addn. to the 20 S proteasome a 19 S regulatory complex composed of multiple ATPases and components necessary for binding protein substrates.  The proteasome has been highly conserved during eukaryotic evolution, and simpler forms are even found in archaebacteria and eubacteria.  Major advances have been achieved recently in the knowledge about the mol. organization of the 20 S and 19 S particles, their subunits, the proteasome's role in MHC-class 1 antigen presentation, and regulators of its activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCV4euIYQJHLVg90H21EOLACvtfcHk0liHRBBnc_BEIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktFamurc%253D&md5=546ea9ad61ac1cf74667da7e5075484c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.65.070196.004101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.65.070196.004101%26sid%3Dliteratum%253Aachs%26aulast%3DCoux%26aufirst%3DO.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DStructure%2520and%2520functions%2520of%2520the%252020S%2520and%252026S%2520proteasomes%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1996%26volume%3D65%26spage%3D801%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A. L.</span><span> </span><span class="NLM_article-title">The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=40-51&author=A.+Ciechanoverauthor=A.+Orianauthor=A.+L.+Schwartz&title=The+ubiquitin-mediated+proteolytic+pathway%3A+mode+of+action+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DOrian%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DA.%2BL.%26atitle%3DThe%2520ubiquitin-mediated%2520proteolytic%2520pathway%253A%2520mode%2520of%2520action%2520and%2520clinical%2520implications%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2000%26spage%3D40%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span> </span><span class="NLM_article-title">The ubiquitin–proteasome proteolytic pathway</span> <span class="citation_source-journal">Cell (Cambridge, MA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2F0092-8674%2894%2990396-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=7923371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2cXmsFWqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1994&pages=13-21&author=A.+Ciechanover&title=The+ubiquitin%E2%80%93proteasome+proteolytic+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin-proteasome proteolytic pathway</span></div><div class="casAuthors">Ciechanover, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-21</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A review, with 61 refs., on the components, mechanisms of action, and cellular physiol. of the ubiquitin-proteasome pathway, including enzymes of the system, recognition of substrates, and cellular substrates of the ubiquitin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKZUwFZmTaxrVg90H21EOLACvtfcHk0lh_athCrawifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsFWqtb4%253D&md5=4430ea222235ad39b0bc0f2799685f67</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2894%2990396-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252894%252990396-4%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DThe%2520ubiquitin%25E2%2580%2593proteasome%2520proteolytic%2520pathway%26jtitle%3DCell%2520%2528Cambridge%252C%2520MA%252C%2520U.%2520S.%2529%26date%3D1994%26volume%3D79%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Baumeister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuhl, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seemuller, E.</span><span> </span><span class="NLM_article-title">The proteasome: paradigm of a self-compartmentalizing protease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2FS0092-8674%2800%2980929-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=9476896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK1cXhtFGisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=367-880&author=W.+Baumeisterauthor=J.+Walzauthor=F.+Zuhlauthor=E.+Seemuller&title=The+proteasome%3A+paradigm+of+a+self-compartmentalizing+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The proteasome: paradigm of a self-compartmentalizing protease</span></div><div class="casAuthors">Baumeister, Wolfgang; Walz, Jochen; Zuhl, Frank; Seemuller, Erika</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">367-380</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with ∼100 refs. on advances in understanding the structure of the proteasome and its mechanism of action which shaped the concept of self-compartmentalization and the proteasome became the paradigm of this form of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tVahAhrt17Vg90H21EOLACvtfcHk0lh_athCrawifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtFGisLY%253D&md5=0a865caef4357214337a03025ba611d6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980929-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980929-0%26sid%3Dliteratum%253Aachs%26aulast%3DBaumeister%26aufirst%3DW.%26aulast%3DWalz%26aufirst%3DJ.%26aulast%3DZuhl%26aufirst%3DF.%26aulast%3DSeemuller%26aufirst%3DE.%26atitle%3DThe%2520proteasome%253A%2520paradigm%2520of%2520a%2520self-compartmentalizing%2520protease%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D367%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditzel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bochtler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartunik, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span> </span><span class="NLM_article-title">Structure of 20S proteasome from yeast at 2.4 .ANG. resolution</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1038%2F386463a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=9087403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2sXisVSqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=1997&pages=463-471&author=M.+Grollauthor=L.+Ditzelauthor=J.+Loeweauthor=D.+Stockauthor=M.+Bochtlerauthor=H.+D.+Bartunikauthor=R.+Huber&title=Structure+of+20S+proteasome+from+yeast+at+2.4+.ANG.+resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of 20S proteasome from yeast at 2.4 Å resolution</span></div><div class="casAuthors">Groll, Michael; Ditzel, Lars; Loewe, Jan; Stock, Daniela; Bochtler, Matthias; Bartunik, Hans D.; Huber, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">386</span>
        (<span class="NLM_cas:issue">6624</span>),
    <span class="NLM_cas:pages">463-471</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structure of the 20S proteasome from the yeast Saccharomyces cerevisiae shows that its 28 protein subunits are arranged as an (α1...α7,β1...β7)2 complex in four stacked rings and occupy unique locations.  The interior of the particle, which harbors the active sites, is only accessible by some very narrow side entrances.  The β-type subunits are synthesized as proproteins before being proteolytically processed for assembly into the particle.  The pro forms of three of the seven different β-type subunits, β1-PRE3, β2/PUP1 and β5/PRE2, are cleaved between the threonine at position 1 and the last glycine of the pro-sequence, with release of the active-site residue Thr 1.  These three β-type subunits have inhibitor-binding sites, indicating that PRE2 has a chymotrypsin-like and a trypsin-like activity and that PRE3 has peptidylglutamyl peptide hydrolytic specificity.  Other β-type subunits are processed to an intermediate form, indicating that an addnl. nonspecific endopeptidase activity may exist which is important for peptide hydrolysis and for the generation of ligands for class I mols. of the major histocompatibility complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUP7-BUWwo-bVg90H21EOLACvtfcHk0lh_athCrawifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVSqsr0%253D&md5=1796bb267e45cc5cdd2c97ecb426f39b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F386463a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F386463a0%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DDitzel%26aufirst%3DL.%26aulast%3DLoewe%26aufirst%3DJ.%26aulast%3DStock%26aufirst%3DD.%26aulast%3DBochtler%26aufirst%3DM.%26aulast%3DBartunik%26aufirst%3DH.%2BD.%26aulast%3DHuber%26aufirst%3DR.%26atitle%3DStructure%2520of%252020S%2520proteasome%2520from%2520yeast%2520at%25202.4%2520.ANG.%2520resolution%26jtitle%3DNature%2520%2528London%2529%26date%3D1997%26volume%3D386%26spage%3D463%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span> </span><span class="NLM_article-title">Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1695</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2Fj.bbamcr.2004.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=15571807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1695&publication_year=2004&pages=33-44&author=M.+Grollauthor=R.+Huber&title=Inhibitors+of+the+eukaryotic+20S+proteasome+core+particle%3A+a+structural+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach</span></div><div class="casAuthors">Groll, Michael; Huber, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1695</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">33-44</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome pathway is particularly important for the regulated degrdn. of various proteins which control a vast array of biol. processes.  Therefore, proteasome inhibitors are promising candidates for anti-tumoral or anti-inflammatory drugs.  N-Acetyl-Leu-Leu-Norleucinal (Ac-LLN-al, also termed calpain inhibitor I) was one of the first proteasome inhibitors discovered and has been widely used to study the 20S proteasome core particle (CP) function in vivo, despite its lack of specificity.  Vinyl sulfones, like Ac-PRLN-vs, show covalent binding of the β-carbon atom of the vinyl sulfone group to the Thr1Oγ only of subunit β2.  However, vinyl sulfones have similar limitations as peptide aldehydes as they have been reported also to bind and block intracellular cysteine proteases.  A more specific proteasome inhibitor is the natural product lactacystin, which can be isolated from Streptomyces.  It was found that this compd. forms an ester bond only to the Thr1Oγ of the chymotrypsin-like active subunit β5 due to specific P1 interactions.  In contrast to most other proteasome inhibitors, the natural α',β'-epoxyketone peptide epoxomicin binds specifically to the small class of N-terminal nucleophilic (Ntn) hydrolases (CPs belong to this protease family) with the formation of a morpholino adduct.  All previously described proteasome inhibitors bind covalently to the proteolytic active sites.  However, as the proteasome is involved in a variety of biol. important functions, it is of particular interest to block the CP only for limited time in order to reduce cytotoxic effects.  Recently, the binding mode of the natural specific proteasome inhibitor TMC-95 obtained from Apiospora montagnei was investigated.  The crystal structure revealed that the TMC-95 blocks the active sites of the CP noncovalently in the low nanomolar range.  This review summarizes the current structural knowledge of inhibitory compds. bound to the CP, showing the proteasome as a potential target for drug development in medical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKy_YEOh4O87Vg90H21EOLACvtfcHk0ljjx7f8engY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVantbzM&md5=657de84e4dd5ce34c5112505543fbd29</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2004.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2004.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DR.%26atitle%3DInhibitors%2520of%2520the%2520eukaryotic%252020S%2520proteasome%2520core%2520particle%253A%2520a%2520structural%2520approach%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2004%26volume%3D1695%26spage%3D33%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kisselev, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: from research tools to drug candidates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2FS1074-5521%2801%2900056-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=11514224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=739-758&author=A.+F.+Kisselevauthor=A.+L.+Goldberg&title=Proteasome+inhibitors%3A+from+research+tools+to+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: from research tools to drug candidates</span></div><div class="casAuthors">Kisselev, A. F.; Goldberg, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">739-758</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The 26S proteasome is a 2.4 MDa multifunctional ATP-dependent proteolytic complex, which degrades the majority of cellular polypeptides by an unusual enzyme mechanism.  Several groups of proteasome inhibitors have been developed and are now widely used as research tools to study the role of the ubiquitin-proteasome pathway in various cellular processes, and two inhibitors are now in clin. trials for treatment of multiple cancers and stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTXBSmAzp9vLVg90H21EOLACvtfcHk0ljjx7f8engY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7g%253D&md5=b729e5f56c402172aca5b139df61c09e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900056-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900056-4%26sid%3Dliteratum%253Aachs%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DProteasome%2520inhibitors%253A%2520from%2520research%2520tools%2520to%2520drug%2520candidates%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D739%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Borissenko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span> </span><span class="NLM_article-title">20S proteasome and its inhibitors: crystallographic knowledge for drug development</span> <span class="citation_source-journal">Chem. Rev. (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0502504" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvF2kuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2007&pages=687-717&author=L.+Borissenkoauthor=M.+Groll&title=20S+proteasome+and+its+inhibitors%3A+crystallographic+knowledge+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development</span></div><div class="casAuthors">Borissenko, Ljudmila; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">687-717</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The aim of this review is to discuss the latest insights on the structure and function of the proteasome, highlighting the structural features that det. its activity and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwElwBj8JBKrVg90H21EOLACvtfcHk0ljjx7f8engY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvF2kuro%253D&md5=af2e998e5443f598a46ffef71118a119</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fcr0502504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0502504%26sid%3Dliteratum%253Aachs%26aulast%3DBorissenko%26aufirst%3DL.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3D20S%2520proteasome%2520and%2520its%2520inhibitors%253A%2520crystallographic%2520knowledge%2520for%2520drug%2520development%26jtitle%3DChem.%2520Rev.%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2007%26volume%3D107%26spage%3D687%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigstad, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sappal, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J. L.</span><span> </span><span class="NLM_article-title">Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2010&pages=461-476&author=C.+Blackburnauthor=K.+M.+Gigstadauthor=P.+Halesauthor=K.+Garciaauthor=M.+Jonesauthor=F.+J.+Bruzzeseauthor=C.+Barrettauthor=J.+X.+Liuauthor=T.+A.+Soucyauthor=D.+S.+Sappalauthor=N.+Bumpauthor=E.+J.+Olhavaauthor=P.+Flemingauthor=L.+R.+Dickauthor=C.+Tsuauthor=M.+D.+Sintchakauthor=J.+L.+Blank&title=Characterization+of+a+new+series+of+non-covalent+proteasome+inhibitors+with+exquisite+potency+and+selectivity+for+the+20S+%CE%B25-subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DGigstad%26aufirst%3DK.%2BM.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DBruzzese%26aufirst%3DF.%2BJ.%26aulast%3DBarrett%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DSoucy%26aufirst%3DT.%2BA.%26aulast%3DSappal%26aufirst%3DD.%2BS.%26aulast%3DBump%26aufirst%3DN.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DBlank%26aufirst%3DJ.%2BL.%26atitle%3DCharacterization%2520of%2520a%2520new%2520series%2520of%2520non-covalent%2520proteasome%2520inhibitors%2520with%2520exquisite%2520potency%2520and%2520selectivity%2520for%2520the%252020S%2520%25CE%25B25-subunit%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D430%26spage%3D461%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Genin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.2174%2F156802610790725515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=20166955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1ent7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=232-256&author=E.+Geninauthor=M.+Reboud-Ravauxauthor=J.+Vidal&title=Proteasome+inhibitors%3A+recent+advances+and+new+perspectives+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry</span></div><div class="casAuthors">Genin, E.; Reboud-Ravaux, M.; Vidal, J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">232-256</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The search for proteasome inhibitors began fifteen years ago.  These inhibitors proved to be powerful tools for investigating many important cellular processes regulated by the ubiquitin-proteasome pathway.  Targeting the proteasome pathway can also lead to new treatments for disorders like cancer, muscular dystrophies, inflammation and immune diseases.  This is already true for cancer; the FDA approved bortezomib, a potent proteasome inhibitor, for treating multiple myeloma in 2003, and mantle cell lymphoma in 2006.  The chem. structures identified in some of the early proteasome inhibitors have led to the development of new anti-cancer drugs (CEP-18770, Carfilzomib, NPI-0052).  All these mols. are covalent bonding inhibitors that react with the catalytic Thr1-Oγ of the three types of active site.  This review covers recent developments in medicinal chem. of natural and synthetic proteasome inhibitors.  Advances in non-covalent inhibitors that have no reactive group will be highlighted as they should minimize side-effects.  New structures and new modes of action have been recently identified that open the door to new drug candidates for treating a range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv2fNL-WAY3LVg90H21EOLACvtfcHk0lgegn6120EhSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1ent7Y%253D&md5=ef6b9b743b0c4f4981ad9138beceb90d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F156802610790725515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790725515%26sid%3Dliteratum%253Aachs%26aulast%3DGenin%26aufirst%3DE.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DJ.%26atitle%3DProteasome%2520inhibitors%253A%2520recent%2520advances%2520and%2520new%2520perspectives%2520in%2520medicinal%2520chemistry%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2010%26volume%3D10%26spage%3D232%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macherla, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manam, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. C.</span><span> </span><span class="NLM_article-title">Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5420</span><span class="NLM_x">–</span> <span class="NLM_lpage">5428</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900559x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5420-5428&author=M.+Grollauthor=K.+A.+McArthurauthor=V.+R.+Macherlaauthor=R.+R.+Manamauthor=B.+C.+Potts&title=Snapshots+of+the+fluorosalinosporamide%2F20S+complex+offer+mechanistic+insights+for+fine+tuning+proteasome+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm900559x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900559x%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DMcArthur%26aufirst%3DK.%2BA.%26aulast%3DMacherla%26aufirst%3DV.%2BR.%26aulast%3DManam%26aufirst%3DR.%2BR.%26aulast%3DPotts%26aufirst%3DB.%2BC.%26atitle%3DSnapshots%2520of%2520the%2520fluorosalinosporamide%252F20S%2520complex%2520offer%2520mechanistic%2520insights%2520for%2520fine%2520tuning%2520proteasome%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5420%26epage%3D5428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of a′,b′-epoxyketone proteasome inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja993588m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=1237-1238&author=M.+Grollauthor=K.+B.+Kimauthor=N.+Kairiesauthor=R.+Huberauthor=C.+M.+Crews&title=Crystal+structure+of+epoxomicin%3A20S+proteasome+reveals+a+molecular+basis+for+selectivity+of+a%E2%80%B2%2Cb%E2%80%B2-epoxyketone+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja993588m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja993588m%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DKairies%26aufirst%3DN.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520epoxomicin%253A20S%2520proteasome%2520reveals%2520a%2520molecular%2520basis%2520for%2520selectivity%2520of%2520a%25E2%2580%25B2%252Cb%25E2%2580%25B2-epoxyketone%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D1237%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kupperman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee Edmund, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannerman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J.</span><span> </span><span class="NLM_article-title">Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1970</span><span class="NLM_x">–</span> <span class="NLM_lpage">1980</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1158%2F0008-5472.CAN-09-2766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=20160034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFWisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1970-1980&author=E.+Kuppermanauthor=C.+Lee+Edmundauthor=Y.+Caoauthor=B.+Bannermanauthor=M.+Fitzgeraldauthor=A.+Bergerauthor=J.+Yuauthor=Y.+Yangauthor=P.+Halesauthor=F.+Bruzzeseauthor=J.+Liuauthor=J.+Blankauthor=K.+Garciaauthor=C.+Tsuauthor=L.+Dickauthor=P.+Flemingauthor=L.+Yuauthor=M.+Manfrediauthor=M.+Rolfeauthor=J.+Bolen&title=Evaluation+of+the+proteasome+inhibitor+MLN9708+in+preclinical+models+of+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer</span></div><div class="casAuthors">Kupperman, Erik; Lee, Edmund C.; Cao, Yueying; Bannerman, Bret; Fitzgerald, Michael; Berger, Allison; Yu, Jie; Yang, Yu; Bruzzese, Frank; Liu, Jane; Blank, Jonathan; Garcia, Khristofer; Tsu, Christopher; Dick, Larry; Fleming, Paul; Yu, Li; Manfredi, Mark; Rolfe, Mark; Bolen, Joe</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1970-1980</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The proteasome was validated as an oncol. target following the clin. success of VELCADE (bortezomib) for injection for the treatment of multiple myeloma and recurring mantle cell lymphoma.  Consequently, several groups are pursuing the development of addnl. small-mol. proteasome inhibitors for both hematol. and solid tumor indications.  Here, we describe MLN9708, a selective, orally bioavailable, second-generation proteasome inhibitor that is in phase I clin. development.  MLN9708 has a shorter proteasome dissocn. half-life and improved pharmacokinetics, pharmacodynamics, and antitumor activity compared with bortezomib.  MLN9708 has a larger blood vol. distribution at steady state, and anal. of 20S proteasome inhibition and markers of the unfolded protein response confirmed that MLN9708 has greater pharmacodynamic effects in tissues than bortezomib.  MLN9708 showed activity in both solid tumor and hematol. preclin. xenograft models, and we found a correlation between greater pharmacodynamic responses and improved antitumor activity.  Moreover, antitumor activity was shown via multiple dosing routes, including oral gavage.  Taken together, these data support the clin. development of MLN9708 for both hematol. and solid tumor indications.  Cancer Res; 70(5); 1970-80.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjauqAFEgDA7Vg90H21EOLACvtfcHk0lgegn6120EhSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFWisro%253D&md5=45636404582fc0eb66581c6c19420458</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2766%26sid%3Dliteratum%253Aachs%26aulast%3DKupperman%26aufirst%3DE.%26aulast%3DLee%2BEdmund%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DBannerman%26aufirst%3DB.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DBruzzese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DDick%26aufirst%3DL.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DManfredi%26aufirst%3DM.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520the%2520proteasome%2520inhibitor%2520MLN9708%2520in%2520preclinical%2520models%2520of%2520human%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1970%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kupperman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannerman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J.</span><span> </span><span class="NLM_article-title">Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">3853</span><div class="note"><p class="first last"> [Erratum to document cited in CA152:517050]</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3853&author=E.+Kuppermanauthor=E.+C.+Leeauthor=Y.+Caoauthor=B.+Bannermanauthor=M.+Fitzgeraldauthor=A.+Bergerauthor=J.+Yuauthor=Y.+Yangauthor=P.+Halesauthor=F.+Bruzzeseauthor=J.+Liuauthor=J.+Blankauthor=K.+Garciaauthor=C.+Tsuauthor=L.+Dickauthor=P.+Flemingauthor=L.+Yuauthor=M.+Manfrediauthor=M.+Rolfeauthor=J.+Bolen&title=Evaluation+of+the+proteasome+inhibitor+MLN9708+in+preclinical+models+of+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKupperman%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DE.%2BC.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DBannerman%26aufirst%3DB.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DBruzzese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DDick%26aufirst%3DL.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DManfredi%26aufirst%3DM.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520the%2520proteasome%2520inhibitor%2520MLN9708%2520in%2520preclinical%2520models%2520of%2520human%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D3853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dick Lawrence, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming Paul, E.</span><span> </span><span class="NLM_article-title">Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=243-249&author=R.+Dick+Lawrenceauthor=E.+Fleming+Paul&title=Building+on+bortezomib%3A+second-generation+proteasome+inhibitors+as+anti-cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDick%2BLawrence%26aufirst%3DR.%26aulast%3DFleming%2BPaul%26aufirst%3DE.%26atitle%3DBuilding%2520on%2520bortezomib%253A%2520second-generation%2520proteasome%2520inhibitors%2520as%2520anti-cancer%2520therapy%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D243%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dorsey, B. D.; Menta, E.; Bernardini, R.; Bernareggi, A.; Casara, P. G.; D’Arasmo, G.; Ferretti, E.; De Munari, S.; Oliva, A.; Iqbal, M.; Chatterjee, S.; Ruggeri, B.; Ator, M. A.; Williams, M.; Mallamo, J. P.</span><span> </span><span class="NLM_article-title">CEP-18770: Discovery of a Potent, Selective and Orally Active Proteasome Inhibitor for the Treatment of Cancer</span>. Presented at Frontiers in CNS and Oncology Medicinal Chemistry, ACS-EFMC, Siena, Italy, October 7–9,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>COMC-027.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+D.+Dorsey&author=E.+Menta&author=R.+Bernardini&author=A.+Bernareggi&author=P.+G.+Casara&author=G.+D%E2%80%99Arasmo&author=E.+Ferretti&author=S.+De+Munari&author=A.+Oliva&author=M.+Iqbal&author=S.+Chatterjee&author=B.+Ruggeri&author=M.+A.+Ator&author=M.+Williams&author=J.+P.+Mallamo&title=CEP-18770%3A+Discovery+of+a+Potent%2C+Selective+and+Orally+Active+Proteasome+Inhibitor+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DCEP-18770%253A%2520Discovery%2520of%2520a%2520Potent%252C%2520Selective%2520and%2520Orally%2520Active%2520Proteasome%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Piva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giai, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coscia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massaia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allievi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescalli, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Giovine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Feudis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strepponi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roato, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferracini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussolati, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camussi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones-Bolin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernareggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inghirami, G.</span><span> </span><span class="NLM_article-title">CEP-18770: a novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">2765</span><span class="NLM_x">–</span> <span class="NLM_lpage">2775</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=2765-2775&author=R.+Pivaauthor=B.+Ruggeriauthor=M.+Williamsauthor=G.+Costaauthor=I.+Tamagnoauthor=D.+Ferreroauthor=V.+Giaiauthor=M.+Cosciaauthor=S.+Peolaauthor=M.+Massaiaauthor=G.+Pezzoniauthor=C.+Allieviauthor=N.+Pescalliauthor=M.+Cassinauthor=S.+di+Giovineauthor=P.+Nicoliauthor=P.+de+Feudisauthor=I.+Strepponiauthor=I.+Roatoauthor=R.+Ferraciniauthor=B.+Bussolatiauthor=G.+Camussiauthor=S.+Jones-Bolinauthor=K.+Hunterauthor=H.+Zhaoauthor=A.+Neriauthor=A.+Palumboauthor=C.+Berkersauthor=H.+Ovaaauthor=A.+Bernareggiauthor=G.+Inghirami&title=CEP-18770%3A+a+novel%2C+orally+active+proteasome+inhibitor+with+a+tumor-selective+pharmacologic+profile+competitive+with+bortezomib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiva%26aufirst%3DR.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DCosta%26aufirst%3DG.%26aulast%3DTamagno%26aufirst%3DI.%26aulast%3DFerrero%26aufirst%3DD.%26aulast%3DGiai%26aufirst%3DV.%26aulast%3DCoscia%26aufirst%3DM.%26aulast%3DPeola%26aufirst%3DS.%26aulast%3DMassaia%26aufirst%3DM.%26aulast%3DPezzoni%26aufirst%3DG.%26aulast%3DAllievi%26aufirst%3DC.%26aulast%3DPescalli%26aufirst%3DN.%26aulast%3DCassin%26aufirst%3DM.%26aulast%3Ddi%2BGiovine%26aufirst%3DS.%26aulast%3DNicoli%26aufirst%3DP.%26aulast%3Dde%2BFeudis%26aufirst%3DP.%26aulast%3DStrepponi%26aufirst%3DI.%26aulast%3DRoato%26aufirst%3DI.%26aulast%3DFerracini%26aufirst%3DR.%26aulast%3DBussolati%26aufirst%3DB.%26aulast%3DCamussi%26aufirst%3DG.%26aulast%3DJones-Bolin%26aufirst%3DS.%26aulast%3DHunter%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DNeri%26aufirst%3DA.%26aulast%3DPalumbo%26aufirst%3DA.%26aulast%3DBerkers%26aufirst%3DC.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DBernareggi%26aufirst%3DA.%26aulast%3DInghirami%26aufirst%3DG.%26atitle%3DCEP-18770%253A%2520a%2520novel%252C%2520orally%2520active%2520proteasome%2520inhibitor%2520with%2520a%2520tumor-selective%2520pharmacologic%2520profile%2520competitive%2520with%2520bortezomib%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sterz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Metzler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahne, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamottke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heider, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terpos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sezer, O.</span><span> </span><span class="NLM_article-title">The potential of proteasome inhibitors in cancer therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=879-895&author=J.+Sterzauthor=I.+von+Metzlerauthor=J.-C.+Hahneauthor=B.+Lamottkeauthor=J.+Rademacherauthor=U.+Heiderauthor=E.+Terposauthor=O.+Sezer&title=The+potential+of+proteasome+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSterz%26aufirst%3DJ.%26aulast%3Dvon%2BMetzler%26aufirst%3DI.%26aulast%3DHahne%26aufirst%3DJ.-C.%26aulast%3DLamottke%26aufirst%3DB.%26aulast%3DRademacher%26aufirst%3DJ.%26aulast%3DHeider%26aufirst%3DU.%26aulast%3DTerpos%26aufirst%3DE.%26aulast%3DSezer%26aufirst%3DO.%26atitle%3DThe%2520potential%2520of%2520proteasome%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D879%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernareggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassara, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arasmo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferretti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pezzoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allievi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strepponi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7010589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1068-1072&author=B.+D.+Dorseyauthor=M.+Iqbalauthor=S.+Chatterjeeauthor=E.+Mentaauthor=R.+Bernardiniauthor=A.+Bernareggiauthor=P.+G.+Cassaraauthor=G.+D%E2%80%99Arasmoauthor=E.+Ferrettiauthor=M.+S.+Deauthor=A.+Olivaauthor=G.+Pezzoniauthor=C.+Allieviauthor=I.+Strepponiauthor=B.+Ruggeriauthor=M.+A.+Atorauthor=M.+Williamsauthor=J.+P.+Mallamo&title=Discovery+of+a+potent%2C+selective%2C+and+orally+active+proteasome+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer</span></div><div class="casAuthors">Dorsey, Bruce D.; Iqbal, Mohamed; Chatterjee, Sankar; Menta, Ernesto; Bernardini, Raffaella; Bernareggi, Alberto; Cassara, Paolo G.; D'Arasmo, Germano; Ferretti, Edmondo; De Munari, Sergio; Oliva, Ambrogio; Pezzoni, Gabriella; Allievi, Cecilia; Strepponi, Ivan; Ruggeri, Bruce; Ator, Mark A.; Williams, Michael; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1068-1072</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome pathway plays a central role in regulation of the prodn. and destruction of cellular proteins.  These pathways mediate proliferation and cell survival, particularly in malignant cells.  The successful development of the 20S human proteasome inhibitor bortezomib for the treatment of relapsed and refractory multiple myeloma has established this targeted intervention as an effective therapeutic strategy.  Herein, the potent, selective, and orally bioavailable threonine-derived 20S human proteasome inhibitor that has been advanced to preclin. development, [(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid 20 (CEP-18770), is disclosed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkNeu3d81vbVg90H21EOLACvtfcHk0liux4msOOT35w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKls78%253D&md5=cfc22ee09c2a4f4d9c695010187c4693</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm7010589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7010589%26sid%3Dliteratum%253Aachs%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DIqbal%26aufirst%3DM.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DMenta%26aufirst%3DE.%26aulast%3DBernardini%26aufirst%3DR.%26aulast%3DBernareggi%26aufirst%3DA.%26aulast%3DCassara%26aufirst%3DP.%2BG.%26aulast%3DD%25E2%2580%2599Arasmo%26aufirst%3DG.%26aulast%3DFerretti%26aufirst%3DE.%26aulast%3DDe%26aufirst%3DM.%2BS.%26aulast%3DOliva%26aufirst%3DA.%26aulast%3DPezzoni%26aufirst%3DG.%26aulast%3DAllievi%26aufirst%3DC.%26aulast%3DStrepponi%26aufirst%3DI.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520proteasome%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1068%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fuchs, O.</span><span> </span><span class="NLM_article-title">Proteasome inhibition as a therapeutic strategy in patients with multiple myeloma</span> <span class="citation_source-journal">Mult. Myeloma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlOmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=101-125&author=O.+Fuchs&title=Proteasome+inhibition+as+a+therapeutic+strategy+in+patients+with+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition as a therapeutic strategy in patients with multiple myeloma</span></div><div class="casAuthors">Fuchs, Ota</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Myeloma</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-125</span>CODEN:
                <span class="NLM_cas:coden">69MVM2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Nova Science Publishers, Inc.</span>)
        </div><div class="casAbstract">A review.  Multiple myeloma (MM) is the second most frequent hematol. malignancy and remains fatal despite all available therapies, because of chemotherapeutic resistance.  Novel targeted drugs for the treatment of MM are therefore needed to improve outcome of MM patients.  Bortezomib (PS-341, Velcade; Millennium Pharmaceuticals, Cambridge MA), a dipeptidyl boronic acid that reversibly inhibits the chymotrypsin-like activity in the 20S core of the 26S mammalian proteasome, is the first proteasome inhibitor that was approved by the US Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products (EMEA) for patients with relapsed and refractory MM who had received at least one prior therapy and who had already undergone or are unsuitable for the transplantation of bone marrow.  Phase I-III trials based on previous preclin. studies showed very good antimyeloma activity.  Bortezomib acts by disrupting various cell signaling pathways, thereby leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis.  The main action of bortezomib is the inhibition of the key transcription factor, nuclear factor-kappaB (NF-κB) activation.  Activation of NF-κB has been noted in MM cells.  Bortezomib interferes with NF-κB-mediated cell survival, tumor growth and angiogenesis.  Several studies have shown that cancer cells are more sensitive than normal cells to the proapoptotic effects of bortezomib, perhaps due to their loss of checkpoint mechanisms for DNA repair.  The accumulation of misfolded proteins in the endoplasmic reticulum (ER) leads to the induction of the unfolded protein response, provoking apoptosis.  Proteasome inhibitors induce ER-mediated apoptosis.  The increased susceptibility of MM cells to ER stress is caused by the large amts. of Igs produced by MM cells.  The clin. success of bortezomib is encouraging.  Bortezomib is relatively well tolerated, causing manageable nonhematol. and hematol. toxicity.  However, the overall response rate was 40-50% and bortezomib resistance was also obsd.  Response rates may be improved with combination therapy (bortezomib with dexamethasone, thalidomide, lenalidomide, arsenic trioxide, cisplatin, doxorubicin, cyclophosphamide, etoposide or with melphalan and prednisone).  Clin. evaluation of addnl. proteasome inhibitors of the next generation with greater efficacy is also needed.  Three such proteasome inhibitors (carfilzomib, salinosporamide A and threonine boronic acid-derived proteasome inhibitor CEP-18770) have been recently tested in preclin. models of MM.  Carfilzomib (PR-171; Proteolix), an epoxyketone related to epoxomicin inhibits the chymotrypsin-like proteasome activity as bortezomib does.  However, carfilzomib is an irreversible inhibitor of all three proteasome proteolytic sites.  Salinosporamide A (NPI-0052), a compd. related to lactacystin binds irreversibly to the 20S proteasome and acts predominantly through caspase-8 activation.  CEP-18770 is a reversible inhibitor of the chymotrypsin-like proteasome activity as bortezomib but it inhibits also the tryptic and peptidyl glutamyl activities of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEgVHeWnqC_rVg90H21EOLACvtfcHk0liux4msOOT35w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlOmtrc%253D&md5=cb6b1732f8d4e3adc619ecb6591e1567</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DO.%26atitle%3DProteasome%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520in%2520patients%2520with%2520multiple%2520myeloma%26jtitle%3DMult.%2520Myeloma%26date%3D2009%26spage%3D101%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuteboom, S. T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palladino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethna, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. C.</span><span> </span><span class="NLM_article-title">From natural products to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent</span> <span class="citation_source-journal">Nat. Prod. Chem. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlCjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=355-373&author=K.+S.+Lamauthor=G.+K.+Lloydauthor=S.+T.+C.+Neuteboomauthor=M.+A.+Palladinoauthor=K.+M.+Sethnaauthor=M.+A.+Spearauthor=B.+C.+Potts&title=From+natural+products+to+clinical+trials%3A+NPI-0052+%28salinosporamide+A%29%2C+a+marine+actinomycete-derived+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">From natural products to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent</span></div><div class="casAuthors">Lam, Kin S.; Lloyd, G. Kenneth; Neuteboom, Saskia T. C.; Palladino, Michael A.; Sethna, Kobi M.; Spear, Matthew A.; Potts, Barbara C.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Chemistry for Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-373</span>CODEN:
                <span class="NLM_cas:coden">69MGLO</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The unique aspects of developing a marine actinomycete-derived therapeutic agent, NPI-0052, are highlighted.  Salinosporamide A (designated as NPI-0052) was first isolated from the fermn. broth of Salinispora tropica strain CNB392.  This highly potent 20S proteasome inhibitor is currently undergoing Phase I clin. studies for the treatment of various hematol. and solid tumor malignancies.  An account is given of events from the early mechanism of action and preclin. studies that supported its entry into clin. trials in cancer patients, to the current strategy for its continued development as an anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzGil7yTcC7Vg90H21EOLACvtfcHk0liux4msOOT35w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlCjug%253D%253D&md5=1498e5081a2ba9e7eff273ecb2124899</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DLloyd%26aufirst%3DG.%2BK.%26aulast%3DNeuteboom%26aufirst%3DS.%2BT.%2BC.%26aulast%3DPalladino%26aufirst%3DM.%2BA.%26aulast%3DSethna%26aufirst%3DK.%2BM.%26aulast%3DSpear%26aufirst%3DM.%2BA.%26aulast%3DPotts%26aufirst%3DB.%2BC.%26atitle%3DFrom%2520natural%2520products%2520to%2520clinical%2520trials%253A%2520NPI-0052%2520%2528salinosporamide%2520A%2529%252C%2520a%2520marine%2520actinomycete-derived%2520anticancer%2520agent%26jtitle%3DNat.%2520Prod.%2520Chem.%2520Drug%2520Discovery%26date%3D2010%26spage%3D355%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zhou, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aujay, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demo, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laidig, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchamuel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenk, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shwonek, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3038</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801329v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3028-3038&author=H.-J.+Zhouauthor=M.+A.+Aujayauthor=M.+K.+Bennettauthor=M.+Dajeeauthor=S.+D.+Demoauthor=Y.+Fangauthor=M.+N.+Hoauthor=J.+Jiangauthor=C.+J.+Kirkauthor=G.+J.+Laidigauthor=E.+R.+Lewisauthor=Y.+Luauthor=T.+Muchamuelauthor=F.+Parlatiauthor=E.+Ringauthor=K.+D.+Shenkauthor=J.+Shieldsauthor=P.+J.+Shwonekauthor=T.+Stantonauthor=C.+M.+Sunauthor=C.+Sylvainauthor=T.+M.+Wooauthor=J.+Yang&title=Design+and+synthesis+of+an+orally+bioavailable+and+selective+peptide+epoxyketone+proteasome+inhibitor+%28PR-047%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)</span></div><div class="casAuthors">Zhou, Han-Jie; Aujay, Monette A.; Bennett, Mark K.; Dajee, Maya; Demo, Susan D.; Fang, Ying; Ho, Mark N.; Jiang, Jing; Kirk, Christopher J.; Laidig, Guy J.; Lewis, Evan R.; Lu, Yan; Muchamuel, Tony; Parlati, Francesco; Ring, Eileen; Shenk, Kevin D.; Shields, Jamie; Shwonek, Peter J.; Stanton, Timothy; Sun, Congcong M.; Sylvain, Catherine; Woo, Tina M.; Yang, Jinfu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3028-3038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epoxypeptides such as I are prepd. as carfilzomib analogs and proteasome inhibitors for use as antitumor agents; the inhibition of human 20S proteasomes and of the growth of multidrug-resistant and nonresistant cancer cells by selected compds. and their stabilities in simulated gastric and intestinal fluids and in liver microsomes are detd.  I selectively inhibits chymotrypsin-like activity of both the constitutive proteasome (β5) and immunoproteasome (LMP7) and demonstrated an abs. bioavailability of up to 39% in rodents and dogs.  I is well tolerated with repeated oral administration at doses resulting in >80% proteasome inhibition in most tissues and elicited an antitumor response equiv. to i.v. administered carfilzomib in multiple human tumor xenograft and mouse syngeneic models.  I is prepd. in eight steps (longest linear sequence) from Cbz-L-phenylalanine, Boc-O-methyl-L-serine, 2-methyl-5-thiazolecarboxylic acid, and isopropenylmagnesium bromide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouNBIBwb8w47Vg90H21EOLACvtfcHk0lg1CiTyHyGXSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFemtLw%253D&md5=688c8d0942539bab2e50617d083bf89a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm801329v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801329v%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.-J.%26aulast%3DAujay%26aufirst%3DM.%2BA.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26aulast%3DDajee%26aufirst%3DM.%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DM.%2BN.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DLaidig%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DRing%26aufirst%3DE.%26aulast%3DShenk%26aufirst%3DK.%2BD.%26aulast%3DShields%26aufirst%3DJ.%26aulast%3DShwonek%26aufirst%3DP.%2BJ.%26aulast%3DStanton%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DC.%2BM.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DWoo%26aufirst%3DT.%2BM.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520orally%2520bioavailable%2520and%2520selective%2520peptide%2520epoxyketone%2520proteasome%2520inhibitor%2520%2528PR-047%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3028%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkers, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploegh, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome</span> <span class="citation_source-journal">Structure (Cambridge, MA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2Fj.str.2005.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=16531229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=451-456&author=M.+Grollauthor=C.+R.+Berkersauthor=H.+L.+Ploeghauthor=H.+Ovaa&title=Crystal+structure+of+the+boronic+acid-based+proteasome+inhibitor+bortezomib+in+complex+with+the+yeast+20S+proteasome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Boronic Acid-Based Proteasome Inhibitor Bortezomib in Complex with the Yeast 20S Proteasome</span></div><div class="casAuthors">Groll, Michael; Berkers, Celia R.; Ploegh, Hidde L.; Ovaa, Huib</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-456</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The dipeptide boronic acid bortezomib, also termed VELCADE is a proteasome inhibitor now in use for the treatment of multiple myeloma, and its use for the treatment of other malignancies is being explored.  We detd. the crystal structure of the yeast 20S proteasome in complex with bortezomib to establish the specificity and binding mode of bortezomib to the proteasome's different catalytically active sites.  This structure should enable the rational design of new boronic acid derivs. with improved affinities and specificities for individual active subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpusGzFSuveALVg90H21EOLACvtfcHk0lg1CiTyHyGXSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ylsL8%253D&md5=d5b4e46e5a9f5259cce758770302b4fe</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2005.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2005.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520the%2520boronic%2520acid-based%2520proteasome%2520inhibitor%2520bortezomib%2520in%2520complex%2520with%2520the%2520yeast%252020S%2520proteasome%26jtitle%3DStructure%2520%2528Cambridge%252C%2520MA%252C%2520U.%2520S.%2529%26date%3D2006%26volume%3D14%26spage%3D451%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. C. M.</span><span> </span><span class="NLM_article-title">Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of β-lactone ring opening and a mechanism for irreversible binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">5136</span><span class="NLM_x">–</span> <span class="NLM_lpage">5141</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja058320b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=5136-5141&author=M.+Grollauthor=R.+Huberauthor=B.+C.+M.+Potts&title=Crystal+structures+of+salinosporamide+A+%28NPI-0052%29+and+B+%28NPI-0047%29+in+complex+with+the+20S+proteasome+reveal+important+consequences+of+%CE%B2-lactone+ring+opening+and+a+mechanism+for+irreversible+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja058320b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja058320b%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DPotts%26aufirst%3DB.%2BC.%2BM.%26atitle%3DCrystal%2520structures%2520of%2520salinosporamide%2520A%2520%2528NPI-0052%2529%2520and%2520B%2520%2528NPI-0047%2529%2520in%2520complex%2520with%2520the%252020S%2520proteasome%2520reveal%2520important%2520consequences%2520of%2520%25CE%25B2-lactone%2520ring%2520opening%2520and%2520a%2520mechanism%2520for%2520irreversible%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D5136%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Schmidtke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzhutter, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Giuli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groettrup, M.</span><span> </span><span class="NLM_article-title">How an inhibitor of the HIV-I protease modulates proteasome activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">35734</span><span class="NLM_x">–</span> <span class="NLM_lpage">35740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=35734-35740&author=G.+Schmidtkeauthor=H.-G.+Holzhutterauthor=M.+Bogyoauthor=N.+Kairiesauthor=M.+Grollauthor=R.+De+Giuliauthor=S.+Emchauthor=M.+Groettrup&title=How+an+inhibitor+of+the+HIV-I+protease+modulates+proteasome+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidtke%26aufirst%3DG.%26aulast%3DHolzhutter%26aufirst%3DH.-G.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DKairies%26aufirst%3DN.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DDe%2BGiuli%26aufirst%3DR.%26aulast%3DEmch%26aufirst%3DS.%26aulast%3DGroettrup%26aufirst%3DM.%26atitle%3DHow%2520an%2520inhibitor%2520of%2520the%2520HIV-I%2520protease%2520modulates%2520proteasome%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D35734%26epage%3D35740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Structure-based optimization of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1331-1334&author=P.+Furetauthor=P.+Imbachauthor=P.+Fuerstauthor=M.+Langauthor=M.+Nooraniauthor=J.+Zimmermannauthor=C.+Garcia-Echeverria&title=Structure-based+optimization+of+2-aminobenzylstatine+derivatives%3A+potent+and+selective+inhibitors+of+the+chymotrypsin-like+activity+of+the+human+20S+proteasome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DImbach%26aufirst%3DP.%26aulast%3DFuerst%26aufirst%3DP.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DNoorani%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DStructure-based%2520optimization%2520of%25202-aminobenzylstatine%2520derivatives%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520chymotrypsin-like%2520activity%2520of%2520the%2520human%252020S%2520proteasome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1331%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeppler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laumen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuerst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia Echeverria, C.</span><span> </span><span class="NLM_article-title">Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4810</span><span class="NLM_x">–</span> <span class="NLM_lpage">4813</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049660v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4810-4813&author=P.+Furetauthor=P.+Imbachauthor=M.+Nooraniauthor=J.+Koepplerauthor=K.+Laumenauthor=M.+Langauthor=V.+Guagnanoauthor=P.+Fuerstauthor=J.+Roeselauthor=J.+Zimmermannauthor=C.+Garcia+Echeverria&title=Entry+into+a+new+class+of+potent+proteasome+inhibitors+having+high+antiproliferative+activity+by+structure-based+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm049660v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049660v%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DImbach%26aufirst%3DP.%26aulast%3DNoorani%26aufirst%3DM.%26aulast%3DKoeppler%26aufirst%3DJ.%26aulast%3DLaumen%26aufirst%3DK.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DFuerst%26aufirst%3DP.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DGarcia%2BEcheverria%26aufirst%3DC.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520potent%2520proteasome%2520inhibitors%2520having%2520high%2520antiproliferative%2520activity%2520by%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4810%26epage%3D4813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapostolou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felten, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderesse, R.</span><span> </span><span class="NLM_article-title">Development of lipopeptides for inhibiting 20S proteasomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3277</span><span class="NLM_x">–</span> <span class="NLM_lpage">3281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3277-3281&author=N.+Basseauthor=D.+Papapostolouauthor=M.+Paganoauthor=M.+Reboud-Ravauxauthor=E.+Bernardauthor=A.-S.+Feltenauthor=R.+Vanderesse&title=Development+of+lipopeptides+for+inhibiting+20S+proteasomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DPapapostolou%26aufirst%3DD.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26aulast%3DBernard%26aufirst%3DE.%26aulast%3DFelten%26aufirst%3DA.-S.%26aulast%3DVanderesse%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520lipopeptides%2520for%2520inhibiting%252020S%2520proteasomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3277%26epage%3D3281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kohno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsubara, S.</span><span> </span><span class="NLM_article-title">Structures of TMC-95A-D: novel proteasome inhibitors from <i>Apiospora montagnei</i> Sacc. TC 1093</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo991375%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=990-995&author=J.+Kohnoauthor=Y.+Koguchiauthor=M.+Nishioauthor=K.+Nakaoauthor=M.+Kurodaauthor=R.+Shimizuauthor=T.+Ohnukiauthor=S.+Komatsubara&title=Structures+of+TMC-95A-D%3A+novel+proteasome+inhibitors+from+Apiospora+montagnei+Sacc.+TC+1093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo991375%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo991375%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKohno%26aufirst%3DJ.%26aulast%3DKoguchi%26aufirst%3DY.%26aulast%3DNishio%26aufirst%3DM.%26aulast%3DNakao%26aufirst%3DK.%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DShimizu%26aufirst%3DR.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DKomatsubara%26aufirst%3DS.%26atitle%3DStructures%2520of%2520TMC-95A-D%253A%2520novel%2520proteasome%2520inhibitors%2520from%2520Apiospora%2520montagnei%2520Sacc.%2520TC%25201093%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D990%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Formicola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier-Durand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet-Delpon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milcent, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongeri, S.</span><span> </span><span class="NLM_article-title">Novel fluorinated pseudopeptides as proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=83-86&author=L.+Formicolaauthor=X.+Marechalauthor=N.+Basseauthor=M.+Bouvier-Durandauthor=D.+Bonnet-Delponauthor=T.+Milcentauthor=M.+Reboud-Ravauxauthor=S.+Ongeri&title=Novel+fluorinated+pseudopeptides+as+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFormicola%26aufirst%3DL.%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DBouvier-Durand%26aufirst%3DM.%26aulast%3DBonnet-Delpon%26aufirst%3DD.%26aulast%3DMilcent%26aufirst%3DT.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26aulast%3DOngeri%26aufirst%3DS.%26atitle%3DNovel%2520fluorinated%2520pseudopeptides%2520as%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D83%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujol, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span> </span><span class="NLM_article-title">Noncovalent inhibition of 20S proteasome by pegylated dimerized inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=322-327&author=X.+Marechalauthor=A.+Pujolauthor=N.+Richyauthor=E.+Geninauthor=N.+Basseauthor=M.+Reboud-Ravauxauthor=J.+Vidal&title=Noncovalent+inhibition+of+20S+proteasome+by+pegylated+dimerized+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DPujol%26aufirst%3DA.%26aulast%3DRichy%26aufirst%3DN.%26aulast%3DGenin%26aufirst%3DE.%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DJ.%26atitle%3DNoncovalent%2520inhibition%2520of%252020S%2520proteasome%2520by%2520pegylated%2520dimerized%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D322%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier-Durand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villoutreix, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span> </span><span class="NLM_article-title">Novel organic proteasome inhibitors identified by virtual and in vitro screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9011092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=509-513&author=N.+Basseauthor=M.+Montesauthor=X.+Marechalauthor=L.+Qinauthor=M.+Bouvier-Durandauthor=E.+Geninauthor=J.+Vidalauthor=B.+O.+Villoutreixauthor=M.+Reboud-Ravaux&title=Novel+organic+proteasome+inhibitors+identified+by+virtual+and+in+vitro+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm9011092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9011092%26sid%3Dliteratum%253Aachs%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DMontes%26aufirst%3DM.%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DBouvier-Durand%26aufirst%3DM.%26aulast%3DGenin%26aufirst%3DE.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DVilloutreix%26aufirst%3DB.%2BO.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26atitle%3DNovel%2520organic%2520proteasome%2520inhibitors%2520identified%2520by%2520virtual%2520and%2520in%2520vitro%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D509%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, J.</span><span> </span><span class="NLM_article-title">Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2001&pages=543-548&author=M.+Grollauthor=Y.+Koguchiauthor=R.+Huberauthor=J.+Kohno&title=Crystal+structure+of+the+20+S+proteasome%3ATMC-95A+complex%3A+a+non-covalent+proteasome+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DKoguchi%26aufirst%3DY.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DKohno%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520the%252020%2520S%2520proteasome%253ATMC-95A%2520complex%253A%2520a%2520non-covalent%2520proteasome%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2001%26volume%3D311%26spage%3D543%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallastegui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reboud-Ravaux, M.</span><span> </span><span class="NLM_article-title">20S proteasome inhibition: designing noncovalent linear peptide mimics of the natural product TMC-95A</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1701</span><span class="NLM_x">–</span> <span class="NLM_lpage">1705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1701-1705&author=M.+Grollauthor=N.+Gallasteguiauthor=X.+Marechalauthor=R.+V.+Leauthor=N.+Basseauthor=N.+Richyauthor=E.+Geninauthor=R.+Huberauthor=L.+Moroderauthor=J.+Vidalauthor=M.+Reboud-Ravaux&title=20S+proteasome+inhibition%3A+designing+noncovalent+linear+peptide+mimics+of+the+natural+product+TMC-95A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3DMarechal%26aufirst%3DX.%26aulast%3DLe%26aufirst%3DR.%2BV.%26aulast%3DBasse%26aufirst%3DN.%26aulast%3DRichy%26aufirst%3DN.%26aulast%3DGenin%26aufirst%3DE.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DMoroder%26aufirst%3DL.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DReboud-Ravaux%26aufirst%3DM.%26atitle%3D20S%2520proteasome%2520inhibition%253A%2520designing%2520noncovalent%2520linear%2520peptide%2520mimics%2520of%2520the%2520natural%2520product%2520TMC-95A%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1701%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siciliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assfalg-Machleidt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milbradt, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroder, L.</span><span> </span><span class="NLM_article-title">Binding mode of TMC-95A analogues to eukaryotic 20S proteasome</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1256-1266&author=M.+Kaiserauthor=M.+Grollauthor=C.+Sicilianoauthor=I.+Assfalg-Machleidtauthor=E.+Weyherauthor=J.+Kohnoauthor=A.+G.+Milbradtauthor=C.+Rennerauthor=R.+Huberauthor=L.+Moroder&title=Binding+mode+of+TMC-95A+analogues+to+eukaryotic+20S+proteasome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DSiciliano%26aufirst%3DC.%26aulast%3DAssfalg-Machleidt%26aufirst%3DI.%26aulast%3DWeyher%26aufirst%3DE.%26aulast%3DKohno%26aufirst%3DJ.%26aulast%3DMilbradt%26aufirst%3DA.%2BG.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DMoroder%26aufirst%3DL.%26atitle%3DBinding%2520mode%2520of%2520TMC-95A%2520analogues%2520to%2520eukaryotic%252020S%2520proteasome%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1256%26epage%3D1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Gallastegui, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arciniega, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillebrand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groll, M.</span><span> </span><span class="NLM_article-title">Hydroxyureas as noncovalent proteasome inhibitors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=247-249&author=N.+Gallasteguiauthor=P.+Beckauthor=M.+Arciniegaauthor=R.+Huberauthor=S.+Hillebrandauthor=M.+Groll&title=Hydroxyureas+as+noncovalent+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3DBeck%26aufirst%3DP.%26aulast%3DArciniega%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DHillebrand%26aufirst%3DS.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DHydroxyureas%2520as%2520noncovalent%2520proteasome%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D247%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Meiners, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyken, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stangl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloetzel, P.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, E.</span><span> </span><span class="NLM_article-title">Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">21517</span><span class="NLM_x">–</span> <span class="NLM_lpage">21525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1074%2Fjbc.M301032200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=12676932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVemsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=21517-21525&author=S.+Meinersauthor=D.+Heykenauthor=A.+Wellerauthor=A.+Ludwigauthor=K.+Stanglauthor=P.-M.+Kloetzelauthor=E.+Krueger&title=Inhibition+of+proteasome+activity+induces+concerted+expression+of+proteasome+genes+and+de+novo+formation+of+mammalian+proteasomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Proteasome Activity Induces Concerted Expression of Proteasome Genes and de Novo Formation of Mammalian Proteasomes</span></div><div class="casAuthors">Meiners, Silke; Heyken, Dirk; Weller, Andrea; Ludwig, Antje; Stangl, Karl; Kloetzel, Peter-M.; Krueger, Elke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21517-21525</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The 26 S proteasome is a high mol. mass proteinase complex that is built by at least 32 different protein subunits.  Such protease complexes in bacteria and yeast are systems that undergo a highly sophisticated network of gene expression regulation.  However, regulation of mammalian proteasome gene expression has been neglected so far as a possible control mechanism for the amt. of proteasomes in the cell.  Here, we show that treatment of cells with proteasome inhibitors and the concomitant impairment of proteasomal enzyme activity induce a transient and concerted up-regulation of all mammalian 26 S proteasome subunit mRNAs.  Proteasome inhibition in combination with inhibition of transcription revealed that the obsd. up-regulation is mediated by coordinated transcriptional activation of the proteasome genes and not by post-transcriptional events.  Our expts. also demonstrate that inhibitor-induced proteasome gene activation results in enhanced de novo protein synthesis of all subunits and in increased de novo formation of proteasomes.  This phenomenon is accompanied by enhanced expression of the proteasome maturation factor POMP.  Thus, our expts. present the first evidence that the amt. of proteasomes in mammalia is regulated at the transcriptional level and that there exists an autoregulatory feedback mechanism that allows the compensation of reduced proteasome activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbyNxj9qhUXLVg90H21EOLACvtfcHk0ljXH8oEKQqkxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVemsrk%253D&md5=2dba4af89533fe1720299bef5653e451</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M301032200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M301032200%26sid%3Dliteratum%253Aachs%26aulast%3DMeiners%26aufirst%3DS.%26aulast%3DHeyken%26aufirst%3DD.%26aulast%3DWeller%26aufirst%3DA.%26aulast%3DLudwig%26aufirst%3DA.%26aulast%3DStangl%26aufirst%3DK.%26aulast%3DKloetzel%26aufirst%3DP.-M.%26aulast%3DKrueger%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520proteasome%2520activity%2520induces%2520concerted%2520expression%2520of%2520proteasome%2520genes%2520and%2520de%2520novo%2520formation%2520of%2520mammalian%2520proteasomes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D21517%26epage%3D21525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5576</span><span class="NLM_x">–</span> <span class="NLM_lpage">5592</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5576-5592&author=H.+R.+Lawrenceauthor=A.+Kaziauthor=Y.+Luoauthor=R.+Kendigauthor=Y.+Geauthor=S.+Jainauthor=K.+Danielauthor=D.+Santiagoauthor=W.+C.+Guidaauthor=S.+M.+Sebti&title=Synthesis+and+biological+evaluation+of+naphthoquinone+analogs+as+a+novel+class+of+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DKendig%26aufirst%3DR.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DDaniel%26aufirst%3DK.%26aulast%3DSantiago%26aufirst%3DD.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520naphthoquinone%2520analogs%2520as%2520a%2520novel%2520class%2520of%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5576%26epage%3D5592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span> </span><span class="NLM_article-title">Discovery and synthesis of hydronaphthoquinones as novel proteasome inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1978</span><span class="NLM_x">–</span> <span class="NLM_lpage">1998</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201118h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1978-1998&author=Y.+Geauthor=A.+Kaziauthor=F.+Marsilioauthor=Y.+Luoauthor=S.+Jainauthor=W.+Brooksauthor=K.+G.+Danielauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=H.+R.+Lawrence&title=Discovery+and+synthesis+of+hydronaphthoquinones+as+novel+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm201118h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201118h%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DY.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DBrooks%26aufirst%3DW.%26aulast%3DDaniel%26aufirst%3DK.%2BG.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520hydronaphthoquinones%2520as%2520novel%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1978%26epage%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ozcan, S.; Aslamuzzaman, K.; Marsilio, F.; Daniel, K.; Brooks, W.; Guida, W.; Lawrence, H.; Sebti, S.</span><span> </span><span class="NLM_article-title">Identification of a Novel Class of Compounds as Proteasome Inhibitors: Synthesis and Structure Activity Relationship Studies of PI-1833 Library</span>.  <span class="citation_source-book">Book of Abstracts</span>, 102nd Annual Meeting of the American Association of Cancer Research, Orlando, FL, April 15, 2011; <span class="NLM_publisher-name">American Association of Cancer Research</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Abstract 1359.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Ozcan&author=K.+Aslamuzzaman&author=F.+Marsilio&author=K.+Daniel&author=W.+Brooks&author=W.+Guida&author=H.+Lawrence&author=S.+Sebti&title=Book+of+Abstracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOzcan%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Class%2520of%2520Compounds%2520as%2520Proteasome%2520Inhibitors%253A%2520Synthesis%2520and%2520Structure%2520Activity%2520Relationship%2520Studies%2520of%2520PI-1833%2520Library%26btitle%3DBook%2520of%2520Abstracts%26pub%3DAmerican%2520Association%2520of%2520Cancer%2520Research%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Villoutreix, B.; Reboud-Ravaux, M.; Basse, N.; Vidal, J.; Montes, M.</span><span> </span><span class="NLM_article-title">Nitrogen Heterocyclic Derivatives as Proteasome Modulators</span>. US 2011/0257176A1, Oct 20,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Villoutreix&author=M.+Reboud-Ravaux&author=N.+Basse&author=J.+Vidal&author=M.+Montes&title=Nitrogen+Heterocyclic+Derivatives+as+Proteasome+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVilloutreix%26aufirst%3DB.%26atitle%3DNitrogen%2520Heterocyclic%2520Derivatives%2520as%2520Proteasome%2520Modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Villoutreix, B.; Reboud-Ravaux, M.; Basse, N.; Vidal, J.; Montes, M.</span><span> </span><span class="NLM_article-title">Nitrogen Heterocycle Derivatives as Proteasome Modulators</span>. WO2010001365A1, Jan 7,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=B.+Villoutreix&author=M.+Reboud-Ravaux&author=N.+Basse&author=J.+Vidal&author=M.+Montes&title=Nitrogen+Heterocycle+Derivatives+as+Proteasome+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVilloutreix%26aufirst%3DB.%26atitle%3DNitrogen%2520Heterocycle%2520Derivatives%2520as%2520Proteasome%2520Modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hales, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagayoshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sappal, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigstad, K. M.</span><span> </span><span class="NLM_article-title">Optimization of a series of dipeptides with a P3 [small beta]-neopentyl asparagine residue as non-covalent inhibitors of the chymotrypsin-like activity of human 20S proteasome</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=710-719&author=C.+Blackburnauthor=C.+Barrettauthor=J.+L.+Blankauthor=F.+J.+Bruzzeseauthor=N.+Bumpauthor=L.+R.+Dickauthor=P.+Flemingauthor=K.+Garciaauthor=P.+Halesauthor=M.+Jonesauthor=J.+X.+Liuauthor=M.+Nagayoshiauthor=D.+S.+Sappalauthor=M.+D.+Sintchakauthor=C.+Tsuauthor=C.+Xiaauthor=X.+Zhouauthor=K.+M.+Gigstad&title=Optimization+of+a+series+of+dipeptides+with+a+P3+%5Bsmall+beta%5D-neopentyl+asparagine+residue+as+non-covalent+inhibitors+of+the+chymotrypsin-like+activity+of+human+20S+proteasome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DC.%26aulast%3DBlank%26aufirst%3DJ.%2BL.%26aulast%3DBruzzese%26aufirst%3DF.%2BJ.%26aulast%3DBump%26aufirst%3DN.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DFleming%26aufirst%3DP.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DHales%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DNagayoshi%26aufirst%3DM.%26aulast%3DSappal%26aufirst%3DD.%2BS.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DTsu%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DGigstad%26aufirst%3DK.%2BM.%26atitle%3DOptimization%2520of%2520a%2520series%2520of%2520dipeptides%2520with%2520a%2520P3%2520%255Bsmall%2520beta%255D-neopentyl%2520asparagine%2520residue%2520as%2520non-covalent%2520inhibitors%2520of%2520the%2520chymotrypsin-like%2520activity%2520of%2520human%252020S%2520proteasome%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D710%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Baciocchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzalunga, O.</span><span> </span><span class="NLM_article-title">Lignin peroxidase-catalyzed oxidation of nonphenolic trimeric lignin model compounds: fragmentation reactions in the intermediate radical cations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">9061</span><span class="NLM_x">–</span> <span class="NLM_lpage">9069</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo035052w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=9061-9069&author=E.+Baciocchiauthor=C.+Fabbriauthor=O.+Lanzalunga&title=Lignin+peroxidase-catalyzed+oxidation+of+nonphenolic+trimeric+lignin+model+compounds%3A+fragmentation+reactions+in+the+intermediate+radical+cations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo035052w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo035052w%26sid%3Dliteratum%253Aachs%26aulast%3DBaciocchi%26aufirst%3DE.%26aulast%3DFabbri%26aufirst%3DC.%26aulast%3DLanzalunga%26aufirst%3DO.%26atitle%3DLignin%2520peroxidase-catalyzed%2520oxidation%2520of%2520nonphenolic%2520trimeric%2520lignin%2520model%2520compounds%253A%2520fragmentation%2520reactions%2520in%2520the%2520intermediate%2520radical%2520cations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D9061%26epage%3D9069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Spurg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldvogel, S. R.</span><span> </span><span class="NLM_article-title">High-yielding cleavage of (aryloxy) acetates</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=337-342&author=A.+Spurgauthor=S.+R.+Waldvogel&title=High-yielding+cleavage+of+%28aryloxy%29+acetates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpurg%26aufirst%3DA.%26aulast%3DWaldvogel%26aufirst%3DS.%2BR.%26atitle%3DHigh-yielding%2520cleavage%2520of%2520%2528aryloxy%2529%2520acetates%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2008%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Shah, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arfan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qadir, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal Choudhary, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanDerveer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed Mesaik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soomro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabeen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, I. U.</span><span> </span><span class="NLM_article-title">Synthesis of new bergenin derivatives as potent inhibitors of inflammatory mediators NO and TNF-α</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2744</span><span class="NLM_x">–</span> <span class="NLM_lpage">2747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2744-2747&author=M.+R.+Shahauthor=M.+Arfanauthor=H.+Aminauthor=Z.+Hussainauthor=M.+I.+Qadirauthor=M.+Iqbal+Choudharyauthor=D.+VanDerveerauthor=M.+Ahmed+Mesaikauthor=S.+Soomroauthor=A.+Jabeenauthor=I.+U.+Khan&title=Synthesis+of+new+bergenin+derivatives+as+potent+inhibitors+of+inflammatory+mediators+NO+and+TNF-%CE%B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%2BR.%26aulast%3DArfan%26aufirst%3DM.%26aulast%3DAmin%26aufirst%3DH.%26aulast%3DHussain%26aufirst%3DZ.%26aulast%3DQadir%26aufirst%3DM.%2BI.%26aulast%3DIqbal%2BChoudhary%26aufirst%3DM.%26aulast%3DVanDerveer%26aufirst%3DD.%26aulast%3DAhmed%2BMesaik%26aufirst%3DM.%26aulast%3DSoomro%26aufirst%3DS.%26aulast%3DJabeen%26aufirst%3DA.%26aulast%3DKhan%26aufirst%3DI.%2BU.%26atitle%3DSynthesis%2520of%2520new%2520bergenin%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520inflammatory%2520mediators%2520NO%2520and%2520TNF-%25CE%25B1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2744%26epage%3D2747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Wrzesien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D.</span><span> </span><span class="NLM_article-title">Synthesis of SERS active nanoparticles for detection of biomolecules</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=1230-1240&author=J.+Wrzesienauthor=D.+Graham&title=Synthesis+of+SERS+active+nanoparticles+for+detection+of+biomolecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWrzesien%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DD.%26atitle%3DSynthesis%2520of%2520SERS%2520active%2520nanoparticles%2520for%2520detection%2520of%2520biomolecules%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D1230%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Joseph, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanujam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, C. P.</span><span> </span><span class="NLM_article-title">Lower rim 1,3-di{bis(2-picolyl)}amide derivative of calix[4]arene (L) as ratiometric primary sensor toward Ag+ and the complex of Ag+ as secondary sensor toward Cys: experimental, computational, and microscopy studies and INHIBIT logic gate properties of L</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">8181</span><span class="NLM_x">–</span> <span class="NLM_lpage">8190</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo901676s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=8181-8190&author=R.+Josephauthor=B.+Ramanujamauthor=A.+Acharyaauthor=C.+P.+Rao&title=Lower+rim+1%2C3-di%7Bbis%282-picolyl%29%7Damide+derivative+of+calix%5B4%5Darene+%28L%29+as+ratiometric+primary+sensor+toward+Ag%2B+and+the+complex+of+Ag%2B+as+secondary+sensor+toward+Cys%3A+experimental%2C+computational%2C+and+microscopy+studies+and+INHIBIT+logic+gate+properties+of+L"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo901676s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901676s%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DR.%26aulast%3DRamanujam%26aufirst%3DB.%26aulast%3DAcharya%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DC.%2BP.%26atitle%3DLower%2520rim%25201%252C3-di%257Bbis%25282-picolyl%2529%257Damide%2520derivative%2520of%2520calix%255B4%255Darene%2520%2528L%2529%2520as%2520ratiometric%2520primary%2520sensor%2520toward%2520Ag%252B%2520and%2520the%2520complex%2520of%2520Ag%252B%2520as%2520secondary%2520sensor%2520toward%2520Cys%253A%2520experimental%252C%2520computational%252C%2520and%2520microscopy%2520studies%2520and%2520INHIBIT%2520logic%2520gate%2520properties%2520of%2520L%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D8181%26epage%3D8190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Gezginci, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzblau, S. G.</span><span> </span><span class="NLM_article-title">Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1560</span><span class="NLM_x">–</span> <span class="NLM_lpage">1563</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000350w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1560-1563&author=M.%E2%80%89H.+Gezginciauthor=A.%E2%80%89R.+Martinauthor=S.%E2%80%89G.+Franzblau&title=Antimycobacterial+activity+of+substituted+isosteres+of+pyridine-+and+pyrazinecarboxylic+acids.+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm000350w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000350w%26sid%3Dliteratum%253Aachs%26aulast%3DGezginci%26aufirst%3DM.%25E2%2580%2589H.%26aulast%3DMartin%26aufirst%3DA.%25E2%2580%2589R.%26aulast%3DFranzblau%26aufirst%3DS.%25E2%2580%2589G.%26atitle%3DAntimycobacterial%2520activity%2520of%2520substituted%2520isosteres%2520of%2520pyridine-%2520and%2520pyrazinecarboxylic%2520acids.%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1560%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Ji, J.; Lee, C.-L.; Sippy, K. B.; Li, T.; Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Oxadiazole Derivatives as Neuronal Nicotinic Acetylcholine Receptor Ligands and a4b2 pos. Allosteric Modulators and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases</span>. 2008-134678 20080269236, 20080606,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Ji&author=C.-L.+Lee&author=K.+B.+Sippy&author=T.+Li&author=M.+Gopalakrishnan&title=Oxadiazole+Derivatives+as+Neuronal+Nicotinic+Acetylcholine+Receptor+Ligands+and+a4b2+pos.+Allosteric+Modulators+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%26atitle%3DOxadiazole%2520Derivatives%2520as%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Ligands%2520and%2520a4b2%2520pos.%2520Allosteric%2520Modulators%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Sindkhedkar, M. D.; Desai, V. N.; Loriya, R. M.; Patel, M. V.; Trivedi, B. K.; Bora, R. O.; Diwakar, S. D.; Jadhav, G. R.; Pawar, S. S.</span><span> </span><span class="NLM_article-title">Preparation of Erythromycin Macrolides and Ketolides Having Antimicrobial Activity</span>. 2007-IB2405 2008023248, 20070822,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+D.+Sindkhedkar&author=V.+N.+Desai&author=R.+M.+Loriya&author=M.+V.+Patel&author=B.+K.+Trivedi&author=R.+O.+Bora&author=S.+D.+Diwakar&author=G.+R.+Jadhav&author=S.+S.+Pawar&title=Preparation+of+Erythromycin+Macrolides+and+Ketolides+Having+Antimicrobial+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSindkhedkar%26aufirst%3DM.%2BD.%26atitle%3DPreparation%2520of%2520Erythromycin%2520Macrolides%2520and%2520Ketolides%2520Having%2520Antimicrobial%2520Activity%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Romeiro, L. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, M. d. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Silva, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, A. L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nascimento, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibirica, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C. A. M.</span><span> </span><span class="NLM_article-title">Discovery of LASSBio-772, a 1,3-benzodioxole <i>N</i>-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking properties</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3000</span><span class="NLM_x">–</span> <span class="NLM_lpage">3012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1016%2Fj.ejmech.2011.04.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=21549456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVOrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3000-3012&author=L.+A.+S.+Romeiroauthor=M.+d.+S.+Ferreiraauthor=L.+L.+da+Silvaauthor=H.+C.+Castroauthor=A.+L.+P.+Mirandaauthor=C.+L.+M.+Silvaauthor=F.+Noelauthor=J.+B.+Nascimentoauthor=C.+V.+Araujoauthor=E.+Tibiricaauthor=E.+J.+Barreiroauthor=C.+A.+M.+Fraga&title=Discovery+of+LASSBio-772%2C+a+1%2C3-benzodioxole+N-phenylpiperazine+derivative+with+potent+alpha+1A%2FD-adrenergic+receptor+blocking+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-Adrenergic receptor blocking properties</span></div><div class="casAuthors">Romeiro, Luiz A. S.; Ferreira, Marcos da Silva; da Silva, Leandro L.; Castro, Helena C.; Miranda, Ana L. P.; Silva, Claudia L. M.; Noel, Francois; Nascimento, Jessica B.; Araujo, Claudia V.; Tibirica, Eduardo; Barreiro, Eliezer J.; Fraga, Carlos A. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3000-3012</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We described herein the discovery of 1-(2-(benzo[d] [1,3]dioxol-6-yl)ethyl)-4-(2-methoxyphenyl) piperazine (LASSBio-772), as a novel potent and selective alpha 1A/1D adrenoceptor (AR) antagonist selected after screening of functionalized N-phenylpiperazine derivs. in phenylephrine-induced vasoconstriction of rabbit aorta rings.  The affinity of LASSBio-772 for alpha 1A and alpha 1B AR subtypes was detd. through displacement of [3H]prazosin binding.  We obtained Ki values of 0.14 nM for the alpha 1A-AR, similar to that displayed by tamsulosin (K i = 0.13 nM) and 5.55 nM for the alpha 1B-AR, representing a 40-fold higher affinity for alpha 1A-AR.  LASSBio-772 also presented high affinity (K B = 0.025 nM) for the alpha 1D-AR subtype in the functional rat aorta assay, showing to be equipotent to tamsulosin (K B = 0.017 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2o5fIs2Ji_rVg90H21EOLACvtfcHk0lg8GmOcASJIJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVOrtr8%253D&md5=2a62b6c9dd4252c69b030b23da8c559f</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.04.032%26sid%3Dliteratum%253Aachs%26aulast%3DRomeiro%26aufirst%3DL.%2BA.%2BS.%26aulast%3DFerreira%26aufirst%3DM.%2Bd.%2BS.%26aulast%3Dda%2BSilva%26aufirst%3DL.%2BL.%26aulast%3DCastro%26aufirst%3DH.%2BC.%26aulast%3DMiranda%26aufirst%3DA.%2BL.%2BP.%26aulast%3DSilva%26aufirst%3DC.%2BL.%2BM.%26aulast%3DNoel%26aufirst%3DF.%26aulast%3DNascimento%26aufirst%3DJ.%2BB.%26aulast%3DAraujo%26aufirst%3DC.%2BV.%26aulast%3DTibirica%26aufirst%3DE.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DFraga%26aufirst%3DC.%2BA.%2BM.%26atitle%3DDiscovery%2520of%2520LASSBio-772%252C%2520a%25201%252C3-benzodioxole%2520N-phenylpiperazine%2520derivative%2520with%2520potent%2520alpha%25201A%252FD-adrenergic%2520receptor%2520blocking%2520properties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3000%26epage%3D3012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Weingarth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raouafi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jouvelet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodenhausen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boujlel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schollhorn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekely, P.</span><span> </span><span class="NLM_article-title">Revealing molecular self-assembly and geometry of non-covalent halogen bonding by solid-state NMR spectroscopy</span> <span class="citation_source-journal">Chem. Commun. (Cambridge, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">5981</span><span class="NLM_x">–</span> <span class="NLM_lpage">5983</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1039%2Fb813237b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=19030559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSqtbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=5981-5983&author=M.+Weingarthauthor=N.+Raouafiauthor=B.+Jouveletauthor=L.+Dumaauthor=G.+Bodenhausenauthor=K.+Boujlelauthor=B.+Schollhornauthor=P.+Tekely&title=Revealing+molecular+self-assembly+and+geometry+of+non-covalent+halogen+bonding+by+solid-state+NMR+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing molecular self-assembly and geometry of non-covalent halogen bonding by solid-state NMR spectroscopy</span></div><div class="casAuthors">Weingarth, Markus; Raouafi, Noureddine; Jouvelet, Benjamin; Duma, Luminita; Bodenhausen, Geoffrey; Boujlel, Khaled; Schollhorn, Bernd; Tekely, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">5981-5983</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report a new spectroscopic fingerprint of intermol. contacts in halogen bond-driven self-assembling aggregates and a precise detn. of intermol. N···I distances in microcryst. samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSwnZRkFpOJLVg90H21EOLACvtfcHk0lg-dtwgL8qQpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSqtbzL&md5=27725228a7c33a19219fec32d29b681a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2Fb813237b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb813237b%26sid%3Dliteratum%253Aachs%26aulast%3DWeingarth%26aufirst%3DM.%26aulast%3DRaouafi%26aufirst%3DN.%26aulast%3DJouvelet%26aufirst%3DB.%26aulast%3DDuma%26aufirst%3DL.%26aulast%3DBodenhausen%26aufirst%3DG.%26aulast%3DBoujlel%26aufirst%3DK.%26aulast%3DSchollhorn%26aufirst%3DB.%26aulast%3DTekely%26aufirst%3DP.%26atitle%3DRevealing%2520molecular%2520self-assembly%2520and%2520geometry%2520of%2520non-covalent%2520halogen%2520bonding%2520by%2520solid-state%2520NMR%2520spectroscopy%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2008%26spage%3D5981%26epage%3D5983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Fenteany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm400221d&amp;key=10.1126%2Fscience.7732382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm400221d&amp;key=7732382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVGitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1995&pages=726-731&author=G.+Fenteanyauthor=R.+F.+Standaertauthor=W.+S.+Laneauthor=S.+Choiauthor=E.+J.+Coreyauthor=S.+L.+Schreiber&title=Inhibition+of+proteasome+activities+and+subunit-specific+amino-terminal+threonine+modification+by+lactacystin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin</span></div><div class="casAuthors">Fenteany, Gabriel; Standaert, Robert F.; Lane, William S.; Choi, Soongyu; Corey, E. J.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">5211</span>),
    <span class="NLM_cas:pages">726-31</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">3H-labeled lactacystin was used to identify the 20 S proteasome as its specific cellular target.  Three distinct peptidase activities of this enzyme complex (trypsin-like, chymotrypsin-like, and peptidylglutamylpeptide hydrolyzing activities) were inhibited by lactacystin, the 1st 2 irreversibly and all at different rates.  None of 5 other proteases were inhibited, and the ability of lactacystin analogs to inhibit cell cycle progression and induce neurite outgrowth correlated with their ability to inhibit the proteasome.  Lactacystin appeared to modify covalently the highly conserved N-terminal Thr residue of the mammalian proteasome subunit X (also called MB1), a close homolog of the LMP7 proteasome subunit encoded by the major histocompatibility complex.  This Thr residue may therefore play a catalytic role, and subunit X/MB1 may be a core component of an N-terminal-Thr protease activity of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2_DiZBqzR7Vg90H21EOLACvtfcHk0lg-dtwgL8qQpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVGitrg%253D&md5=6e3cf44432ad42b1aa17d246873292b9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1126%2Fscience.7732382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7732382%26sid%3Dliteratum%253Aachs%26aulast%3DFenteany%26aufirst%3DG.%26aulast%3DStandaert%26aufirst%3DR.%2BF.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DInhibition%2520of%2520proteasome%2520activities%2520and%2520subunit-specific%2520amino-terminal%2520threonine%2520modification%2520by%2520lactacystin%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1995%26volume%3D268%26spage%3D726%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Fenteany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Lactacystin, proteasome function, and cell fate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">8545</span><span class="NLM_x">–</span> <span class="NLM_lpage">8548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=8545-8548&author=G.+Fenteanyauthor=S.+L.+Schreiber&title=Lactacystin%2C+proteasome+function%2C+and+cell+fate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFenteany%26aufirst%3DG.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DLactacystin%252C%2520proteasome%2520function%252C%2520and%2520cell%2520fate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D8545%26epage%3D8548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lg-dtwgL8qQpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Eng, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, J. R.,  III.</span><span> </span><span class="NLM_article-title">An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database</span> <span class="citation_source-journal">J. Am. Soc. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks">[<a href="/doi/10.1016/1044-0305%2894%2980016-2" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm400221d&amp;key=1%3ACAS%3A528%3ADyaK2MXhvF2htLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=976-989&author=J.+K.+Engauthor=A.+L.+McCormackauthor=J.+R.+Yates&title=An+approach+to+correlate+tandem+mass+spectral+data+of+peptides+with+amino+acid+sequences+in+a+protein+database"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database</span></div><div class="casAuthors">Eng, Jimmy K.; McCormack, Ashley L.; Yates, John R., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society for Mass Spectrometry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">976-89</span>CODEN:
                <span class="NLM_cas:coden">JAMSEF</span>;
        ISSN:<span class="NLM_cas:issn">1044-0305</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A method to correlate the uninterpreted tandem mass spectra of peptides produced under low energy (10-50 eV) collision conditions with amino acid sequences in the Genpept database has been developed.  In this method the protein database is searched to identify linear amino acid sequences within a mass tolerance of ±1 u of the precursor ion mol. wt.  A cross-correlation function is then used to provide a measurement of similarity between the mass-to-charge ratios for the fragment ions predicted from amino acid sequences obtained from the database and the fragment ions obsd. in the tandem mass spectrum.  In general, a difference >0.1 between the normalized cross-correlation functions of the first- and second-ranked search results indicates a successful match between sequence and spectrum.  Searches of species-specific protein databases with tandem mass spectra acquired from peptides obtained from the enzymically digested total proteins of E. coli and S. cerevisiae cells allowed matching of the spectra to amino acid sequences within proteins of these organisms.  The approach described in this manuscript provides a convenient method to interpret tandem mass spectra with known sequences in a protein database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-W7KmqWaYm7Vg90H21EOLACvtfcHk0lhE0CxAa5ZfBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhvF2htLw%253D&md5=1a47bd23e76df9208ffdab41baed1880</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F1044-0305%2894%2980016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1044-0305%252894%252980016-2%26sid%3Dliteratum%253Aachs%26aulast%3DEng%26aufirst%3DJ.%2BK.%26aulast%3DMcCormack%26aufirst%3DA.%2BL.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26atitle%3DAn%2520approach%2520to%2520correlate%2520tandem%2520mass%2520spectral%2520data%2520of%2520peptides%2520with%2520amino%2520acid%2520sequences%2520in%2520a%2520protein%2520database%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D1994%26volume%3D5%26spage%3D976%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruikshank, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destree, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melandri, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plamondon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. L.</span><span> </span><span class="NLM_article-title">Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=182-188&author=L.+R.+Dickauthor=A.+A.+Cruikshankauthor=A.+T.+Destreeauthor=L.+Grenierauthor=T.+A.+McCormackauthor=F.+D.+Melandriauthor=S.+L.+Nunesauthor=V.+J.+Palombellaauthor=L.+A.+Parentauthor=L.+Plamondonauthor=R.+L.+Stein&title=Mechanistic+studies+on+the+inactivation+of+the+proteasome+by+lactacystin+in+cultured+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DCruikshank%26aufirst%3DA.%2BA.%26aulast%3DDestree%26aufirst%3DA.%2BT.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DMcCormack%26aufirst%3DT.%2BA.%26aulast%3DMelandri%26aufirst%3DF.%2BD.%26aulast%3DNunes%26aufirst%3DS.%2BL.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DParent%26aufirst%3DL.%2BA.%26aulast%3DPlamondon%26aufirst%3DL.%26aulast%3DStein%26aufirst%3DR.%2BL.%26atitle%3DMechanistic%2520studies%2520on%2520the%2520inactivation%2520of%2520the%2520proteasome%2520by%2520lactacystin%2520in%2520cultured%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D182%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i82"><a href="/doi/suppl/10.1021/jm400221d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36802"></div></div></div></div></div><hr /></hr><p class="last">(i) Synthetic protocols and characterization for libraries <b>5</b> and <b>10</b> and compounds <b>15</b>, <b>18a</b>,<b>b</b>, <b>20</b>–<b>27</b> (except <b>23</b>); (ii) scanned NMR spectra, HPLC, HRMS, and LC–MS reports for <b>1</b>, <b>11x</b>, <b>11aa</b>, <b>11ab</b>, <b>11ac</b>, <b>11ad</b>, <b>11ae</b>, <b>11af</b>, <b>11ah</b>, <b>11al</b>, <b>11am</b>, <b>11an</b>, <b>11ao</b>, <b>11ap</b>, <b>12d</b>, <b>12e</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400221d/suppl_file/jm400221d_si_001.pdf">jm400221d_si_001.pdf (5.76 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400221d&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm400221d%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400221d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799794e5d1b3de3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
